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SUMMARY
Lactoferrin is a non-haem iron binding glycoprotein present in virtually all 
mammalian body fluids, especially milk, as well as being secreted from the 
secondary granules of activated neutrophils. It is structurally similar to the 
plasma iron transport protein transfenin, and shares with it the ability to 
bind reversibly two fenic ions per molecule of the protein. This work is 
undertaken to investigate the possible role of lactoferrin in iron transport 
and the mechanism of iron transfer involved. The transfer of iron to the 
cells by transfenin occurs by a mechanism involving binding to a specific 
receptor followed by endocytosis, during which iron is retained by the cell 
and the receptor is recycled. Assuming that lactofenin could deliver its iion 
utilising a similar pathway, this work has been focussed to study the 
interactions of lactofenin with a promonocytic cell line, U937. Binding 
studies have shown that both lactoferrin and transfenin could bind to these 
cells. There are however some fundamental differences in the binding 
pattern. The total binding of lactofenin to the cells was about ten times 
greater than total binding of transferrin but most of the lactoferrin binding 
was non-specific. In contrast most of transfenin binding occuned via a 
specific receptor. Nevertheless the number of specific binding sites on the 
cell is similar for both proteins (Lf, 3.0 x 10^; Tf, 1.9 x 10^) with the 
dissociation constant for the specific binding of lactofenin (83 nM) 4-fold 
lower than that for transferrin (21 nM). Human lactofenin did not inhibit 
binding of bovine lactofenin or human transferrin, and vice versa, 
suggesting different binding sites exist for each protein. In addition its 
binding was not inhibited by 30 mM glucose or fucose, nor by incubating 
the cells with heparinase.
XXI
Two main biological effects that follow protein binding have been studied. 
The fii'st is non uptake from each protein; while transferrin was 
internalised, and accumulated intracellulaiiy in the presence of 3 mM 
prhnaquine, lactoferrin on the other hand did not release its iron to the cell 
nor was it internalised. A slow apparent uptake of iron observed from 
lactoferrin probably resulted from transfer of ^^Fe from lactofenin to 
unlabelled tiansfenin during culture. Bound lactofemn, but not tiansferrin, 
was found to release its hon to the exti'acelluiai' medium. The second effect 
of lactoferrin binding that was studied is its iion scavenging activity. 
Lactofenin inhibited cellular uptake of hon irom fenic nitiilotriacetate 
(59FeNTA) but not from tiansfenin, suggesting that it may regulate uptake 
of potentially toxic non-transfenin-bound hon.
Another area of contioversy sunounding lactofenin function is its role in 
iron absorption. As well as the lactofenin interactions with a monocytic 
cell line, this work has also included interaction with an enterocyte-like cell 
line, Caco-2. Transport of lactoferrin-bound hon across differentiated 
monolayer cultures of these cells grown in bicameral chambers was similar 
to that of ferric citrate, while transport of transfenin-bound hon was lower. 
Lactofenin and tiansfenin themselves were not transported, although some 
proteolytically degraded material did cross the monolayer. This study has 
been reinforced by measurement of plasma lactofemn levels in newly born 
infants undergoing different feeding regimes taken as a variable affecting 
these levels. This work has shown that plasma lactofemn levels of breast 
fed infants are not significantly different from those of formula fed, 
suggesting that in the newly born, when the levels of endogenous hon are 
adequate, lactofenin is not itself transported to the chculation, and may 
instead function as a regulator of hon absorption.
xxii
Taken together all these findings, it can be concluded that lactofenin, unlike 
transfenin, is not an important hon donor to monocytic cells, nor does it 
enhance hon transport across the mucosal cells. Lactoferrin may instead 
serve to regulate uptake of hon in time of adequacy or from other sources 
which may otherwise be hai'mful to the cells.
xxui
CHAPTER ONE
REVIEW OF LITERATURE
PART ONE: REVIEW OF LITERATURE ON TRANSFERRIN AND 
LACTOFERRIN
1.1.1 GENERAL ASPECTS OF IRON METABOLISM
Iron is an essential element for all forms of life with the possible exception 
of lactic acid bacteria (Neilands,]1981), It is required for normal cellulai' 
functions as iron is involved in numerous key biochemical reactions 
which govern the cell's metabolism. In man, most of the iron plays an 
important role as a component of haemoglobin and myoglobin involved in 
oxygen transport. However the smaller amount that occurs in the enzyme 
systems which catalyse the electron transfer and respiration reactions are 
vital for cell viability. Iron is also an essential component of proteins and 
enzymes that participate in the oxidation-reduction reactions other than 
those comprising cellular respiration which include those that protect 
against reactive oxygen species.
The total quantity of iron in the adult human male is about 4 g. Sixty 
percent of this iron is found in haemoglobin, 14 % in the myoglobin and 
tissue enzymes and most of the rest (21%) is stored as ferritin and 
haemosiderin, principally in the reticuloendothelial cells and hepatocytes 
(Morns 1987). The total body iron of a healthy mature newborn is in the 
range of 250-280 mg which is about 6 % of the total iron content of the 
adult (Heubers and Finch, 1987). In the infant, a higher percentage of iron 
is found in haemoglobin (75%) with less iron being stored (15 %) as 
compaied to the adult.
Daily loss of iron in the adult male is about 1 mg and this can be reduced 
to 0.5 mg in the iron-deficient individual. In the infant daily loss is about
1
0.1 mg (Bothwell et a /.,1958). Physiological iron losses occur thi'ough 
acute bleeding from the intestine, iron in bile, exfoliation of iron- 
containing mucosal cells from the intestine, urinary iron and skin 
desquamation (Bothwell et a/., 1971). The amount of iron lost is actually 
small but it must be compensated by intake of dietary iron in similar 
amount in order to maintain a normal iron balance. An unfavourable 
balance will eventually lead to iron deficiency resulting in inadequate 
levels of one or more of the essential iion complexes. Excess of intake 
over excretion will lead to increasing accumulation of iron which can 
seriously impair cellular function. It has been estimated that more than 500 
million people in the world aie iron-deficient and several million are 
iron-overload (Halliwell and Gutteridge, 1985). Iron overload is especially 
dangerous since it can lead to the presence of forms of iron that can catalyse 
free radical formation which has been implicated to be involved in many 
degenerative diseases. Thus not only must sufficient iron be present for 
normal metabolic processes, but its uptake, transport and intermediary 
metabolism must be carefully controlled in order to prevent inappropriate 
iron loading and cellular and subcellular distribution.
The importance of iron derives from its ability to exist in two stable and 
interchangeable forms, ferions (Fe^+) and fenic (Fe^+). Under 
physiological pH and ionic strength, Fe^+ predominates. Since it is a 
strongly hydrolytic ion with low solubility it tends to polymerise in aqueous 
environment (Halliwell and Gutteridge, 1985). Free iron also catalyses 
hydroxyl-radical-mediated oxidative damage whether within cells or in the 
extracellular fluid. In view of the solubility problems and the danger of 
free radical formation, free Fe^+ is present in exceedingly low 
concentration in biological fluids. Hence iron is bound by a number of
proteins which convert it to a stable and soluble form. These iron-binding 
proteins can be divided into two main categories (Brock, 1989):
(1) haem proteins such as haemoglobin and myoglobin, cytochromes and a 
variety of enzymes
(2) iron transport proteins (transfenins) and iron storage proteins 
(ferritin and hemosiderin).
This review will only concentrate on transferrins with special emphasis on 
lactoferrin.
1.1.2 TRANSFERRINS
1.1.2.1 Introduction
Transferrins are a group of iron-binding proteins which share the 
property of reversibly binding two fenic ions per molecule of protein 
( Aisen and Listowsky, 1980 ; Morgan, 1981 ; Brock, 1985). Members of 
the group which are all glycoproteins include the following (de Jong et aL, 
1990):
(i) transferrin (siderophilin), the iron-transport protein in the blood of 
vertebrates and some invertebrates
(ii) ovotransferrin (conalbumin) of bird and reptile oviduct secretions 
and egg whites
(iii) lactoferrin (lactotransferrin), found in mammalian extraeellular 
secretions especially milk and in the secondary granules of neutrophilic 
leucocytes
(iv) melanotiansferrin, an integral membrane protein of human malignant 
melanoma cells.
The term tiansfenin is now universally used for the iron-transport protein
of plasma, in preference to the earlier name of siderophilin, whereas
lactofenin is now almost always used for the ii'on-binding protein of
milk, other secretions and neutrophil granules, as the alternative name
is
lactotiansfenin implies an iron transport function which^at best only 
doubtfully established (Brock, 1985). Hence in the following review, 
plasma transfeirin will be refeired to simply as transferrin and lactoferrin 
will be used instead of lactotransfeiTin.
1.1.2.2 Occurence and Synthesis of Transferrin and Lactoferrin
Transfeirin was first isolated by Schade and Caroline (1946) from 
human plasma. On average, the serum level of transferrin is between 2-4 
mg/ml at an iion saturation of about 30 %. However, both these figures 
vary considerably in pathological conditions (Morgan, 1981). Increased 
plasma tiansferrin concentrations aie found in childhood, pregnancy, iron- 
deficiency anaemia and after oestrogen administration. Decreased plasma 
transfeirin levels aie found in conditions associated with iron overload, 
protein malnutiition and many other disorders. These changes are probably 
due to increased and decreased rates of tiansfeirin synthesis respectively.
Lactofenin was first isolated about thirty years ago by two groups of 
investigators, Groves (1960) who isolated lactofenin from bovine miUc and 
Johansson (1960) from human milk. Lactofenin in contrast to tiansfeirin 
is scarcely detectable in the serum with an average concentration of less 
than 1 mg/ml (Bennet and Mohla, 1976). In milk however, it is present at 
high concentrations ranging from about 7 mg/ml in colostrum to about 1 
mg/ml in mature milk though it may rise again towards the end of lactation 
(Masson and Hereman, 1970; Hennart et a l ,  1991). The amount of iron in 
milk on the other hand is only 0.1-0.3 mg/ml which would saturate 
lactofenin at most by 20 %. However, it is found that actually only 6-8 % 
of the ii'on binding capacity of lactofenin in human milk is utilised 
(Lonnerdal, 1990). Possible reasons suggested for this finding were firstly, 
low moleculai' weight ligands such as citrate which are able to chelate iron 
aie present at considerably higher concentiation than lactofenin and 
secondly, most of the iron is present in the lipid fraction and in the casein 
micelles which is inaccessible for ligand exchange.
Lactofenin levels in the cow ai'e also highest in the colostrum (0.83 mg/ml) 
but the concentration in mid-lactation milk is very much lower, only about 
0.1 mg/ml (Sanchez et a l ,  1988). Apait from milk, lactoferrin is also found 
in a wide range of external secretions such as seminal fluid, tears, sweat, 
nasal and genital secretions (Masson et a l ,  1966) as well as in the 
secondary granules of neutrophils (Masson et aL, 1969). In most cases 
lactofenin appears to be largely devoid of iron as in the case of lactoferrin 
in milk.
The principal site of tiansfenin synthesis is the liver where it is produced 
by hepatocytes (Morgan, 1981), as shown in studies of isolated rat 
hepatocyte suspension using immunological techniques (Jeejebhoy et aL,
1975) and by the presence of specific inRNA in chick hepatocytes 
(McKnight et a l ,  1980). Synthesis also occurs in other tissues such as 
placenta, Sertoli cells and the central nervous system (Skinner et ah, 1984). 
In the fetus, transferrin synthesis may occur in the yolk sac (Gitlin and 
PeiTicelli, 1970). The rate of synthesis vaiies considerably in pathological 
states. The major factors which are known to influence transfenin 
synthesis are the storage iion levels, certain hormones (especially 
oestrogen) and nutritional status.
Lactofenin is synthesised in many of the secretory organs in which it is 
found (Masson and Heremans 1970). The iron nutritional status of the 
mother has no diiect influence on milk content of lactoferrin (Hennart et al„ 
1991; Prentice et a l ,  1989). However, lactoferrin levels decreased in 
conditions of overall malnutiition (Houghton et aL, 1985), which suggests 
that protein energy malnutrition rather than iion defeciency influences 
lactofenin synthesis in the mammary gland.
1.1.3 STRUCTURE OF TRANSFERRIN AND LACTOFERRIN
1.1.3.1 General Aspects
Transfenin and lactofenin are both monomeric glycoproteins with 59% 
homology in their amino acid sequence (Metz-Boutigue et al., 1984); 
(Fig.l). The single polypeptide chain of human serum transfenin 
consists of 679 amino acid residues, which together with two 
oligosaccharide chains gives a calculated molecular weight of 79,570 
(MacGillivray et a l ,  1983). The polypeptide chain of human 
lactofenin consists of 692 amino acid residues with a molecular 
weight of 80,600 (Rey et a l ,  1990; Powell and Odgen, 1990)-
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FIG. 1: Amino acid sequence of human lactofemn(LTFXRey et al, 1990) 
and human transfemn(STFXMacGillivray et a l ,  1983)
Transfenin has an isoelectiic point in the range of 5.4-5.9 with diferric 
transfenin having a slightly higher pi than apotransferrin (Keller and 
Fennel, 1959; Hovanessian and Awdeh, 1976). Lactofenin has a much 
higher pi than transfenin with a value in the range 8.4-9.0 (Van Snick and 
Masson, 1976). This is due to the presence of a large number of basic 
residues at the surface of the lactofenin molecule (Anderson et a l ,  1989). 
Because of its high isoelectiic point, lactofenin displays a marked 
tendency to complex with other molecules.
1,1,3.2 Overall Molecular Organisation
The overall molecular organisation of lactofenin molecule as described by 
Anderson et al. (1987; 1989; Fig. 2) is essentially the same as that of rabbit 
transfenin (Bailey et a l ,  1988). The three-dimensional structure of human 
milk lactofenin as determined by X-ray crystallography at 3.2 Â resolution 
(Anderson et al., 1989) revealed that the single polypeptide chain is folded 
into two lobes. The two lobes are refened to as the N-lobe, comprising the 
N-terminal half of the molecule and the C-lobe consisting the C-terminal 
half. The N-lobe is made up of residues 1-332 and the C-lobe constitutes 
residues 344-703.
The shape of each lobe can be described as a prolate ellipsoid (Taylor et a l ,  
1983) of approximate dimensions 55 x 35 x 35 A . Theii* axes run roughly 
anti-parallel to each other at an angle of 150° between them. One lobe is 
superimposed on the other by a rotation of about 180°, followed by a 
translation of 25 A but the equivalent parts of the two lobes do not 
superimpose on each other. The two lobes are connected by a three turn a- 
helix consisting of residues 333-343.
c  -L obe
FIG. 2: Schematic diagram of the complete human lactoferrin molecule. 
The positions of carbohydrate attachment are marked: T, human transferrin; 
L, human lactoferrin. The disulphide bridges are indicated by solid lines, 
and the iron- and bicarbonate- (or carbonate) binding sites are indicated by 
filled or open circles, respectively (From Baker et a i ,  1987).
In transfenin, the connecting peptide is two residues longer and includes 
thiee prolines. Both lobes have very similar structures with at least 40 of 
their amino acid sequence being homologous. Each lobe is further 
organised into two dissimilar' domains, having about 160 residues each. 
Thus the total number of domains in the molecule is four; N l, N2, C l 
and 0 2 .
The basic folding pattern of secondary structures is illustrated in Fig.3 
(Anderson et aL, 1989, Bailey et aL, 1988). A similar folding pattern is 
obsei'ved within the N- and C- lobes. Each domain consists of a central 
core of five or six iiTegular twisted 6-sheets, connected to each other by 
helices and loops. Helices and mixed 6-sheet make up about 41% and 24% 
respectively of the secondary structures. The chain starts in domain N l and 
initially folds to form the first four stiands in a 6-sheet; a, b, c and d which 
are connected through helices 1,2 and 3 respectively. From strand d, the 
chain traverses into the lower domain N2, where it folds into 6-sheet 
consisting of strands e, f, g, h and i. These strands are connected to each 
other by helices 4, 5, 6 , 7, 8 and 8a. After strand i, the chain returns to 
domain N l through strand j where the folding in domain N l is completed 
by helix 9, (3-sheet k and terminate as helices 10 and 11. Helix 12 then 
connects the N-lobe to the C-lobe.
Sbands of |3-sheet e, i and j together with helices 10 and 11 form an 
important part of the lobe. These striictures not only connect the two 
domains but they provide a flexible hinge which allows movements of the 
two domains with respect to one another. This will result in the opening 
and closing of the iron binding cavity.
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FIG. 3: Schematic representation of the folding pattern for the N-lobe and 
C-lobe of human lactoferrin. Helices are shown as cylinders; ^-strands as 
arrows. (From Anderson e ta l ,  1989).
1 1
1.1.3.3 Disulphide Bridges
There are 16 disulphide bridges in lactoferrin and 19 in transferrin 
(Williams, 1982), The disulphide bridges in both proteins are located in 
quite homologous positions. In lactoferrin six disulphide bridges are 
located in the N-lobe and ten in the C-lobe. There are no disulphide bridge 
linking the two lobes. The fact that the C-lobe contains 4 additional 
disulphide bridges could explain the stability towards dénaturation and 
proteolysis.
1.1.3.4 Iron and Anion Binding Sites
There are two iron-binding sites per molecule of transfenin or 
lactoferrin. The iron site is found in each lobe of the protein molecule. 
They are located in the interdomain cleft about 4.2 nm apart. The iron 
atoms are deeply buried in the cleft at least 1 nm from the exterior of 
the molecule. They are sunounded by a hydrophilic environment with 
numerous polar' side chains in the vicinity.
The coordination sphere of the iron atom is the same for both lobes. Each 
iron atom is coordinated to four protein ligands and two non-protein 
ligands. The protein ligands are provided by one cartoxylate oxygen, two 
phenolate oxygens and one imidazole nitrogen. This has resulted in the hon 
site being highly anionic and easily attracts cations with a high positive 
charge. Therefore Fe^+ ions which favour anionic oxygen ligands bind 
more strongly (binding constant: 10 °^ M-i) than Fe^+ (binding constant: 10  ^
) (Baker et aL, 1987).
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In the N“lobe of lactofenin (Fig.4), the carboxylate oxygen is provided 
by Asp 60, two phenolate oxygens are side chains of Tyr 92 and Tyr 192, 
and His 253 provides the imidazole nitrogen. Asp 60 and Tyr 192 are trans 
to one another while Tyr 92 and His 253 occupy cis positions. In the C- 
lobe, the conesponding residues are Asp 395, Tyr 528, Tyr 435 and His 
597. All these ligands are widely spaced along the polypeptide chain.
The carboxylate group of Asp 60 in the N-lobe and Asp 395 in the C- 
lobe has a dual role. One oxygen is bound to iron while the other oxygen 
forms two hydrogen bonds linking domain 1 to domain 2. The other 
three protein ligands do not seem to be constrained by the surrounding 
protein structure and this has resulted in greater flexibility in the iron 
binding site.
Beside the four protein ligands, there are two remaining octahedral 
positions surrounding the iron atom which are filled by non-protein 
ligands. Binding of iron to lactoferrin and transferrin occurs with 
synergistic binding of a bicarbonate (or carbonate) (Bates and Schlabach, 
1975; Anderson et a l  1989). Kinetic and spectroscopic data indicate that 
binding of bicarbonate precedes iron binding. The role of bicarbonate in 
binding is probably two fold (Baker and Lindley, 1992). First, it neutralises 
positive charges which might otherwise repel ferric ion. Second, it partially 
prepares the iron binding site of the apoprotein by adding two more 
potential ligands (two carbonate oxygens) to the four protein ligands 
already present in the site.
Crystallographic refinement of lactoferrin structure at 2.8 Â (Anderson et 
al., 1989) has revealed that the carbonate fits perfectly in a pocket 
between the non and two positively charged groups, an arginine side
13
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Fig, 4: Schematic representation of the iron and anion-binding sites in 
lactoferrin (N-lobe) (from Anderson et a l ,  1989)
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and the N-terminus of helix 5. One oxygen of the carbonate is bound to 
kon and also forms a hydrogen bond with Arg 121. The second oxygen 
also binds to iion and forms a hydrogen bond with the peptide bond NH of 
residue 123. The thiid oxygen makes two hydrogen bonds with the NH of 
residue 124 and the side chain of Thi’ 117 (see Fig. 3).
1.1.3.5 Carbohydrate Moiety
Human transferrin and lactofenin contain approximately 6 % 
carbohydrate. They both have biantennary glycans of the N- 
acetyllactosaminic type (Spik, et al. 1982; Spik et al, 1985) (Fig. 5). 
However tiansfenin in addition possesses triantennary glycans, but the 
biantennary glycans are more prominent (Fig. 6). In tiansferrin, the 
glycans aie located in the C-lobe at residues 413 and 611. Both glycans are 
devoid of fucose residues. The glycans of lactoferrin from human milk on 
the other hand aie fucosylated. They are located in each lobe in 
homologous positions at residues 137 and 490 (Montieuil et al., 1985). 
However a later study by Derisbourg et al. (1990), revealed that both 
glycans in neutiophilic lactoferrin aie devoid of fucose residues just like 
in transferrin.
1.3.6 Metal Binding to Lactoferrin and Transferrin
In vivo, iron is the most important metal bound by tiansferrins. As 
mentioned earlier transferrin and lactoferrin are both capable of binding 
two ferric ions per molecule of protein. Hence transferrin and lactofenin 
may exist in the apo-, mono- (with either the N- or C-terminal binding 
sites occupied) and difeiric forms.
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G a U p i - 4 ) G l c N A c ( p i - 2 ) M a n ( a l - 6 )
NeuAc(a2-6)Gal(pl-4)GlcNAc(pl-2)Han{al-3)
• Ma n (p i - 4 )G lc HA ctp l -4 )G lc HA c( p i -N) As n
( a l - 6 )
F u c
NeuAc(a2-6)Gal{pi-4)GlcNAc(pi-2)Man(al-6),
HeuAc(a2-6)Gal(pi-4)GlcNAc(pi-2)Han(al-3)'
Fuc
( 1- 2 )
Gal(pl-4)GicNAc(pl-2)Man{al-6).
NeuAc(a2-6)Gal(pl-4)GlcNAc(pi-2)Han(al-3)
B
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Fuc
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Fig. 5: Structure of glycans of human lactoferrin with B being the
principle glycan (Spik et a l ,  1985)
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NeuAc ( a2 -6 )  Gal  ( B l - 4 )  GlcNAc (61-2  ) Man ( a l - 3 ) .
NeuAc(a2-6) Gal(6l-4)GlcNAc(6l-2)Man(al-6)
A
:Man(6l-4)GlcNAc(6l-4)GlcNAc(Sl)Asr
N euA G{a2-6)G al(6 l -4 )GlcNAc(B1-2)Man( a i - 3),
NeuAc(a2-6)Gal(61-4)GlcNAc(61-2)Man (al-6)  
NeuAc(a2-3) Gal (61-4) GlcNAc ( 6 l - 6 ) ^
:Man( 6 l -4 ) G l c N A c ( 6 1 - 4 ) G l c N A c ( 6 I ) Asr
NeuAc(02-3)Gal(6l-4)GlcNAc(6l-4)
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\Gal(6l-4)GlcNAc(6l-2)Man(01-3)
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(Gal(6 l-4))GlcNAc(61-6)
:Man(6 1-4)G l c N A c (61-4) G l c N A c ( 6 1 ) A s r
FIG. 6 ; Structure of glycans of human transferrin with A being the 
piincipie glycan (Spik et a l ,  1985).
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Apotransfeixin and apolactofenin aie coloiuiess but develop a red brown 
colour when iron is bound, giving Xmax at 465-470 nm.
Iron binding by transfenins varies with pH (Morgan, 1981). It is maximal 
at about pH 7.0. As the pH is reduced, the iron starts to dissociate from the 
molecule at about pH 6.5 and is completely dissociated by pH 4.5 for 
transfenin. Lactofenin, by virtue of its higher binding constant, retains its 
iron until the pH is reduced to about 2 (Masson and Heremans, 1968). 
Hence, under physiological conditions, the affinity constant for difenic 
transfenin is of the order 10^^  M -\ but this value decreases to less than 10 ®^ 
M'^ at pH 4.5. The affinity constant of lactofenin on the other hand is 26 
times greater than that of tiansfenin at pH 6.4 (Aisen and Leibman, 1972) 
Therefore, despite their high sequence identity and generally sunilar binding 
properties, lactofenin binds iron more strongly than tiansfenin and at 
distinctly lower pH values. This difference in iion binding may be critical 
to the different roles played by these two proteins.
Piinciotto and Zapolski (1975) observed a difference in binding affinities 
for iron between two sites of both proteins. Factors which influence 
preferential binding to either site depend not only on the binding affinities 
of the sites but also on pH and the nature of the iron donor (Brock, 1985). 
Thus, when nitiilotiiacetate is used as an iron donor to transferrin, the C- 
terminal site is preferentially occupied. With other donors including fenic 
citiate, feiTic oxalate, feiTous ammonium sulphate or ferric chloride, iron 
binding favours the N-terminal site even though the C-terminal site has a 
higher affinity constant (Zapolski and Piinciotto, 1977; Aisen et a l ,  1978; 
Evans and Williams, 1978).
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Recent work on the crystal stmctnre of human apolactoferrin at 2.8 Â 
resolution by Anderson et al, (1990), has shown that a substantial 
conformational change accompanies iron binding and release. In 
apolactoferrin, the N-lobe is in an open configuration, whereas the C-lobe 
is a closed configuration as in the iron-bound structure. The open 
sti'ucture is due to the opening of the interdomain cleft. This is brought 
about by a rotation of the N2 domain about a hinge at the back of the iron 
binding site (Fig. 7). The rotation axis lies almost exactly along the axis of 
helix 11. N2 domain rotates about 54 relative to domain N l causing the 
binding cleft to open wide.
The opening of the cleft exposes three basic side chains previously buried 
within it (Arg 121, Arg 210 and Lys 301). These side chains tend to attract 
the bicarbonate anion which is then bound to the N-terminus of helix 5. 
Four of the six metal ligands (Tyr 92, Tyr 192 and the two carbonate 
oxygens) are then in a position to bind the ferric ion to the N2 domain. 
Binding is completed by rotation of N2, elosing the cleft with Asp 60 and 
His 263 completing the coordination. Asp 60 further links the two 
domains by hydrogen bonding.
Upon iron binding the isoelectric point increases (Keller and Pennell, 
1959; Hovanessian and Awdeh, 1976). This causes molecules of different 
iron content to elute sequentially from DBAE cellulose columns with a 
gradient of increasing ionic strength (Lane, 1973). The structure of the 
protein molecule becomes more compact and as a result, the protein 
becomes less susceptible to proteolytic degradation (Brock et ah, 1976; 
Esparza and Brock, 1980).
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Fig. 7: Schematic representation of the N-lobe polypeptide chain fold
showing the conformational change between open (left) and closed (right) 
forms. An arrow marks the approximate hinge point in the two anti-parallel 
b-strands connecting the two domains (from Anderson et al., 1990)
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1.1,3 7 Metal and Anion Substitution
Transfenins are capable of binding a large number of other metal ions 
other than iron at the same binding site. Metal ions which have been found to 
bind to tiansfenin include divalent and tiivalent metal ions such as copper, 
vanadium, chromium, aluminium, cobalt, gallium, manganese, plutonium, 
indium, zinc, terbium, europium, platinum, americium and curium 
(reviewed by Huebers and Finch, 1987). Some of these cations, like 
gallium, bind with an affinity close to that of iron. Lanthanide ions also 
bind to tiansfenin but much more weakly.
Some iron chelates, such as nitrilotriacetate, can also act as synergistic 
anions. Substitution of oxalate for carbonate in the C-lobe of lactofenin 
has been shown to occur without any change to the overall protein 
structure (Baker and Lindley, 1992).
1.1.3.6 Comparison Between Lactoferrin and Transferrin Structures
The lactofenin structure is consistent with known structural data on 
tiansfenin. There is a high level of amino acid sequence homology 
between lactofenin and tiansfenin. The iron binding sites in both proteins 
are also similai'.
A comparison of the difenic human lactofenin and rabbit transferrin 
structures (Baker and Lindley, 1992), has revealed two interdomain 
interactions which differ between the two proteins. These 
interactions could account for the characteristic differences in binding 
properties of lactoferrin and transfenin. Firstly, a salt bridge across the 
N-lobe domain interface between Lys 301— Glu 216 exists in difenic
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lactoferrin but not in transferrin. An equivalent interaction does not occur 
in the C-lobe of lactoferrin either. Secondly, instead of a salt bridge, 
the conesponding Lys in transfenin (Lys 296) is differently oriented and 
makes close contact with another Lys (Lys 206) from other domain. The 
salt bridge is replaced by a hydrogen bond between Ser 298 and Glu 212. 
These two changes are close to the iron site in the hinge region and 
could account for the lower acid stability towards iron binding of the N-lobe 
of transfenin as compared to lactofenin.
Another difference between lactofenin and transferrin lies in the 
distribution and composition of the glycan chains. Those of lactofenin 
are being distributed one on each lobe, whereas for transferrin, both 
glycan chains are bound to the C-teiminal lobe only. Also as mentioned 
eaiiier, the glycans of milk lactofenin has terminal fucose residues but those 
of neutrophilic lactofenin like transfenin are devoid of fucose. Studies on 
the interaction of lactofenin with the small intestine receptor (Davidson 
and Lonnerdal, 1988), suggest that the fucosylated glycans on the 
carbohydrate chain of milk lactofenin are necessary for receptor 
recognition. However, Anderson et a l ,  (1989) have focussed attention 
on the fir st 55 residues of transferrin and the first 40 residues of lactoferrin, 
which contain at least nine basic side chains as the likely receptor binding 
region.
1.1.4 FUNCTIONS OF LACTOFERRIN AND TRANSFERRIN
1.1.4.1 Introduction
A number of biological functions have been proposed for transferrin and 
lactoferrin. Many of these are still controversial particularly in the case of
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lactoferrin. Functions of lactofenin and transferrin are dependent on the 
ability of the proteins to bind iron very tightly and reversibly. They both 
share the common function of controlling the levels of free iron in the 
biological fluids. While a major biological role as an iron transport and 
delivery protein has been established for transferrin, there is no well defined 
role for lactoferrin (Sanchez et a l, 1992). However both proteins have been 
implicated as bacteriostatic agents, aiding in the body's defences against 
bacterial infection. A role in the suppression of iron catalysed free-radical 
formation (Baldwin et a l ,  1984) has been proposed for lactoferrin. 
Although there are reports of receptors for lactoferrin on intestinal cells, it is 
not clear whether lactofemn plays a role in iron absorption. Lactoferrin has 
also been reported to stimulate growth of some cell lines but little is known 
about the mechanisms of growth stimulation.
1.1.4,2 Iron Donation to Cells
(a) Transferrin receptor (TfR)
It is now well accepted that iron donation is a major function of transferrin. 
Cells which requke kon express a receptor for transferrin which has been 
well characterised (Sutherland et a l ,  1981). Transferrin receptors are 
present on virtually all proliferating, differentiating, and haemoglobin- 
synthesizing cells (Trowbridge and Omary, 1981; lacopetta and Morgan, 
1983) (Fig. 8).
The major structural features of the transferrin receptor of different 
species, based on studies in human, mouse, rat and chicken cells 
are very similar' (reviewed by Dautiy-Varsat, 1986). The receptor is 
a tiansmembrane, homodimeric glycoprotein with a
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Fig. 8 : Structure of the transferrin receptor (from Dautry-Varsat, 1986).
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moleculai' weight of 180,000 dalton. The 90,000 dalton subunits, are 
covalently linked by a single disulphide bridge and can bind one transferrin 
molecule per subunit. Each subunit can be divided into three domains. The 
cytoplasmic N-terminal domain consists of 61 amino acids and is 
phosphorylated at residue Ser 24. The hydrophobic transmembrane domain 
which is inaccessible to proteolytic attack, consists of 28 residues; 14 
hydrophobic and 14 uncharged residues. This domain presumably contains 
the signal for tianslocation of the receptor across the membrane.
Cys 62 at the internal face of the cytoplasmic membrane, is acylated by a 
palmitate. These fatty acids aie thought to anchor the receptor 
hydrophobically to lipids in the plasma membrane of the cell. The rest of 
the amino acids (671 residues) make up the external domain. The 
disulphide bridges are formed between residues Cys 89 and Cys 98 with 
their homologues. The external domain is N-glycosylated at Asn 251, 317 
and 727.
TfR preferentially binds iron-containing hansfenin molecule rather than 
apotiansferrin. Affinity constants for binding of difenic tiansferrin 
molecule have been found in the range of 5 x 10^ - 2.3 x 10  ^M ^  depending 
on temperature, pH and cell type (Young and Aisen, 1980). Using the 
interaction of different fornis of ^^^I-labelled tiansfemn and rabbit 
reticulocytes, Young et a l  (1984) have found that the affinity constant for 
receptor binding is 4.6 x 10  ^ M  ^ for apotransferrin, 2.5 x 10? M-i for 
monoferric transfeiiin (C-terminal). 2.8 x 10'^  M-^ for monoferric (N- 
terminal), and 1.1 x 10^ M  ^ for diferic tiansferrin. It therefore seems that 
the amount of iron taken up depends on the number of each molecular’ 
species present.
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(b) Transferrin-to-Cell Cycle
In most mammalian cell types, the uptake of transi^TJ?^ tfon occurs by 
receptor mediated endocytosis (Theil and Aisen, 1987) (Fig. Once the 
transfeiiin has bound to its receptor, the tiansfenin-tiansferrin receptîkf 
TfR) complex accumulates in coated pits. Coated pits are specialised 
regions of the cell surface that mediate endocytosis of a variety of receptors 
and then extracellulai' ligands (Goldstein et a l ,  1985). These pits aie 
covered on the outer side with lattices of a fibrous protein, clathiin. Studies 
by lacopetta et a l  (1988) and Miller et a l  (1991) have shown that recycling 
receptors such as those for tiansferrin can influence the formation of coated 
pits and promote the growth of clathrin lattices.
The molecules present in the coated pits on the other hand can interact with 
the cytoplasmic domains of the receptor proteins that become concentrated 
above them (Pearse, 1987; Moiiis et a l ,  1989). An interaction between the 
ti'ansfeiTin receptor and these proteins has not been demonstrated but it has 
been shown that the ability of this receptor to internalise with high 
efficiency depends upon this interaction (Collawn et a l ,  1990). The 
cytoplasmic domain of the tiansfeiTin receptor has been suggested to 
contain a specific signal sequence located within amino acid residues 19-28 
that determines high efficiency endocytosis (lacopetta et a l ,  1988). Within 
1-2 min, the coated pits aie pinched off from the outer surface of the cell to 
be internalised as clathrin-coated vesicles. As the clathrin coated vesicles 
move deeper into the cytoplasm they rapidly lose their clathrin coats in an 
energy requiring process to form smooth surfaced vesicles.
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1987).
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The vesicles associate and diffuse to form an endosome, which has an 
internal pH of ai’ound 5-6.5 (van Renswoude et a l ,  1982). This results in 
protonation of the anion (COg^ or HCO3 ) in the binding site adjacent to the 
kon and provokes its release . It has been shown that methylamine, 
ammonium chloride and chloroquine, which increase vesicular pH, decrease 
the release of iron from the protein to the cell (Morgan, 1981), without 
inhibiting internalisation of tiansferrin. Other studies employing mutants of 
CHO cells which are defective in endosomal acidification, have 
demonstiated that such cells cannot remove iron from internalised 
tiansfenin (Klausner et al,  1983).
Eai’lier report by Fletcher and Huehns (1968) had suggested a 
nonhomogeneous Uansfer of kon from the two kon binding sites of 
transferrin with one binding site preferentially delivers kon to the erythron 
while the other supplies nonerythroid tissues. Further work has shown that 
kon release to the erythroid cells could occur from either mono- or difenric 
tiansferrin following an "all or none" phenomenon, leaving only 
apotiansferrin (de Jong, 1991). kon is subsequently transported into the 
cytoplasm, while apotransfeiiin remains bound to the TfR at the vesicular 
pH. As mentioned earlier, apotransfeiiin binds more strongly to the 
receptor at pH <6.5, so that when the recycling vesicles fuse with the 
plasma membrane at neutr al or slightly alkaline pH of the extracellular fluid 
or of the growth medium, apotransferrin starts to dissociate from its 
receptor and is now available for another endocytic cycle. This cycle may 
repeat as many as 300 times before TfR is degraded (Omary and 
Trowbridge, 1981).
The return of apoti'ansfeixin to the cell surface after having released its kon 
at 37 “C takes 7-15 min (Hopkins, 1985; Bleil and Bretscher, 1982,
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Hopkins and Trowbridge, 1983; Harding et a l ,  1983; lacopetta and 
Morgan, 1983; Watts, 1990). However in vitro studies showed that the rate 
of spontaneous dissociation of iron from transferrin at pH 5.0-5.5 is much 
too slow. When transferrin is bound to its receptor, the rate is substantially 
increased even when the pH is slightly increased (5.6-6.0) (Bali et a l ,  1991; 
Sipe and Murphy, 1991). Studies by Schwartz et a l ,  (1984), Stoorvogel et 
a l,  (1987) and Watts (1990) found that lysomotropic amines, chloroquine 
and primaquine inhibit exocytosis of internalised ligands including 
transferrin.
(c) Other Mechanisms o f Iron Uptake from Transferrin
Apart from the well established receptor mediated endocytosis, other 
mechanisms have been proposed for the uptake of iron from transferrin, 
particularly in hepatocytes. These mechanisms involve the release of iron 
from transfetTin to a plasma membrane component (Nunez et a l ,  1982). 
Two models have been proposed for the release of iron at the plasma 
membrane.
In the first model, difenic transferrin can be reduced once bound to its 
receptor by transmembrane NADH: ferricyanide oxidoreductase ( Crane et 
al,  1985) which has been located in several cell types including hepatocytes 
(Clark et a l ,  1982; Sun et a l ,  1985). The reduction of iron to the divalent 
state destabilises the transferrin-kon bond and favours its transport through 
the plasma membrane (Grohlich et a l ,  1977). Ferrous ion is trapped by 
appropriate plasma membrane iron ligands and subsequently internalised 
and taken up by the various biosynthetic pathways. Iron depleted 
transferrin is displaced from the receptor by diferric transferrin (Nunez et 
a/., 1983; ThorstensenandRomslo, 1988) (Fig. 10).
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Fig. 10: Model for the uptake of iron from transferrin by rat hepatocytes. 
Difenic transferrin binds to the transferrin receptor which is located in close 
proximity to the proton- and electron- pumping NADH:transferrin 
(feiiicyanide) oxidoreductase (I). The iron-transferrin bond is destabilised 
by proton fluxes, making ferric iron susceptible to reduction (II). Ferrous 
iron is trapped by a plasma membrane ferrous iron binder and translocator 
(III) and apotransferrin is displaced by another diferric transferrin (IV). 
This series of events (I-IV) is repeated until the transfenin/transferrin- 
receptor complex is hidden from the extracellular space by internalisation 
into an endosome. Iron translocated through the plasma membrane or the 
endosomal membrane is picked up by intracellular iron ligand (s) (V) which 
pass iron to the various intracellular iron requiring compounds (VI) and 
processes (VII) (from Thorstensen and Romslo, 1988).
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In the second model, the binding of tiansfemn to its receptor promotes a 
comformational change in transfenin resulting in a decreased affinity of 
tiansfemn for fem e ion. Ferric ion that has been released is bound by a 
membrane ligand which is subsequently reduced (Nunez et a l ,  1983) and 
available for chelation by intiacellular iion caniers,
(d) Role o f Lactoferrin in Iron Donation
Even though lactofenin is stiucturally similar to transfeirin in reversibly 
binding two fem e ions per molecule of the protein, the ability of lactofenin 
to fuction as an iion donor like transfeiiin remains doubtful. Lactoferrin 
has been shown to bind to many cells especially monocytes and 
macrophages (Van Snick and Masson., 1976; Birgens et a l ,  1983). In 
some of these studies, uptake of iron was observed, whereas in others, the 
amount taken up was considered insignificant. More detailed discussion on 
the possible role of lactoferrin in iion donation is included in Part Two of 
this chapter.
1.1.4.3 Role of Lactoferrin in Inflammation
(a) Role o f Lactoferrin in Hypoferraemia
Van Snick et a l  (1974) proposed that lactofenin released from specific 
granules of neutiophils was involved in the hypofenaemia associated with 
inflammation. It was suggested that lactofenin competes with bacterial 
siderophores to remove iion from plasma tiansferrin and unloading it to 
macrophages of the mononucleai' phagocyte system where it is incorporated 
into feiiitin. In so doing, the plasma non decreases (Fig. 11).
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(transferrin and lactofenin) in the iron-limiting mechanism conducted in 
blood, resulting in hypoferraemia and thus in iron deprivation of pathogenic 
microorganisms, which try to obtain the iron by their siderophores (From 
Sawatzki, 1987).
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(b) The effect o f Lactoferrin on Hydroxyl Radical Formation
During phagocytosis, neutrophils consume oxygen and convert it to 
superoxide anion (Og ) and hydrogen peroxide (Hj O2 ), which react 
together to generate the highly reactive hydroxyl radical (OH*) (Babior, 
1978). The diiect reaction of superoxide anion and hydrogen peroxide 
known as Haber-Weiss reaction, proceeds at a significant rate only in the 
presence of a tiansition metal ion. Iion is the most likely candidate to be 
active in vivo (Flitter et a l ,  1983).
Fe3+ + 0 2 - ^ F e 2+ 4- O2 
Fe2+ + H2O2— >Fe3+ + OH* + OH 
Net: O2 + H2O2—>0H  + OH + O2
Hydroxyl radical, due to its high reactivity, can attack almost all biological 
molecules usually setting off free radical chain reactions (Halliwell et 
a/.,1986). It is implicated in phagocytic bactericidal activity (Babior, 1978) 
as well as promoting lipid peroxidation with consequent cell damage (Lai 
and Piette, 1978 ; Gutteridge et a l ,  1979). Generation of hydroxyl radical 
in vivo could be site specific depending on the location of metal ion 
complexes used in the Haber Weiss reaction. Hence the extent of the effect 
of hydroxyl radical vaiies according to the location of its generation.
The involvement of lactoferrin in the generation of hydroxyl radical is 
controversial (Andrews et a l ,  1989). Ambruso and Johnston (1981) 
reported that iron-loaded lactoferrin from both milk and neutrophil is an 
efficient catalyst for hydroxyl radical formation and therefore an important 
contiibutor to the microbicidal activity of neutrophils. It was supported by 
the work of Bannister et a l  (1982). However, other workers have reported
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no evidence for the enhancement of hydroxyl production by lactoferrin 
(Winterbourn, 1983; Baldwin a/., 1984; Gutteridge a/., 1981). This is 
in line with the finding that in normal subjects lactoferrin has a very low 
iron content, well below saturation either in neutrophils (Bullen and 
Armstrong, 1979) or in milk (Fransson and Lonnerdal, 1980). Also as 
mentioned earlier in section 1.3.7, iron starts to mobilise from transferrin at 
pH values ^ 6.5, which is actually the pH of the microenvironment of 
adherent phagocytic cells. Hence, lactofenin that is present is expected to 
sequester any "free" non that transfenin is unable to bind and thus offer a 
protective mechanism against hydroxyl radical formation. Further evidence 
that lactoferrin does not enhance hydroxyl radical generation is provided by 
the observation that activated human neutrophils did not produce hydroxyl 
radical unless non ions were added to the reaction mixture, even though the 
activated neutrophils were found to release superoxide anions, hydrogen 
peroxide and lactofenin extracellulaiiy (Britigan et a l ,  1986). Lactoferrin 
can also withstand oxidative stress and therefore makes a good candidate as 
an antioxidant at the sites of inflammation (Winterbourn and Molley, 1988; 
Halliwell et a l ,  1988).
Thus, evidence from various studies seem to indicate that lactoferrin 
released from neutiophils inhibits rather than promotes the generation of 
hydroxyl radical (Britigan et a l ,  1986; Flitter et a l ,  1983). However 
conditions within the phagocytic vacuole with iron being made available from 
phagocytosed paiticles may cause lactofenin to promote its production ^
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(c) Inhibition o f Lipid Peroxidation by Lactoferrin
Exposure of membrane lipid to systems generating oxygen radicals in the 
presence of iron accelerates the process of lipid peroxidation which 
produces a mixture of organic peroxides. Lactoferrin as well as transferrin 
at physiological degrees of saturation are inhibitors of iron dependent lipid 
peroxidation (Gutteridge et a l,  1981). This is again due to their iron 
binding capacity, since saturation of the proteins abolishes their inhibitory 
effect. Therefore, secretion of lactofenin from neutrophils in large amount 
during phagocytosis might be a protective mechanism by which 
surTounding tissues are protected against membrane damage especially in 
inflammatory joint diseases.
1.1.4.4 Role of Lactoferrin in Microbial Infections
(a) Introduction
Just as iron is essential to human and other animals, a source of iron is also 
required for the growth of almost all microorganisms, including those 
pathogenic to humans. To sustain growth and multiplication of 
microorganisms, iron must be present at a minimum concentration of 0.3 
mM (Finkelstein et a l ,  1983). The total concentration of iron in various 
biological fluids far exceeds the minimum requirements for microbial 
growth. However iron is relatively unavailable extracellularly as it is bound 
to transferrin and lactoferrin.
Microorganisms have to compete with their hosts for their supply of iron. 
Many of them have well-developed biochemical mechanisms for extracting 
and trapping the iron. These include the production of siderophores and
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their receptors (Neilands,1981), and receptors for iron saturated transferrin 
and lactofenin (Schi'yvers and Morris, 1988) that allow them to remove 
and utilise iron from these proteins.
(b) Growth Inhibition o f Microorganisms by Transferrin and 
Lactoferrin
Many in vitro experiments have demonstrated the bacteiiostatic effects of 
tiansfemn and lactofenin. In some cases bactericidal effects of lactofenin 
have also been reported (reviewed by Weinberg, 1984). Growth inhibition 
was observed with a wide range of microorganisms including gram-positive 
and gram-negative bacteria, aerobes, anaerobes and yeasts. Lactoferrin was 
found to be bactericidal on Streptococcus mutans and Vibrio cholerae but 
bacteriostatic against E.coli (Arnold et a l,  1982).
The bacteriostatic effect of these proteins was mai'kedly reduced or 
abolished by the addition of iron to the growth media. This formed the 
basis for the argument that the important factor for the antibacterial effect is 
the percentage of iron saturation of these proteins. It was then hypothesised 
that these proteins act by depriving the microorganisms of thek iion supply 
(reviewed by Weinberg, 1984).
Evidence from a number of studies, however indicates the anti-microbial 
action of lactoferrin is more complex than simple nutiitional iron 
deprivation (Arnold et a l ,  1977; Ellison et a l,  1988). Visca et a l  (1990) 
point out the existence of additional anti-microbial mechanisms based on 
the interference between lactofenin and microbial structures (both apo- and 
iion-saturated forms). Other mechanisms of action include blocking of 
microbial carbohydrate metabolism (Arnold et a l ,  1982; 1977) and
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destabilising the integrity of the outer membrane of gram-negative bacteria 
causing the release of lipopolysacchaiides (Ellison et a l ,  1988; 1990). A 
more recent study by Bellamy et a l ,  (1992) identified the bactericidal 
domain of the lactofenin molecule which may be responsible for the 
membrane disruptive effects.
(c) Anti-microbial Activity o f Lactoferrin in the Gut o f the Newborn 
Infant
It has long been known that breast fed infants are better protected against 
gastrointestinal infections than infants fed with cow milk formula (Brock, 
1980; Bullen et a l ,  1972). Escherichia coli, a member of the normal 
intestinal flora is also a frequent aetiological agent of intestinal infections, 
in particular, infantile gastroenteritis. It has been estimated to affect more 
than 500 million children below 5 years of age with an annual mortality rate 
of 1 to 4 % worldwide (Snyder and Merson, 1982).
The antimicrobial activity of lactofenin against E.coli in vitro has been 
well documented (Bullen et a l , 1972; Rogers and Synge, 1978; Spik et a l , 
1978; Reiter et a l ,  1975; Griffith and Humphreys, 1977). In vitro 
inhibition of E.coli requires the addition of bicarbonate to the milk or 
colostrum as to simulate the condition in the intestine as well as to enhance 
iron-binding by lactoferTin and prevent iron being made available to 
bacteria. Inhibition also requires specific antibodies, although good 
bacteriostatic activity in the absence of specific antibodies has also been 
reported (Arnold et a l ,  1977; Law and Reiter, 1977). The bacteriostatic 
activity of lactoferTin was also enhanced by the presence of lysozyme 
(Montreuil et a l,  1985; Ellison and Giehl, 1991). The study by Ellison and 
Giehl (1991) found that while each protein alone is bacteriostatic, together
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they can be bactericidal in a manner that was dose dependent and blocked 
by kon saturation of lactofenin. Despite the wealth of in vitro obseiwations 
on the antimicrobial role of milk lactofenin, in vivo data is less convincing 
(Sanchez, 1992). Bullen et a l  (1972) suggested based on the results of 
experiments with guinea pigs, that the protective effect of human milk in 
the small intestine toward E.coli could be due to lactofenin and possibly 
transferrin as well, acting in concert with specific E.coli antibody. However 
the outcome of the experiment could have other interpretations as discussed 
by Brock (1980).
Another in vivo study by Antonini et al. (1977), showed that the number of 
coliforms in the intestine of newborn guinea pigs dosed with E.coli and fed 
cow’s milk was lower if the milk was supplemented with ovotransferrin 
which is structurally related to lactoferTin. More recent clinical studies 
analysed the faecal flora of infants fed a diet supplemented with bovine 
lactoferrin (Baimer et a l ,  1989; Roberts et a l, 1992). The addition of 
lactoferrin had little or no effect on the faecal flora of infants fed lactoferrin 
supplemented formula and controls with unsupplemented formula.
1.1.4.5 Role of Lactoferrin as a Growth Factor
Iron plays an important role in cell growth. Transfenin, being an kon 
transport protein has been shown to transport kon to growing cells (Aisen 
and Listowsky, 1980). It was fkst demonstrated by Hayashi and Sato 
(1976) to be an essential growth factor for a rat pituitary cell line, GH3 in 
serum free medium. Transferrin is now used for the culture of various cell 
lines in synthetic medium.
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More recent studies have suggested that lactoferrin may also promote cell 
growth. Hashizume et a l  (1983) reported that lactoferrin was an essential 
growth factor for lymphoma cell lines in serum free medium. Subsequently 
it was reported by Amouric et a l  (1984) that lactoferrin stimulated the 
growth of the human adrenocarcinoma cell line HT 29 in the presence of a 
low concentr ation of ir on, either of which alone was unable to promote cell 
growth. Further work by Nichols et a l  (1990) showed that lactoferrin 
enhanced proliferation of rat mucosal crypt cells suggesting that it might 
play a part in maturation of the intestine of the newborn. The effect of 
lactoferrin on the proliferation of lymphocytes is not clear. Mazurier et a l 
(1989) have reported enhancement, whilst others (Richie et a l ,  1987; Slater 
and Fletcher, 1987) have reported inhibition. However recent work by 
Djeha and Brock (1992a) has shown that apolactofemn can overcome the 
inhibitory effect of "free" iron on lymphocyte proliferation, but itself 
inhibits proliferation when iron is bound to transferrin.
The mechanism by which lactofenin is able to stimulate cell growth is 
unclear* but appears somewhat different from that of transferrin (Hashizume 
et a l,  1987 ; Roiron-Lagroux and Figarella, 1990). Unlike transfenin 
which donates iron to the cell via the route described in section 1.4.2(a), 
lactofenin does not seem to enhance growth in analagous manner. 
Lactofenin is not internalised and little or no iron is taken up from the 
protein (Brock and Esparza, 1979; Oiia et a l,  1988). In some cases, 
growth enhancement required iron (Azume et a l, 1989) whereas in others 
iron was unimportant (Nichols et al,_\99D', Oria et a l ,  1988).
According to Roiron-Lagroux and Figarella (1990), lactoferrin may induce 
cell proliferation by releasing iron at the plasma membranes without itself 
being internalised. This process has been proposed for the uptake of iron
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from tiansfenin (section 1.4.2(b)) in reticulocytes (Nunez et a l ,  1983) and 
isolated rat hepatocytes (Moiiey et a l,  1985; Thorstensen and Romslo,
1988). The release of kon from lactoferrin at the plasma membrane could 
thus involve activation of membrane oxidoreductase activity (Sun et a l, 
1991).
1.1.4.6 Role of Lactoferrin in Iron Absorption
The role of lactofenin in kon absorption will be discussed in Part Three of 
this chapter.
PART TWO: REVIEW OF LITERATURE ON CELLULAR 
INTERACTIONS OF LACTOFERRIN
1.2.1 BINDING STUDIES OF LACTOFERRIN
1.2.1.1 Binding of Lactoferrin to Cells
A crucial step in understanding the biological role of lactoferrin is to study 
its interaction with cells. Lactofenin binding has been reported on many 
cell types especially cells from the monocyte/macrophage system (see 
section 2.1.2), but also to lymphocytes (Van Snick and Masson, 1976), 
intestinal brush border membranes (Hu et a l ,  1988; Davidson and 
Lonnerdal, 1985); a variety of cultured leukemic cell lines (Yamada et al,
1987) and human colon adenocarcinoma cell line ( Rokon-Lagroux et a l
1989). Hepatocytes, Kupffer and liver endothelial cells have been observed
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to bind lactofenin as well (Courtoy et a l, 1984; Regoeczi et a l ,  1985; 
McAbee and Esebensen, 1991; Ziere et a l  1992).
The existence of lactofemn receptors has been reported on some of these 
cells. Lactofenin receptorsfiavebeen demonshated in B and T-lymphocytes 
(reviewed by Birgens, 1991). Mazurier et a l (1989) have isolated the 
receptor from a tiiton X-100 soluble extiact of phytohaemagglutinin- 
stimulated human lymphocytes. Purification using anti-ligand affinity 
chromatography yielded two major proteins molecular weights of 107 kDa 
and 115 kDa. A lactoferrin receptor has also been isolated from 
solubilised human fetal intestinal brush-border membranes (Kawakami and 
Lonnerdal, 1991). The molecular weight of the receptor was found to be 
110 kDa by SDS-Page.
Quantitative binding data, dissociation constants and molecular weights of 
the receptors in studies dealing with lactofenin binding to various cell types 
are summarised in Table 1.
1.2.1.2 Binding of Lactoferrin to Monocytes and Macrophages
(a) Mononuclear-Phagocyte System
The macrophage and its precursors in the same cell lineage make up the 
mononuclear* phagocyte system. The cells include promonocytes and their 
precursors in the bone manow, monocytes in the circulation and 
macrophages in tissues (reviewed by Johnston, 1988). The transit time in 
the bone marrow from the first monocytic precursor to the mature monocyte 
is about six days. The monocytes randomly leave the bone manow within 
24 hours and remain in the circulation with a ti/2 of approximatelythree
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days (Whitelaw, 1972). Migration of monocytes into the different tissues 
appears to be a random phenomenon in the absence of localised 
inflammation. Once in the tissues, monocytes probably do not reenter the 
circulation but instead undergo tiansformation into tissue macrophages with 
morphological and sometimes functional properties that are characteristic 
for the tissus in which they reside. The life span of individual macrophages 
in human tissues is believed to be months, but precise data are not available 
(Johnston, 1988).
The most important step in the maturation of macrophages from the 
standpoint of function is the conversion of the normal resting or resident 
cell to the activated macrophages. Macrophage activation is accomplished 
during infection through the release of macrophage-activating lymphokines 
from T-lymphocytes specifically sensitised to antigens for the infecting 
organisms (North, 1978). Activated cells have enhanced capacity to kill 
intracellular* microorganisms and tumor cells.
There are many functional activities carried out by mononuclear 
phagocytes. Perhaps the best known of all the functions is its ability to 
phagocytose and kill microorganisms. In response to invading 
microorganisms, the phagocytes undergo metabolic stimulation, i.e. the 
respiratoi*y burst. It results in marked increase in oxygen consumption, 
oxidation of glucose via the hexose monophosphate shunt and generation of 
reactive oxygen intermediates such as hydrogen peroxide and superoxide 
anion (Babior et a l ,  1978). Superoxide anion and hydrogen peroxide 
interact with each other in a cycle of reactions to form the potent oxidant, 
hydoxyl radical, which is probably the most important microbicidal oxygen 
species. The production of the hydroxyl radical is catalysed by iion, the 
overall reaction is known as the Haber-Weiss reaction (see section 1.4.3(b)).
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TABLE I
Dissociation constants (Kd), and molecular weights 
of receptors fo r lactoferrin hound to various cell types
Cells Molecular weight 
of receptor (kDa)
Kd (nM) Ref
Enterocvtes
Rabbit 100 830 Mazurier et al. {19S5)
Mouse 130 380 Hu er a/.(1988,)
Monkey - “ Davidson & Lonnerdal 
(1988)
HT - 29 
Human “ 3.9 Derisbourg (1990)
HT 29 - D4 
Human - 408 Doii’on-Lagroux et al. 
(1989)
Lvmphocvtes
Human
lymphocytes - 43 Bennett & Davis (1981) 
Birgens et al. (1984)
Activated
lymphocytes 110 83 Mazurier et a/. (1989)
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Superoxide and hydrogen peroxide are produced within most cells in 
microsomes, mitochondria, peroxisomes or elsewhere by the action of 
certain cytochromes, amino acid oxidases and other enzymes.
Another major function of the mononuclear macrophage system is in 
regulation of iron réutilisation especially those of the liver and spleen cells, 
which in normal conditions is highly efficient. They remove damaged and 
senescent red blood cells, convert the haem moiety to bilirubin and 
eventually return the iron into circulation, making it available to the 
haemopoietic system and the rest of the cells or it can be stored as fenitin. 
In inflammatory lesions, macrophages may also phagocytose other iron- 
containing cellular debris.
The activity of mononuclear phagocytes against cancers in human is less 
well understood, but these are thought to suppress the growth of 
spontaneously arising tumors. This control activity may not involve the 
phagocytic process. Macrophages may kill tumor cells by means of 
secreted products including lysosomal enzymes, oxygen metabolites and 
tumor necrosis factor-cachectin (Johnston, 1988).
One of the essential factors involved in the monocyte’s protective function 
is its capacity to undergo diapedesis across the endothelial wall of blood 
vessels and to migrate to sites of microbial invasions in tissues. These cells 
would be expected to enter sites of inflammation.
Other equally important function of macrophages is processing antigen and 
presenting it to lymphocytes (Unanue and Allen, 1987). Monocytes and 
macrophages are also primary sources of the polypeptide hormones termed
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interleukin-1 (IL-1) which have a particulaily potent effect on the 
inflammatory response.
(b) Binding o f Lactoferrin
The ability of lactofenin to bind to cells of the mononuclear macrophage 
system was first reported by Van Snick et a l (1976), who showed that 
lactoferrin bound to mouse peritoneal macrophages. Since then many 
studies have confirmed the binding of lactoferrin to monocytes and 
macrophages (Bennett and Davis, 1981; Steinmann e ta l ,  1982; Birgens et 
a l,  1983; B artalera/., 1987 ; Oria era/., 1988 ; 1993).
Binding of lactofemn to these cells has been suggested to occur through 
specific receptor (Van Snick et a l,  1976 ; Bii'gens et a l ,  1983), but so far 
no receptor molecule has been isolated. Others have suggested that the 
binding is relatively non-specific (Goavec et a l,  1985). Quantitave binding 
data, dissociation constant and number of binding sites per cell have been 
determined in various studies as summarised in Table ÏT.
The specificity of lactofenin binding to monocytes and macrophages has 
been demonstrated in competitive binding studies with various proteins. 
Binding of bovine lactoferrin to a monocytic cell line was inhibited by 
excess bovine lactofenin but not by human lactoferrin, suggesting that the 
recognition mechanisms for human and bovine lactoferrin are not 
identical (Oria et a l ,  1993). Transferrin, despite its structural homology to 
lactoferrin, did not inhibit the binding of lactoferrin (Van Snick and 
Masson, 1976; Bennett and Davis, 1981; Birgens et a l 1983).
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TABLE II
The parameters o f lactoferrin binding to macrophages 
and monocytes
Cells Kd
(nM)
Sites / cell 
(x 10-6)
Ref
Alveolar
macrophages - 2 MiU’kowetz et aL(\919)
Peritoneal
macrophages
(murine) 1500 22
van Snick & Masson 
(1976)
Peritoneal
macrophages
(murine) 28 Imber & Pizzo (1983)
Alveolar
macrophages
(human) 1700 54 Campbell (1982)
Alveolar
macrophages
(human) 500 12 Goavec et al. (1985)
Blood
monocytes
(human) 1800 33 Bennett & Davis (1981)
Blood
monocytes
(human) 4.5 1.6 Birgens et al. (1983)
Blood
monocytes
(human) 430 10 Moguilevsky et a/.(1985)
Blood
monocytes
(human) 3560 34 Britigan et al. (1991)
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Other proteins such as IgG (Van Snick and Masson, 1976; Bennett and 
Davis, 1981; Birgens et a l, 1983), bovine albumin (Campbell, 1982), 
cytochrome c (Van Snick and Masson, 1976) and various milk proteins 
(Oria et a l,  1993) have no effect on binding of lactofenin.
1.2.2.3 The Nature of Lactoferrin Binding Sites
The nature of the recognition site on the cells responsible for binding of 
lactofenin is not known for certain. The protein moiety of lactoferrin 
molecule has been shown to be of pivotal importance in binding. 
According to Rochaid et a l  (1989), the cell binding site may be located in 
the N-terminal lobe of the molecule (residues 4-90 and/or 258-281). 
Further study by Ziere et a l  (1992) using liver cells had reported that N- 
terminal aiginine residues which resemble the arginine-rich receptor 
binding sequence in apoE, may be responsible for the interaction of 
lactoferrin with its receptor.
Others have suggested that electrostatic interactions, specific and non­
specific, exist between lactofenin and the negatively charged cell surface. 
This conclusion is based on competition binding studies between 
lactoferrin and other cationic proteins mentioned above. However the 
results of these studies are often not consistent. Cationic proteins such as 
lactoperoxidase (pi 9.6; McAbee and Esbensen, 1991 ; Oria era/., 1993), 
protamine sulphate (pi 12.1; Yamada et a l ,  1987 and McAbee and 
Esbensen, 1991) and other neutrophil granule glycoproteins, elastase and 
cathepsin G (Campbell, 1982) decreased the binding of lactoferrin. 
Another basic protein, lysozyme (pi 11.4) was found to be inhibitory by 
Moguilevsky (1985) but not inhibiting by other workers (Yamada a l, 
1987, McAbee and Esebensen, 1991).
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Removal of sialic acid, one of the major sources of negative charge by 
neuramidase decreased binding of lactofemn (Yamada et a l,  1987). On the 
other hand, Moguilevsky et a l  (1985) found that sialic acid as well as 
glycosaminoglycans and phospholipids did not contribute to the binding. 
Taken together these findings, it seems that the binding of lactoferrin to the 
cells may not be due solely to electrostatic interactions between the protein 
and acidic groups on the cell surface.
Recognition of lactofenin by the cell could also be mediated by the glycan 
moiety of lactofemn, with fucose being one of the sugars playing an 
important role in the association (Prieels et a l,  1978; Goavec et a l ,  1985). 
However, subsequent studies showed that binding of lactoferrin did not 
require recognition of the sugar components. Glycoconjugates bearing 
fucose, galactose, N-acetylglucosamine or mannose did not inhibit binding 
of lactofemn to receptors on murine peritoneal macrophages (Imber and 
Pizzo, 1983).
1.2.3 UPTAKE OF IRON FROM LACTOFERRIN
1.2.3.1 Iron Uptake by Monocytes and Macrophages
Just as binding studies of lactofemn to cells of the monocytes/macrophage 
system was first reported by Van Snick et ai. ,(1976), so also was the first 
report of uptake of iron from lactofemn. They reported that iron-loaded 
lactofemn when bound to murine peritoneal macrophages delivered its iron 
into intiacellular fenitin. Similar* findings were later obtained by 
Moguilevsky et a l  (1985) and Birgens et a l  (1988) using human 
monocytes. However iron uptake in these studies was found to be 
extremely slow with detectable net accumulation of iron and incorporation
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into fenitin being observed only after about 24 h of incubation. Indeed a 
study by Oria et a/. (1988) cleaily indicated that within 6 h of incubation 
there was no net accumulation of iron from lactofenin by a murine 
macrophage cell line, P388 D l, whereas there was a substantial uptake of 
iron from transfenin.
The eaiiier workers who reported iron uptake from lactoferrin suggested 
that lactofenin was internalised into the cell after binding to its plasma 
membrane receptor, in order to release its kon. According to Moguilevsky 
(1985) once inside the cell, lactofemn unlike tiansfenin was degraded 
concomitantly with the binding sites, probably in the lysosomes, and in the 
process iron was released. Further studies by Bkgen and Kristensen (1990) 
reported that the interaction of lactoferrin with monocytes caused a change 
in the moleculai* conformation of lactofenin, resulting in inability to rebind 
to its receptor, suggesting lactofenin cannot operate in a cyclic manner to 
deposit kon like transfenin.
1.2.3.2 Iron uptake by other cells
Besides monocytes and macrophages, studies dealing with possible 
lactofenin-mediated kon uptake has been canied out with reticulocytes 
which showed no evidence for such a process (Zapolski and Princiotto, 
1976 ; Brock and Espai’za, 1979). Translocation of kon from lactoferrin 
was also not observed in human lymphocytes (Bkgens, 1991). Rokon et 
al. (1990) found that unlike tiansfenin, lactoferrin was not internalised by a 
human adenocarcinoma cell line, HT 29-D4 even though lactofenin might 
have relesed its iron to the cell (Rokon et al, 1989).
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Studies with hepatocytes revealed that these cells bound and endocytosed 
lactofenin regardless of its iron content (McAbee and Esbensen, 1991). 
This is different from the action of transferrin which interacts with cells 
only in the difenic form. Hence, a possible role for hepatocytes could be to 
clear apo- and difeiTic lactoferrin that have been released from 
granulocytes, especially during inflammation. In this way, lactoferrin was 
taken up not to supplement nutritional iron requirements of the cells but 
rather to regulate it's blood levels.
Clearance of lactofenin by liver hepatocytes could also occur by adsorptive 
pinocytosis (Regoeczi e ta l  1985).
1.2.3 INTERACTION OF MILK PROTEINS WITH LACTOFERRIN
1.2.3.1 Milk Proteins
(a) Protein Content o f Human Milk
Human milk has many unique properties that benefit the breast-fed infant. 
Some of these properties reside in the protein fraction of the milk. These 
include host defence factors (immunoglobulins, lysozyme and lactoferrin), 
digestive enzymes (lipases, proteases and amylase) as well as specific 
binding proteins and growth factors.
Human milk, compared to the milks of other animals, is relatively poor in 
protein. The amount of whey protein is also higher than casein. Colostrum, 
(milk obtained 1 to 5 days following parturition) and transitional milk (6 to 
10 days following parturition) have higher amount of protein than mature 
milk. The increase is largely due to a higher amount of whey protein rather
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than casein. The amount of protein in coloshum is about 23 mg/ml and in 
tr ansitional milk about 16 mg/ml (Bezkorovainy, 1977).
(b) Casein
Casein in human milk is present exclusively in micellar form. The casein 
micelles in human milk are considerably smaller than those in cow's milk. 
Each micelle consists of a group of protein subunits associated and linked 
together with and Ca^+. The major casein subunit is |3-casein,
representing 50% of the total casein fraction. Cow's milk, however contains 
a large proportion of of a-casein which is apparently absent in human milk 
(Lonnerdal, 1985a). Casein can form complexes with some of the whey 
proteins. It was shown that casein prepared by acid precipitation contained 
lactoferrin, senim albumin and a-lactalbumin (Lonnerdal, 1985b).
(c) Whey proteins
Whey proteins have received much more attention than casein. This may be 
due to the physiological activities of some of the whey components. This 
review will only focus on some of these whey proteins.
a~lactalbumin
a-lactalbumin has a very high nutritional value (Forsum, 1973) and an 
amino acid composition well adapted to the requirements of the newborn 
infant. Besides the nutritional role of a-lactalbumin, this protein is part of 
the enzyme lactose synthase, which is responsible for lactose synthesis in 
the mammary gland, a-lactalbumin also has a metal-ion binding site which 
binds calcium in a 1:1 molar ratio (Segawa and Sugai, 1983).
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Immunoglobulins
Human colostrum is rich in immunoglobulins especially secretory 
IgA(sIgA), with monomelic IgA, IgG and IgM being minor components. 
The sIgA molecule is resistant against proteolysis and therefore able to 
exeit its function in the gut of the newborn.
Lactoperoxidase
Lactoperoxidase is an enzyme of human and cow's milk. It joins with two 
other chemical factors, hydrogen peroxide and thiocyanate to produce a 
defense against a variety of human pathogens. Lactoperoxidase system 
works most effectively at pH levels below that of milk, hence stomach acids 
(pH 2.0) help serve this function. As the enzyme is active at relatively low 
pH, it is most likely to survive the acid condition (reviewed by Lonnerdal 
(1985b).
Lysozyme
Lysozyme is another important human whey protein with a concentration 
3000x higher than in cow’s milk. This enzyme catalyses cleavage of the 
chemical bond between N-acetylglucosamine and N-acetylmuramic acid 
which are part of the cell wall structure bacteria. Therefore lysozyme from 
milk can function as a bacteriostatic agent in the intestine of a breast-fed 
infant. Lysozyme has a very high isoelectric point ( p i l l )  and consequently 
is positively charged at physiological pH. It can therefore form aggregates 
with other proteins which are anionic at this pH.
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1.2.3.2 Association of Lactoferrin with Milk Proteins
Both human and bovine lactofenin have been shown to interact with milk 
proteins and other macromolecules. Human lactoferrin interacts with 
casein, a-lactalbumin, albumin (Hekman,1971), sIgA (Watanabe et 
a /.,1984) and lysozyme (Jorieux et a/.,1985). It has also been shown to 
undergo polymerisation in the presence of calcium to form a tetiamer 
(Bennett et a/., 1981).
In general the interaction between lactofenin and milk proteins has been 
considered to be non-specific. However there are reports suggesting some 
degree of specificity in the interaction. Lampreave et a/. (1990) reported a 
stoichiometric relationship for the interaction of lactoferrin with P~ 
lactoglobulin and with albumin; 2:1 in the first case and 1:1 in the second.
The nature of the interaction between lactoferrin and these proteins is not 
known for certain. The dissociation of the lactoferrin-milk protein complex 
by increasing the ionic shength points to electrostatic interaction. This is in 
agreement with the pronounced tendency of lactoferrin to become 
associated with more acidic proteins such as albumin or casein. Watanabe 
et a/. (1984) also found that the binding of lactoferrin to IgA increased with 
the molarity of salt. Their findings also suggested that binding of 
lactofenin to IgA could occur through the formation of disulphide bonds. 
However not all interactions between lactofenin and milk proteins can be 
attributed to electrostatic forces because human lactoferrin has been found 
to interact with basic proteins like lysozyme and lactoperoxidase.
The importance of these associative properties of lactoferrin is not known. 
It is also not known for certain whether these properties have any effects on 
the binding of lactoferrin to cells.
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The importance of these associative properties of lactofenin is not known. 
It is also not known for certain whether these properties have any effects on 
the binding of lactofenin to cells.
PART THREE: REVIEW OF LITERATURE ON THE ROLE OF 
LACTOFERRIN IN IRON ABSORPTION
1.3.1 FACTORS AFFECTING IRON ABSORPTION
There are two fundamental factors which influence the amount of iron being 
absorbed from the gastiointestinal tract. The first is the physiological and 
nutritional status of the individual, and the second is the nature of the diet.
1.3.1.1 Physiological factors
The absorption of iron is linked to the individual's need. Growth is most 
rapid in infancy and around puberty, so the requirement for non is greatest 
around these times. Absorption of iron is also dependent on the iron status 
of the individual. In general, absorption is increased in iron deficiency and 
depressed in iron overload.
Both iron deficiency and iron deficiency anaemia occur with greater 
frequency during the first two years of life than at any other period in the 
life span (Oski, 1983). However in the early period up to 6 months, 
anaemia is not a problem among healthy full term infants (Wharton, 1989), 
iriespective of whether they are breast fed or fed with iron supplemented or 
unsupplemented formulas. The reason for this is that these infants have
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sufficient endogenous iron to meet their requirements (Aggett et a/. 1989). 
As a result, iron absorption in the early postnatal period is lower than at any 
later time in childhood. The amount and bioavailability of dietary iron are 
therefore less important before 4 months of age (Cook and Bothwell, 1984). 
Nonetheless as infants grow their endogenous iron reserves become 
increasingly marginal and become appreciably depleted after 6 months of 
age. Without adequate intake, iion deficiency frequently occurs in these 
term infants between the ages of 9 to 24 months.
Data on the iion status of infants who have been exclusively breast fed 
beyond 6 months are limited. McMillan et at.(1976) found that human 
milk, fed to the exclusion of other foods, was adequate to preserve a 
positive iron balance in four infants. These data were supported by the 
work of Saarinen et a l{\911)  and Siimes et a/.(1984) who studied 56 and 
36 infants respectively that were exclusively breast-fed for 9 months. They 
both found no indication of iron deficiency among these infants. Instead 
infants who were breast fed had higher iron status than infants fed iron- 
supplemented formula and solid foods (Fig. 12). Similar finding was 
obtained from the work of Pastel et a/. (1981) on seven healthy infants in the 
Peruvian Andes who had been exclusively breast-fed for 7 to 12 months. 
These studies suggested that exclusive breast feeding was sufficient to 
maintain adequate iron nutrition for the first year of life, even without iron 
supplementation. However iron sufficiency may be reduced in infants 
given solid foods (Saarinen et aL, 1977) and hence iron supplementation 
might be required.
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Fig, 12: Changes in haemoglobin concentrations of exclusively breast-fed 
infants (dashed line) and infants fed-supplemented formula (solid line) 
(from Siimes et aL, 1984).
56
1.3.1.2 Dietary factors
The reason for the delayed onset of kon depletion in breast fed infants is 
atüibuted to the greater bioavailability of iron from breast milk (Saarinen et 
a l,  1977), which is not paralleled by artificial feed based on cow's milk or 
soy protein isolate (Saarinen and Siimes; 1979). The finding that plasma 
fenitin levels at 6 months in breast fed babies were higher than those of 
infants receiving a formula without added iron further suggests a better 
absorption of iron from breast milk (Wharton, 1989). The reason why the 
iron in breast milk is so well absorbed is not known. However, protein 
mediated uptake of iron by the intestinal mucosal cell has received much 
attention. Lactofenin, due to its high level in milk has been postulated to 
promote iron absorption but the mechanism of action is not known (Cox et 
a l , 1979; Frans son et aL, 1983 ; Kawakami et aL ,
1988).
As the diet becomes more complex, absorption of iron may be affected by 
some components of the diet. The presence of chelating agents which bind 
iron in the diet can either enhance or inhibit its absorption. The enhancing 
effect of organic acids, sugars and amino acids is primarily due to their 
ability to form stable complexes with iron. Meat enhances the absorption of 
non-haem iron by a factor of 2-3 (Cook and Monsen, 1976), but the factor 
responsible for the facilitating effect is still unknown. The enhancing effect 
of ascorbic acid on non-haem iron absorption is profound whether it is 
contained naturally in the food or is added as synthetic vitamin (Derman et 
a/,1980; Lynch and Cook, 1980; Sayers et aL, 1974). The facilitating 
effect of ascorbic acid is due to its ability to form a soluble complex with 
iron at a low gastric pH, thus preventing formation of insoluble hydroxides.
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The presence of tannin in tea and to a lesser extent in coffee results in the 
formation of insoluble iron tannates. Tannins are also widely distributed in 
vegetable foods and may be partly responsible for the overall low 
bioavailability of iron in many such foods (Gillooly et a l ,  1983). Another 
important inhibitor of iron absorption is bran, which impairs iron absorption 
due to the presence of phytate (Simpson et a l, 1981)
1.3.2 PATHWAYS OF IRON ABSORPTION
1.3.2.1 Overall Pathway
Ii'on absorption occurs predominantly in the proximal end of the duodenum. 
The precise path as well as the actual proteins and ligands involved in the 
absorption of kon aie not fully understood (Flanagan, 1989). However the 
process may involve the following steps:
(1) iron binding to the brush border of enterocytes
(2) kon uptake by enterocytes
(3) kon transport within enterocytes
(4) transfer of part of the kon from enterocytes to 
the blood
(5) return of the remaining kon to the lumen when 
enterocytes aie shed from the villous tips
1.3.2.2 Iron Uptake by Enterocytes
The mechanism for the uptake of kon from the intestinal lumen by the 
enterocyte is illustrated in Fig. 13 (Flanagan, 1989).
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FIG. 13: Possible mechanisms for the absorption of iron by enterocytes. HfR,
haem receptor; LfR, lactoferrin receptor; Fe(II) carrier, microvillus membrane 
carrier for chelated Fe(II); Fe(in) carrier, microvillus membrane carrier for 
chelated Fe(IH); FeR, putative basolateral membrane carrier (from Ranagan,
1989).
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Iron that is ingested may enter one or two common pools before being 
absorbed. The smaller pool comprises heme iron compounds derived from 
meat sources. Iron in this form is highly available. It is absorbed by a 
pathway distinct from that of ionic iron since intraluminal factors such as 
acidity and chelating agents do not affect the process (Turnbull et a/., 1962). 
Furthermore, the intestinal haem receptor has been partially characterised 
from both pig and human brush border membranes (Grasbeck et a l ,  1979). 
It is likely that haem is released from haemoglobin during intraluminal 
digestion and taken up by the intestinal mucosa. Once in the cell, iron is 
then released from poiphyrin by haem oxygenase.
The second pool of iron is composed of all other forms of food iron as well 
as any organic iron present. This iron is much less bioavailable than haem 
ir on and its absorption is dependent on other dietary factors in the meal as 
mentioned above. Much evidence indicates that absorption of feiTous iron 
is preferred over feiiic iron but the precise biochemical explanation is 
unclear. However the iron must be present in a soluble form to be taken by 
the mucosal cell. PeiTous iron being more soluble is more effectively 
absorbed than fem e iron. In the acid condition of the stomach, most of the 
dietary iron is solubilised but upon passing into the alkaline medium of the 
duodenum, any free iron will be precipitated as insoluble fenic hydroxide 
which cannot be absorbed.
Non-haem iron can also be taken up by the mucosal cell via specific protein. 
Transfenin is unlikely to be involved in the luminal uptake because 
repeated studies have failed to identify transferrin receptors in the intestinal 
brush border membranes (Cox et a l ,  1979; Parmley et a/.,1985 ; Banerjee 
et a l  ,1986). On the other hand, lactofen'in receptors have been identified in 
the brush border membranes of rabbit (Mazurier et a /.,1985), mouse (Hu et
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a/.,1990), rhesus monkey (Davidson and Lonnerdal, 1988) and human fetal 
and infant brush border membranes (Lonnerdal, 1992).
The receptor from infant rhesus monkey intestine exhibited saturation 
kinetics and the binding was found to be specific for both human and 
monkey lactoferrin but not for bovine lactofenin or human transfenin. The 
receptor had a higher affinity for difeiiic lactoferrin than apolactofenin 
(Davidson and Lonnerdal, 1988).
Partial proteolysis of lactofenin did not seem to inhibit its binding to the 
intestinal receptor. The human lactofenin receptor was found to have a 
molecular weight of about 110 kDa (see Table 2). Binding of lactoferrin to 
its receptor was significantly reduced by removal of terminal fucose 
residues, implying that fucosylated glycans of lactofenin could be important 
for receptor recognition.
Despite having identified lactofemn receptors in the bnish border 
membrane, the role of lactofenin in iion absorption is not known for 
certain. By using human mucosal biopsies, Cox et a/.(1979) found that 
human lactoferrin has the ability to deliver ii on to mucosal cells of the small 
intestine of human adults. In another study, a significant increase in red 
blood cells, haematocrit and haemoglobin values was obtained from iron- 
deficient rats fed with iron-saturated lactofemn as compared to ferrous iron 
(Kawakami gr a/., 1988), indirectly demonstrating that iron from lactoferrin 
was more readily absorbed, as also suggested earlier by Fransson et a l 
(1983).
Contrary to those findings, McMillan et a l  (1976) showed that infant 
formula fortified with bovine lactoferrin administered to adult humans did
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not increase ir on absorption. This was supported by an in vivo study in rats 
(Failweather-Tait et a /.,1986) and in newborn infants (Fahweather-Tait et 
a /.,1987) in which the effect of lactoferrin on iron absorption was 
determined by comparing iron retention from ^^Fe-labelled bovine 
lactoferrin with that from ^®Fe chloride added as a supplement to the infant 
formula. Both studies reported that bovine lactoferrin had no effect on 
iron absorption in rats or newborn infants. Infact, eaiiier work by De Vet 
and Van Gool (1974) reported a negative correlation between iron 
absorption and the duodenal concentration of lactoferrin in adult humans. 
De Laey et a l  (1968), studied the effects of human lactofemn on iion 
absorption using everted duodenal sacs from rats and guinea pigs. They 
concluded that exogenous apolactofenin significantly decreased the 
mucosal iron uptake, whereas no significant uptake was observed with 
diferric-lactofenin.
Considering both sides of the argument plus the lack of evidence that the 
receptor proteins on the mucosal membrane actually mediate uptake or 
transport of lactofenin-bound iron, the role of lactofemn in iron absolution 
remains contioversial. However reviews by Brock (1980) and more 
recently by Sanchez et a l  (1992), suggest that lactoferrin may act to 
regulate iron absorption, and perhaps even to facilitate excretion of iron in 
the immediate postnatal period rather than promote iron absorption, thereby 
protecting against too large of an iron accumulation at a period of low need 
for kon. Later in infancy, the proteolytic activity of the infant’s gut is 
increased and lactoferrin can be degraded and the bound iron released and 
can then be absorbed.
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1.3.3 ABSORPTION OF LACTOFERRIN BY NEWBORN INFANTS
1.3.3.1 Survival of Lactoferrin in the Gastrointestinal Tract
The possible involvement of lactofenin in non absorption and protection 
against gastrointestinal infection, depends upon whether it can remain in the 
intestinal tract without being destroyed by gastric acidity or proteolytic 
activity (reviewed by Brock, 1980). In newborn infants, the proteolytic 
activity in the duodenum is better developed than the gastric activity. Both 
acid and pepsin production are low in relation to body weight, hence there is 
little gastric proteolytic activity. However these infants can still digest milk 
proteins, presumably due to pancreatic protease production, which appears 
to be comparable with that of adults (Hadorn et a l,  1968; Lindberg, 1974).
In vitro studies by Brines and Brock (1983) have shown that apolactofenin 
was more sensitive than kon saturated lactofenin to the action of trypsin 
and human lactoferrin was found to be less sensitive than bovine lactoferrin. 
Bovine apolactofenin was rapidly degraded by trypsin to small peptides, 
whereas the iron-saturated form was relatively resistant to prolonged tryptic 
digestion and gave rise only to large fragments which still retained thek 
iron-binding capacity (Brock et a l, 1976). Pepsin, however can partly 
digest human iron-saturated lactofenin, leaving a half-molecule containing 
one kon-atom.
Nevertheless, in in vivo studies, several groups have reported that intact 
lactoferxin had been recovered in the feces of term infants (Davidson and 
Lonnerdal, 1985; Prentice et a l ,  1989; Spik et a l ,  1982) as well as in 
premature infants (Scharher et a l ,  1986; Goldman et a l, 1990). The fecal 
excretion of lactofenin was greater in breast-fed infants than those fed with
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cow's milk based formula. IgA was also detected in the feces of the 
newborn infants but not lysozyme, suggesting that the infants was capable 
of digesting proteins but somehow lactoferrin and IgA escaped digestion.
The digestive ability increases with age, presumably as a result of an 
increase in gastric proteolytic activity (Brock, 1980). This is in line with 
the finding that the amount of lactofenin excreted was found to decrease 
with age, so that by 6 and 12 weeks of age, about 99% of lactoferrin was 
degraded in exclusively breast-fed infants (Prentice et a l ,  1987).
1.3.3.2 Plasma and Urine Levels of Lactoferrin
Intact lactofenin and two large fragments have been detected in the urine of 
premature infants receiving human milk (Hutchens et a l ,  1990) and have 
been shown to be of maternal origin (Hutchens et al., 1991). This suggests 
that lactofenin was paitially degraded in the gut and that significant 
absoiption of this protein occuned in the premature infant. However, some 
lactofenin fragments could have been present in the milk before ingestion, 
as reported by Calvo et a/. (1991).
Even though lactofemn had been detected in the urine of premature infants 
receiving human milk, it seems less likely that lactofenin absorption occurs 
in term infants, as no difference in plasma lactofemn concentrations was 
found between breast and bottle fed infants ( Scott, 1989).
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AIMS OF THESIS
Many biological roles have been proposed for lactoferrin but so far none 
has been fully established. Several of these proposed functions imply an 
interaction with cells of the mononuclear phagocyte system, but the nature 
of this interaction is uncleai'. The fust part of this thesis reports a study of 
lactoferrin interaction with the human promonocytic cell line, U937 and 
compares its behaviour with that of transferrin, the serum iron transport 
protein. The binding pattern of lactoferrin to these cells and the possible 
involvement of a receptor molecule are examined. In addition the effect of 
heat treatment and other milk proteins on the binding of human and bovine 
lactoferrin to these cells have also been investigated.
Due to its close str uctural similarity to tr ansferrin, one of the main functions 
that has been ascribed to lactofenin is in iron transport and uptake. Work 
along this line has been conducted specifically to study the ability of 
lactoferxin to donate its iron to these cells and the possible mechanism of 
kon donation involved.
Apart from kon donation, binding of lactoferrin to the cells may also exert 
some other biological effects. Two of these potential effects have been 
studied. The fkst of these is to determine if lactoferTin can stimulate the 
growth of U937 cells as has been reported by others using different cell 
types. Secondly, since cells may be exposed to "free" kon especially in 
conditions of kon overload or at the sites of inflammation and may acquke 
it in due process, it is important to study whether binding of lactoferrin to 
these cells can inhibit the uptake of this kon.
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Another area of controversy involves the role of lactoferrin in iron 
absorption. The second part of this thesis focusses on this aspect of 
lactofemn function. Caco-2, a human colon carcinoma cell line capable of 
differentiating and forming a mucosal cell monolayer in culture is used as 
an in vitro model to study the involvement of lactoferrin in the iron 
transport mechanism. Since lactoferrin from maternal origin has been 
detected in the urine of preterm newborn infants, it has been postulated that 
lactofenin and its iron may be tiansported across the mucosa. It is therefore 
worthwhile to find out if similar transport occurs in newborn term infants 
and further to investigate if there is a difference between the plasma 
lactoferrin level in breast-fed and formula-fed infants.
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CHAPTER TWO
INTERACTIONS OF LACTOFERRIN WITH A 
PROMONOCYTIC CELL LINE, U937;
ITS ROLE IN IRON UPTAKE
2.1 INTRODUCTION
A considerable amount of work has been done on lactoferrin since it was 
first isolated in 1960. This work has led to a better understanding of its 
chemical stiucture and its physicochemical properties. Consequently much 
attention has been focussed on the similaiities between lactofenin and 
transfenin (Aisen and Leibman, 1972; Metz-Boutigue et a l , 1978). They 
have nearly identical molecular weight, with similar amino acid 
composition and high identity of sequence. They both bind two ferric 
ions per molecule of the protein with high affinity, concomitantly with the 
binding of two bicarbonate or carbonate ions. However the binding affinity 
of lactofenin for iron far exceeds that of transfeiTin by a factor of 260 and 
lactofenin requires exposure to pH 2 to be free of its bound non while 
transfenin releases its iron at pH 4.5 (Brock, 1985).
Work of similar magnitude has also been canied out to study the functional 
activities of lactofenin. While transfenin has a well defined function in 
iron transport to cells, the biological significance of lactofenin remains 
obscure. Although lactoferrin has many structural and biochemical 
similaiities to transfenin, its role in iron transport is not cleai'. The first 
suggestion that lactofenin might play such a role came from the work of 
Van Snick et a l (1974) who demonstrated that lactofenin could bind to 
peritoneal macrophages and transfer its iron to these cells. They also 
reported that during acute inflammation induced by the administration of 
endotoxin to rats, injection of lactofemn caused a decreased level of plasma 
iron. These observations led them to propose that lactofenin might 
contiibute to the hypofenaemia associated with inflammation by capturing 
iron released from transfenin as a result of a reduced pH in the 
microenvii'onment and diverting this iron to the macrophages. No similar
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studies have been published nor have their findings been supported by later 
studies. In addition diiect evidence that lactoferrin acts as an iron donor is 
scarce. Work with transfenin has shown that in most cells, the uptake of 
iron requires the expression of a receptor that allows endocytosis of 
transfenin and intracellular iron release to occur (Dautry-Varsat, 1986). 
Although there are reports on the existence of specific lactofenin receptors 
on various types of cells (reviewed by Birgens et a l,  1991), no such 
mechanism of iron transport has been described for lactoferrin. A putative 
receptor molecule has been isolated from activated lymphocytes (Mazurier 
et a l ,  1989), but the nature of the molecule and its interaction with 
lactofenin remains largely unknown. It is also not clear whether these 
membrane proteins can mediate uptake of kon from lactoferrin in an 
analagous way to that of transferTin.
In order to understand better the possible involvement of lactoferrin in 
cellular' kon uptake, it is important to examine its interaction with cells in 
particular* cells of the reticuloendothelial system. To accomplish this 
purpose, a human promonocytic cell line, U937 was chosen for the study.
U397 originated from the pleural fluid of a patient with diffuse histioeytic 
lymphoma (Sundstrom and Nilsson, 1976). Morphologically the cells are 
monoblastic and the histochemical profile reveals monocytic lineage. The 
cells grow as a single-cell suspension culture with a doubling time 
originally reported to be 95 h (Sundstrom and Nilsson, 1976). However 
recent passages of the line grow more quickly, 20-48 h per population 
doubling (Harris and Ralph, 1985). The cells are round with small 
cytoplasmic projections present on some cells. The mean diameter is 12.5 
|Lim with a range of 8.1-16.9. Maturation of the cell line increases the size 
of the cells and acqukes a lobated nucleus. The surface marker study
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revealed the presence of C3 and Fc receptors on the cells (Sunstrom and 
Nilsson, 1976). The Fc receptors bind IgGl with an affinity comparable to 
that of Fc receptors on normal mononuclear phagocytes (Anderson and 
Abraham, 1980).
Therefore, considering the monocytic characteristics of U937, this cell line 
was used in this research to study the cellular interaction of lactoferrin and 
to determine the effects of this interaction on the cells. A comparison is 
made between the interactions of lactoferrin and that of transferrin. The 
specific objectives of the study include the following:
1 . to study the binding and dissociation pattern of lactofemn and transferrin
2 . to determine iron uptake from lactoferrin and transferrin
3. to determine whether lactoferrin and tr ansferrin are internalised by the 
cells
4. to determine the effect of lactoferrin on the uptake of non-transferrin 
bound iron
5. to investigate the effect of lactoferrin and transferrin on cell proliferation
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2.2 MATERIALS
2.2.1 Cell Line
U937 was kindly provided by the Department of Biochemistry, Royal 
Infirmary, Glasgow.
2.2.2 Human Milk
Human milk was supplied by the Department of Paediatrics, Queen 
Mother's Hospital, Glasgow.
2.2.3 Proteins
2.23.1 Lactoferrin
Human lactoferrin was purified from milk according to the procedure 
reported by Johansson (1969). Bovine lactofemn was obtained from Pina 
Research (Seneffe, Belgium). Heat-treated bovine lactoferrin was prepared 
at the Veterinary Faculty, University of Zaragoza, Spain, according to the 
method described by Sanchez et a l  (1992).
2.2.3.2 Transferrin
Apo-transferrin (Behringwerke, Marburg, Germany) solution was prepared 
in PBS-1 % bicarbonate at the required concentration and filter sterilised. 
When necessary, it was saturated with iron at appropriate percentages with 
FeNTA. The purity of human transferrin was ckecked by SDS-PAGE.
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2.2,33 Other proteins
Bovine a~lactalbumin and ovine (3-iactoglobulin were obtained from 
Veterinary Faculty, University of Zaragoza, Spain. Human a-lactalbumin, 
IgA, lactoperoxidase, lysozyme and hepatinase III were obtained from 
Sigma (Poole, U.K.)
2.2.4 Radioisotopes
1231, carrier free (500 mCi/mg), ^^Pe-citrate (10 mCi/mg) and ^H-thymidine 
(52 Ci/mmol) were purchased from Amersham International, Amersham, 
U.K.
2.2.5 Monoclonal Antibodies
Monoclonal antibodies to the monocyte cell-surface markers, CD3, CD4, 
GDI lb , CD 14, CD25, CD45 and HLA-DR were purchased from Becton 
Dickinson. Monoclonal antibodies specific for CD3, GDI lb, GD14, GD25 
and GD45 were labelled with fluorescein isothiocyanate (FITG), while the 
remaining antibodies were labelled with R-phycoerythrin (PE).
2.2.6 Reagents
Reagents used in all the experiments were of analytical grade. Most of 
them were prepared in iron-free apparatus i.e. plastic, or glassware rendered 
iion-free by soaking in 10 % HGl overnight and rinsing three times in 
deionised, distilled water.
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2.2.6.1 Standard Culture Medium
The complete culture medium consisted of RPMI 1640 (w/o Hepes; Flow 
Laboratories, Irvine, U.K.), supplemented with penicillin (100 units/ml; 
Flow), streptomycin (100 mg/ml; Flow), sodium pyruvate (0.1 mg/ml; 
Flow) and 10 % final concentration of fetal calf serum (Flow). When 
required, serum free medium was prepared using human serum albumin 
(Behringwerke) at 1 mg/ml final concentration in place of fetal calf serum.
2.2.6.2 Human Serum Albumin Solution
A stock of 1 % (w/v) human serum albumin (Behringwerke) was prepared 
in RPMI-1640 medium (w/o Hepes; Flow), filter sterilised and stored at 4 
°C. The solution was tested by radial immunodiffusion assay (kindly done 
by Dr. S. McGregor) and found not to contain any detectable transfenin.
2.2.6.3 Phosphate Buffered Saline
This buffer contained NaCl (8 g/1), KCl (0.2 g/1), Na2HP0  ^ (1.15 g/1) and 
KH2PO4 (0.2 g/1) (BDH Chemicals Ltd., Poole, England) in deionised, 
distilled water and filter sterilised.
2.2.6.4 Ferric Nitrilotriacetate
FeNTA was prepared at a molar ratio of 4:1 of NT A to iron, to ensure the 
foimation of low moleculai weight rather than hydrated polymeric 
complexes (Spko e t a l, 1967). One volume of a freshly prepaied solution 
of FeClg (40 mM; BDH) was slowly added dropwise with constant stirring, 
to an equal volume of NT A (160 mM, pH 7.0; Sigma) and the pH finally
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adjusted to 5.0 with 1 M sodium hydroxide to prevent the NTA-free acid 
precipitating. The final concentration of iron was 10 mM.
2.2.6.5 Acetic acid/sodium acetate buffer (pH 4.0)
This contained 410 ml acetic acid (0.2 M; BDH) and 90 ml sodium acetate 
trihydrate (0.2 M; BDH), made up to 1 litre.
2.2.6.Ô TriS‘HCl buffer (0.05 M, pH  8.0)
This buffer contained 250 ml Tiis (0.2 M, BDH) and 26.8 ml HCl (1 M), 
made up to 1 litre.
2.2.6.7 Coupling buffer
This buffer contained 8.4 g sodium bicarbonate and 29.2 g sodium chloride 
in 1 litre of deionised and distilled water, with pH adjusted to 8.3.
2.2.7 Reagents for SDS-PAGE
2.2.7.1 Stock acrylamide solution (40 %)
38.96 g acrylamide (BDH)
1.04 g bisacrylamide (BDH)
Made up to 100 ml with distilled water, filter sterilised and kept in the dark 
a t4 'C .
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2.2.7.2 Running gel (10 %)
The running gel was made up as follows:
8.75 ml stock acrylamide (40%)
8.75 ml 1.5 M tris-HCl, pH 8.8 
16.3 ml distilled water
0.7 ml SDS (10 % w/v)
2.2.7.3 Stacking gel
Stacking gel was prepared by mixing the following in a universal: 
1.25 ml 0.5 M tris-HCl, pH 6.8
1.0 ml stock acrylamide (40 %)
7.5 ml distilled water
100 [Û SDS (10 % w/v)
2.2.7.4 Tank buffer
24 g tris (Boehringer, Mannheim)
115.2 g glycine (Sigma)
4.0 g SDS (Sigma)
Made up to 4 litre with distilled water.
2.2.7.5 Sample Buffer
50 % (v/v) glycerol (BDH)
0.25 M tris-HCl, pH 6.8 (Boehringer)
5.0 % (w/v) SDS (Sigma)
5.0 % (v/v) p-mercaptoethanol (Sigma)
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0.0125 % (w/v) bromophenol blue (BDH)
2,2 J ,6 Fixer
10 % (v/v) Trichloroacetic acid 
10 % (v/v) acetic caid 
30 % (v/v) methanol
2.2.7.7 Staining Solution
0.25 % (w/v) Coomassie brilliant blue 
50 % (v/v) methanol 
10 % (v/v) acetic acid
The solution was stiiTed overnight and filtered before use.
2.2.7.8 De staining Solution
20 % (v/v) methanol 
10 % (v/v) acetic acid 
made up with distilled water
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2.3 METHODS
2.3.1 Isolation of Human Lactoferrin
2.3,1.1 Ion-Exchange Chromatography
Lactofenin was isolated from milk by the method of Johansson (1960) with 
slight modification. One litre of frozen human milk was diluted with two 
volumes of deionised and distilled water containing 30 mg fenous 
ammonium sulphate (BDH) and was stiiTed gently with a magnetic stuTer 
for 30 min. To this 3 g of CM-Sephadex C-50, Cl" form (Pharmacia, 
Uppsala, Sweden) was added and stirred for 1 h after which the gel was 
allowed to settle. The gel was washed by suspending it in 1 litre of 
deionised, distilled water for 10 min and then decanted. This washing was 
repeated twice until the water looked clear* indicating that most of the 
unbound proteins had been washed away. The gel was then packed into a 
column made from a 60 ml syringe, and washed with 400 ml tris-HCl (0.05 
M) at a flow rate of 10 ml/h which eluted small amounts of uncoloured 
proteins. About 2.5 ml fraction was collected for every 15 min. The 
column was eluted until the nm reading was negligible. The washing 
step was repeated with 200 ml each of tris-HCl (0.05 M) buffer containing 
increasing molarity of NaCl, from 0.5 M to 2 M when lactoferrin was eluted 
from the column. The /igso readings of all fractions were taken and 
plotted in the elution profile as shown in Fig. 14.
Two peaks were observed, the first appealed when the gel was eluted with 
0.05 M Tris/0.5 M NaCl, but the major lactoferrin peak appeared when the 
column was eluted with 0.05 M Tris/2 M NaCl, the protein eluting as a clear 
red solution.
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Fig. 14 : Elution profile of lactoferrin prepared from  hum an m ilk 
according to the m ethod o f Johansson (1960), w hich had been passed 
through CM -Sephadex C-50, using 0.05 M  Tris, pH  8.0, follow ed by 
increasing concentration o f NaCl.
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About 35 ml of the eluate was pooled from fractions 40-50 andthe A280 nm 
and A455 nm were measured, the ratio of was calculated. The
pooled fraction was concentrated using an Amicon filter until the volume 
was reduced to 4 ml and this was further concentrated to about 1 ml using 
Amicon ultiafilti'ation cell equipped with a PM 10 membrane (Amicon Co., 
Lexington, Massachusettes, U.S.A.). The Amicon cells were centrifuged in 
a fixed angle rotor (Super minor, Mk 2, MSB). The purity of the pooled 
fraction was checked by SDS-PAGE as shown in Fig. 15. Two bands were 
observed, one coiTesponding to lactoferrin and the other being weak could 
be an impurity.
2.3 J ,2 Gel Filtration
A second chromatographic step was necessary in order to remove the 
impurity, consisting of gel filtration through Ultrogel ACA 34 (LKB, 
Uppsala, Sweden), which has a separation range of molecular' weights 
between 20,000-350,000 daltons. The column, 34 cm x 3.0 cm was 
equilibrated overnight with tris-HCl (0.05 M, pH 8.0) containing 0.5 M 
NaCl. The concentrated lactoferrin prepared from section 2.3.1.1 was 
applied and the column was eluted with the same buffer at a flow rate of
16.8 ml/h at 2.1 ml/tube. The Ajgo nm of each fraction was measured and 
an elution profile was plotted (Fig. 16). All fractions contributing to the 
major peak (15 ml; fractions 20-28) were pooled, concentrated and the 
A465/A280 was found to be 0.041, suggesting that the preparation was 
quite pure. Indeed it was found on SDS-PAGE to give a single band, 
having the same molecular weight as transferrin (Fig. 17).
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Fig. 15: Electrophoretic patterns of human lactoferrin preparations from
milk by passing through CM-Sephadex C-50, according to the method of 
Johansson (1960). The lanes are referred to as: (1) 10 pi of lactoferrin 
preparation, (2) standard molecular weight markers, (3) 1 pi lactoferrin 
preparation and (4) 100 pi lactoferrin preparation applied to the column.
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Fig. 16: Gel filtration on Ultrogel ACA 34 of human milk prepared from 
passage through CM-Sephadex C-50.
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Fig. 17: Electrophoretic patterns in SDS-PAGE of human lactoferrin
which has been passed through CM-Sephadex C-50 and Ultrogel ACA 34. 
The lanes are referred to as: (1) 100 p,l of lactoferrin preparation, (2) 10 pi 
of lactoferrin preparation (3) standard molecular markers and (4) 1 pi 
lactoferrin preparation.
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2.3.2 SDS-PAGE
The LKB 2001 Vertical Electrophoresis System was used with L5 mm 
spacers.
2 3 ,2 1  Preparation o f the Running Gel
About 20 ml of running gel was prepared per slab in a 100 ml Buchner 
flask. The gel solution was degassed for about 30 seconds, after which 450 
pi of 10 % (w/v) ammonium persulphate (Sigma) and 25 pi TEMED 
(Sigma) were added. The gel solution was pipetted into the gel foimer to a 
mark made previously at about 1 cm from the bottom. A few ml of water- 
saturated butanol was added to remove any air bubble and to ensure a 
straight surface. The gel was allowed to solidify for about 30 minutes after 
which butanol was tipped out and the remaining space was washed twice 
with distilled water.
2.3.2.2 Preparation o f Stacking Gel
The stacking gel was mixed with 100 pi ammonium persulphate (10 % w/v) 
and 10 pi TEMED. A small volume of stacking gel was used to wash the 
top of the running gel before pouring the stacking gel. A comb was 
carefully inserted in the stacking gel and was allowed to set for about 15 
min after which the comb was carefully extracted.
2.3.2 3 Running the Gel
Three volumes of lactofenin preparation i.e. 1, 10 and 100 pi as well as 10 
pi of SDS molecular weight markers (Sigma) were mixed with 20 pi
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sample buffer and heated at 100 °C for 5 min before loading the samples in 
appropriate spaces in the stacking gel. A constant voltage giving a cuiTent 
of 25 mA per slab was applied until the dye entered the running gel when 
the current was increased to 45 mA. Cunent was switched off when the 
frontline of the dye was about 1 cm from the bottom edge of the gel. The 
gel was placed in a fixing solution for about 20 min until the bluish 
frontline turned yellowish. It was then stained for 1.5 h and later destained 
overnight. The gel was rinsed twice with water, carefully transferred to a 
piece of blotting paper, placed on a gel dryer plate, and covered with a cling 
film. The plate was connected to a vacuum freeze-dryer for 4-6 h to dry ; 
overdrying the gel would cause it to crack. The gel was later 
photographed^
2.3.3 Desaturation of Lactoferrin
Lactoferrin as prepared in section 2.3 was iron-saturated. It was rendered 
iron free according to the protocol described by Mazurier and Spik (1980) 
by dialysis overnight, against acetic acid/sodium acetate buffer (0.1 M) 
containing EDTA ( 40 mM) and sodium phosphate (0.2 M) at pH 4.0, with 
two changes of buffer. It was finally dialysed against PBS. The ratio of 
A465 : A280 was determined to estimate the percentage of iron saturation of 
lactofeiTin.
2.3.4 Radiolabelling of Lactoferrin and Transferrin
LactofeiTin and ti'ansfenin were labelled singly either with ^^Fe or ^^ I^ or 
whenever required they were labelled with both isotopes.
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2.3.4.1 Radiolabelling with ^^Fe
Lactoferrin and transferrin were dissolved in PBS-1 % bicarbonate. To 
obtain iron saturated -^^Fe-labelled proteins, sufficient ^^Fe citrate 
(Amersham) to give 30 % ii’on saturation was added and the proteins were 
left overnight at 4 °C to allow specific binding of ^^Fe. FeNTA (20 mM) 
was then added to fully saturate the proteins. This sequential addition of 
^^Fe followed by unlabelled FeNTA ensured that all radioiron was 
specifically bound to the proteins.
23,4,2 Radiolabelling with
Labelling with (Amersham) was caiiied out by the chloramine-T 
method (Greenwood et a l ,  1963). Lactoferrin and transfenin were 
dissolved in PBS at the high concentration of 20 mg/ml because the 
effectiveness of iodination is proportional to the protein concentration. To 
1 mg of protein was added 5 |Ll1 (0.5 mCi) (Amersham) and were mixed 
gently by sucking a few times into the micropipette. Five p.1 of chloramine 
T (1 mg/ml; Sigma) was next added and was mixed for only 20 seconds 
after which 5 p.1 sodium metabisulphite (1 mg/ml; Sigma) was immediately 
added. Lastly 5 |il potassium iodide (5 mg/ml; Sigma) was mixed with the 
solution. The protein solution was then passed through a prepacked 
Sephadex G25 column (Pharmacia LKB Technology AB, Uppsala, 
Sweden) to remove any unbound Fractions of about 1 ml were
collected until the radioactivity in the gel as measured by a hand y-detector 
diminished. Five pi aliquots were taken from each fraction and counted for 
1251 in a Compugamma 1232 gamma counter (LKB-Pharmacia, Croydon, 
U.K.). Fractions giving rise to the first i^sj^peak were pooled and the A^ gQ
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nm was measured to determine the protein concentiation. The protein 
solution was filter sterilised and kept at 4 °C.
2,3,43 Double labelling with ^^Fe and ^^5/
To label the proteins with both 59pe and they were first labelled with 
^^Fe and then saturated with FeNTA according to the procedure in section 
2.3.4.1 except that the proteins were dissolved in PBS instead of PBS-1 % 
bicarbonate. The proteins were next labelled with as in section 2.3.4.2.
2.3.5 Affinity Chromatography
Four affinity columns were prepared which were: Sepharose-sheep anti­
human transferrin (S-Sa-HTf), Sepharose-normal sheep immunoglobulin 
(S-NSIg), Sephai'ose-rabbit anti-human lactofenin (S-Ra-HLf) and 
Sepharose-normal rabbit immunoglobulin (S-NRIg).
2,3,5,1 Production o f Antibodies Against Lactoferrin
The inoculum was prepared by emulsifying 1 ml of complete Freund's 
adjuvant (Difco) with an equal volume of lactofenin (1 mg/ml) in a plastic 
bijou, which was taped to a vortex and shaken vigorously for 20 min. The 
stability of the emulsion was tested by dropping a small volume of the 
emulsion into a beaker of water. The emulsion was ready to be injected if 
the drop retained its globular’ form and did not diffuse in the water. The 
emulsified inoculum was injected into two rabbits (1 ml per rabbit) by 
multiple subcutaneous inoculations at various sites followed by 3 weeks 
rest. After 3 weeks, a booster was given (1 mg/ml of lactofenin in PBS) to 
each rabbit as before, followed by a week's rest and then a trial bleed.
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Approximately 20 ml blood was collected from the ear vein of each rabbit 
into a glass universal and allowed to clot at room temperature. The serum 
was then pooled, transferred to plastic conical-bottomed test tubes (Sterilin) 
and centrifuged twice at 500 g for 5 min to remove any erythrocytes. The 
antibody titre was checked by the ring precipitin test as follows. A small 
volume of lactofenin solution (10 p,g/ml; 100 pg/ml and 1 mg/ml) was 
gently layered on top of a similar’ volume of antiser'um in a Durham tube. 
The formation of strong precipitin bands with all three concentration of the 
protein indicated a very good titre.
23,5 ,2  Preparation ofIgG  from  Anti-Serum
IgG was prepared from rabbit anti-serum by ammonium sulphate 
precipitation. Ten ml of ice-cold serum was pipetted into a small beaker 
and saturated ammonium sulphate solution was gradually added with 
constant stining, and then left to stir for 1 h. The precipitate was recovered 
by centrifugation at 3000 rpm for 10 min at 4 °C, resuspended in 20 ml of 
50 % saturated ammonium sulphate solution and left to stir for another 1 h. 
The precipitate was spun down as before and resuspended in 5 ml PBS. It 
was then dialysed against 2 x 2  litre coupling buffer to remove traces of 
ammonium sulphate. The purity of IgG preparation was checked by 
measuring its /Igso and A^gg nm. The ratio of A28o-A25o was found to 
be 2.7, indicating that the prepaiation was pure. Finally the concentration 
of the IgG preparation was adjusted to 5-10 mg/ml.
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2.3.5,3 Coupling o f  Lactoferrin and Transferrin to CNBr-Activated 
Sepharose 4B
The required amount of freeze-dried CNBr-activated Sepharose 4B 
(Pharmacia Ltd., Milton Keynes, U.K.) was swollen in 1 mM HCl for 15 
min, then washed with the same solution on a sintered glass filter (200 ml/g 
gel). The gel was finally washed and resuspended in the coupling buffer 
(see section 22.6.1). The proteins to be conjugated were previously 
dialysed against the coupling buffer for 2 days, the concentration then 
adjusted to 5-10 mg/ml as judged by spectroscopic absorption at 280 nm. 
Two volumes of the swollen gel were immediately mixed with one volume 
of the protein (5 mg protein per ml swollen gel). The mixture was left 
rotating in an end-over-end mixer for 2 h at room temperature after which it 
was centrifuged and the supernatant saved to calculate by the difference the 
amount of the protein coupled. Excess ligand was washed away with the 
coupling buffer on the glass filter and any remaining active groups was 
blocked by treatment with 2 volumes of 1 M glycine for 2 h at room 
temperature. The final product was washed with 3 cycles of 0.1 M sodium 
acetate buffer (pH 4) containing 0.5 M NaCl followed by the coupling 
buffer, to remove traces of non-covalently adsorbed materials.
23,5 ,4  Preparation o f  Insolubilised Sepharose-Antibody Conjugates
The gel prepared as in section 2.3.5.3 was placed in a column made from a 
10 ml syringe. Ten ml of anti-serum was passed through the column twice. 
The column was washed with PBS to elute any unbound protein. It was 
then washed with 3 M KSCN (BDH) in 0.1 M NaHCOg (pH 8.5) to elute 
bound antibody. The washes containing the antibody were next passed 
through prepacked Sephadex G-25 columns (Pharmacia) to remove any
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salts. About 10 ml fraction was collected and its Aggg nm was measured. It 
was then coupled with 0.5 g CNBr-activated Sepharose 4B gel following 
similar procedure as described in section 2.3.5.3. The conjugates were 
stored at 4 °C in PBS containing 0.02 % (w/v) sodium azide.
23,5 .5  Specific Activity o f  Sepharose-Antibody Conjugates
The binding capacity and cross reactivity of the immunoabsorbents were 
checked by passing 5 p,g of ^^Fe-lactofenin and ^^Fe-transferrin through 50 
|il of each gel. Cross reactivity of Sepharose-rabbit anti-human lactoferrin 
with transferrin was negligible but for Sepharose-sheep anti-human 
transferrin, it was necessary to pass through 1 mg of unlabelled lactoferrin 
to reduce cross reactivity with lactoferrin to < 10 %. The binding capaeities 
of the anti-transferiin and anti-lactoferrin immunoabsorbents were 82 and 
92 jag of ligand per ml of settled gel respectively.
2.3.6 Cell Culture
U937 cells were routinely cultured in RPMI 1640 medium supplemented 
with 10 % FCS in a humidified atmosphere of 95 % ah' and 5 % CO^ They 
were subcultured every 3 days at 3 x 10^ cells/ml and were maintained for 
8-10 weeks. Except where otherwise stated, serum-free medium containing 
HSA (1 mg/ml) in place of FCS was used in all experimental procedures in 
order to eliminate interference by transferrin and other proteins present in 
the serum. The iron concentration of RPMI 1640 was estimated at 6-12 
ng/ml by carbon furnace atomic absorption spectroscopy. Log-phase cells 
obtained 18 h after subculture were used in all experiments. The cells were 
washed twice with warm Hanks buffered salts solution (HBSS; Flow),
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resuspended in semm-free medium and incubated for 30 min at 37 °C to 
ensure exocytosis of serum proteins prior to use,
2.3.7 Binding of Lactoferrin and Transferrin to U937 Cells
Log-phase cells (1 x 10^ cells/ml) were incubated with 10 p,g/ml 2^5%_ 
labelled lactoferrin or transferrin and an equal amount of unlabelled 
transferrin or lactofenin respectively, to ensure that the two cultures 
contained both iron-binding proteins. The tubes were incubated either at 4 
°C or 37 °C for various time intervals from 30 to 360 min. At each time 
interval, an aliquot (0.5 ml) of cell suspension was removed and 
immediately placed in ice water, and the cells spun down at 1500 rpm for 5 
min in a refrigerated centrifuge; the supernatant removed and the cells were 
washed with ice-cold HBSS. The washing was repeated three times and 
prior to the last wash the cell suspension was transferred to a fresh tube to 
minimise the problem of non-specific binding of radioisotope to the tube. 
Radioactivity in the supernatants, washes and cell pellets was measured in a 
Compugamma 1232 gamma counter.
2.3.8 Determination of Lactoferrin and Transferrin Receptors on 
U937 Cells
A polystyrene 96-well round bottom plate (Flow) was coated with 100 p,l of 
gelatin (0.25 % in 1 % BSA-PBS; Sigma) per well at 37 °C for 1 h. 
Aliquots of 25 pi of log-phase cells (2 x 10  ^ cells/ml) were placed in each 
well, giving 5 x 10^ cells/well. Cells were incubated either with varying 
amounts of ^^si-iabelled proteins alone (2 - 24 pg/ml in 0.2 % BSA-PBS), 
to deteiinine the total binding sites, or with the same amounts of labelled 
proteins plus a 200 fold excess of competing unlabelled protein, to
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determine the non-specific binding. The plate was incubated at 4 °C for 1 h 
after which the cells were harvested using a cell harvester (Ilacon, 
Tonbridge, U.K.) on to a glass fibre mat which had been prewashed with 
0.2 % BSA-PBS. Each filter was cut out and counted in the gamma 
counter. The number and affinity of the receptors were calculated by the 
method of Scatchard (1949).
2.3.9 Determination of Specificity of Lactoferrin and Transferrin 
Binding to U937 Cells
To log-phase cells in plastic conical tubes were added 10 pg/ml ^^spiabelled 
lactofeiTin or tr ansfeiTin each with the addition of equal amount of opposite 
unlabelled proteins or PBS as a control. All tubes were incubated at 4 °C 
for 30 min after which the cells were treated as in section 2.3.7.
2.3.10 Effect of Milk Proteins on Binding of Lactoferrin to U937 Cells
To duplicate tubes of 1 ml cell suspensions (lOVml) were added 
labelled human or bovine lactoferrin (10 pg/ml) and unlabelled competing 
proteins (a-lactalbumin, P-lactoglobulin, lactoperoxidase, IgA and 
lysozyme) at 10 pg/ml or 200 pg/ml and incubated for 30 min at 4 °C. The 
cells were then treated as in section 2,3.7.
2.3.11 Effect of Heparinase on Binding of Lactoferrin and Transferrin
Log-phase cells were prepared, as in 2.3.6 but were resuspended in warm 
serum-free RPMI 1640 medium plus 0.2 % BSA (Sigma). To 200 pi 
aliquots of cell suspension (lOVml) were added 10 pi of PBS (control), 1 or 
2 units of Heparinase III (Sigma) and incubated at 37 “C for 1 h after which
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the cells were immediately placed in ice water, lactoferrin or
transferrin (10 pg/ml) was added to appropriate tubes and were then 
incubated at 4 °C for 30 min. All tubes were treated as in section 2.3.7.
2.3.12 The Effect of Fucose on Binding of Lactoferrin and Transferrin
To U937 cells prepared as in section 2.3.11 were added 10 pi fucose (5 
mg/ml; kindly provided by Dr. D.A.R Simmons, Department of 
Bacteriology, Western Infirmary, Glasgow) or glucose (5 mg/ml; Fisons, 
Loughborough, U.K.) and mixed well. lactofenin or
transfenin (10 pg/ml) was added and the cells were incubated at 4 °C for 1 
h. All tubes were treated as in section 2.3.7.
2.3.13 Effect of lactoferrin on the binding of monoclonal antibodies 
to monocyte surface markers
To one ml aliquots of cell suspension (5 x lOVml) were added lactoferrin 
(10 pg/ml) or PBS (control) and these were incubated at 4 °C for 30 min. 
Five pi of monoclonal antibodies to monocyte cell surface markers were 
next added and incubated for 30 min after which the fluorescence was 
measured in the Fluorescence Activated Cell Sorter (FACSCAN, Becton 
Dickinson). In another experiment, increasing concentrations of lactofenin 
(0, 10, 50 and 250 pg/ml) were used to confirm the effect of monoclonal 
antibodies against CD4 and DR on the binding of lactoferrin to the cells.
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2.3.14 Iron Uptake from Lactoferrin and Transferrin by U937 Cells
Iron uptake from lactoferrin and transferrin was determined by incubating 
10 ml of cell suspension (2 x 10^ cells/ml) at 37 °C with ^^Fe-labelled 
lactofenin or transfenin (50 pg/ml) plus unlabelled transferrin or lactofenin 
(50 pg/ml) respectively at various time intervals. The thud tube contained 
equal amount of unlabelled lactofeiTin and transfeiTin to study the 
thymidine uptake of these cells, in parallel with the measurement of iron 
uptake. At each interval 2.5 ml cell suspension was removed and treated as 
in section 2.3.7.
2.3.15 Exchange of Iron Between Lactoferrin and Transferrin During 
Cell Culture
In order to examine the possibility that there might be a transfer of ^^Fe 
from one iron-binding protein to another during culture, 50 pi aliquots of 
each culture supernatant were removed and passed through 50 pi of anti- 
transferrin and anti-lactoferrin immunoabsorbents. The gels were washed 
with 1 ml PBS to remove all unbound protein and the washes and gels 
assayed for ^^Fe activity.
2.3.16 The Effect of Lactoferrin on Iron Uptake from Other Sources
To determine the effect of lactoferrin on iron uptake from other sources, 
cells were incubated with 50 pg/ml ^^Fe-transferrin or 8 mM Fe as 
^^FeNTA in the presence or absence of 50 pg/ml of unlabelled 
apolactofenin or 50 % Fe-saturated lactoferrin.
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2.3.17 Internalisation of Lactoferrin and Transferrin (Acid Treatment)
Cells (2 X 1Q5 in 200 pi) were incubated with 50 pg/ml ^^spi^belled 
lactoferrin or transferrin at 4 °C or 37 '"C for 30 min, then spun down and 
washed three times with ice cold PBS. Surface and intracellular distribution 
of the labelled proteins was determined by treating the cells with 200 pi of 
0.25 M acetic acid/0.5 M NaCl, pH 2.3 for 5 sec, followed by addition of 
100 pi of 1 M sodium acetate which raised the pH to 6.3. Cells and 
supernatant were separated by rapid centrifugation through Versilube F50 
oil (Alfa, Wokingham, U.K.).
2.3.18 The Effect of Primaquine on Internalisation of Lactoferrin and 
Transferrin
To determine whether endocytosed proteins were recycled back to the cell 
membrane, cells that had been initially incubated with ^^Fe,^25i_iabelled 
lactofenin or transferrin (50 pg/ml) were treated for 30 min at 37 “C with 3 
mM primaquine (Sigma) following removal of unbound labelled proteins. 
The cells were then subjected to acid-washing as in 2.3.17.
2.3.19 Dissociation Studies
Cells were preincubated with 59pe,i25i_iabelled lactoferrin or transferrin (10 
pg/ml). Unbound proteins were removed by centrifugation as in 2.3.7 and 
the washed cells reincubated in the presence of 1 mM desferrioxamine 
(CIBA, Horsham, U.K.). In another expeiiment, desferrioxamine was 
replaced by apotransfeirin or apolactoferrin (50 pg/ml). At various time 
intervals, aliquots were removed and centrifuged. Radioactivity in the cells 
and supernatants was assayed. In some expeiiments, the supernatant was
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treated with 10 % (w/v, final concentration) trichloroacetic acid to check 
whether proteins released into the medium had been degraded.
2.3.20 Measurement of Cell Proliferation
Log-phase cells (3 x lOVml) in serum-free medium were incubated with 
appropriate additions (apolactofenin, lactofenin, apotransferrin and 
transferrin) at 50 pg/ml for 28 h after which 5 x 100 pi aliquots were pulsed 
with 1 pCi ^H-thymidine (Amersham) for 4 h. The cells were then 
harvested on glass fibre mats using a cell harvester (Skatron, Lierbyen, 
Noiway), which were usually left overnight on the bench to dry. Individual 
discs, each with contents of a single well, were added to 2 ml of scintillation 
fluid (LKB, Croydon, Suney, England) and counted for 5 min on a 
scintillation counter (Packard, Pangbourne, Berkshiie, England).
2.3.21 The Effect of Milk Proteins on Cell Proliferation
Measurements of cell proliferation was as in 2.3.24 except that samples 
contained 50 pg/ml native apolactoferrin or Fe-transferrin plus 50 pg/ml 
test protein (milk proteins or heated lactofenin) or 100 pg/ml native 
lactoferrin alone. Controls contained no added proteins.
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2.4 RESULTS
2.4.1 Binding Studies of Lactoferrin and Transferrin to U937 Cells
2 .4 J J  Binding pattern o f  Lactoferrin and Transferrin
Binding of lactofenin and transferrin to U937 cells as a function of time and 
temperature is shown in Fig. 18 and Fig.l9 respectively. Binding of 
lactoferrin and tiansferrin was found to be temperature dependent; at 4 °C, 
binding of both lactofenin and transfenin remained almost constant but at 
37 °C, lactofenin associated with the cells increased gradually throughout 
the 6 h incubation period. Binding of transfenin at 37 “C was more rapid 
than that of lactofenin and reached a plateau after 2 h. At both 
temperatures, the cells bound about ten times more lactoferrin than 
transfenin.
To characterise the binding in more detail the specific and non-specific 
binding was detenuined (Figs. 20 and 21) and the results subjected to 
Scatchard analysis. Again, it was found that total binding of lactoferrin to 
the cells was about 10 times greater than total binding of transferrin. 
However, most of the lactofenin binding was non-specific, although 
Scatchard analysis revealed that there was nevertheless a specific element 
(Figs. 22 and 23). The number of lactofenin binding sites per cell (3.0 x 
10^) was similar’ to that for transferrin (1.9 x 10^). The dissociation constant 
for the specific binding of lactoferrin to U937 cells was 4-fold higher (83 
nM) than that for transferrin (21 nM).
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2A .1,2 Competitive Binding o f Lactoferrin and Transferrin to U937
Cells
In order to determine whether lactofenin shares the same binding sites as 
transfeiiin on U937 cells, these cells were incubated with labelled 
lactofeiTin or transfenin and an equal amount of unlabelled proteins. 
Binding of lactofeixin was not greatly affected by Fe-tiansfemn or 
apotransfeirin (Fig.24), and neither form of lactoferrin affected transferrin 
binding (Fig. 25). These findings suggest that lactoferrin binding sites are 
different from those for transfenin.
In other competitive experiments to investigate whether fucose residues 
present in human milk lactofenin were involved in its binding to the 
receptor, it was found that binding was not inhibited by 30 mM fucose, nor 
glucose of similar' concentration (Table III). Furthermore treatment of the 
cells with heparinase (1-2 units/ml), which cleaves the acidic sugar residues 
did not result in reduced binding of lactofenin as well (Table III).
When monoclonal antibodies were added with lactoferrin to the cells, it was 
found in preliminary experiments that in most cases lactoferrin did not 
inhibit the binding of monoclonal antibodies to CD3, C D llb , CD 14, CD 
25 and CD 45 but somehow in these initial experiments anti-CD4 and anti 
HLA-DR showed a significant shift in the peak fluorescent channel as 
compared to the control. However further test to determine the effect of 
increasing concentration of lactofenin did not alter the peak fluorescent 
channel values (Fig. 26). These results indicate that none of of the nine 
monoclonal antibodies tested was found to share the same binding site as 
lactofenin on U937 cells.
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Fig. 24 : Effects of transferrin on the binding of
lactoferrin to U937 cells. Values represent means ± SD 
(n = 4).
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Fig. 25 : Effects o f lactoferrin on the binding of
transferrin to U937 cells. Values represent means ±  SD 
(n = 4).
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TABLE III
Effect o f heparinase, fucose and glucose on the binding o f
lactoferrin 
and transferrin to U937 cells
U937 cells were incubated with heparinase HI (1-2 units/ml) for 1 h at 
37°C in serum-free RPMI medium plus 0.2 % BSA, after which the 
tubes were immediately placed in ice water before adding 10 (xg/ml 
125i_iactofeiTin or l^^I-tiansfenin and incubated at 4°C for 30min. In 
another experiment, the cells were incubated with 30mM L-fucose or 
D-glucose together with labelled lactoferrin or ti'ansfeiiin in serum-free 
RPMI medium containing 0.2% BSA for 30min at 4°C. At the end of 
incubation, cells were washed 3 x with HBSS and assayed for cell- 
associated radioactivity. Values represent means + S.D. for thiee 
determinations
Cell-associated radioactivity 
sample/conü'ol x 100 ( % )
Addition Heparinase L-Fucose D-Glucose
Lactoferrin 96.7 ±19.1 100.7 + 13.3 101.4 + 0.05
Transfenin 78.7 + 10.8 101.9 + 4.3 103.8 ±14.9
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Fig. 26: The effect of different concentrations of lactoferrin on the binding 
of monoclonal antibodies to CD4 and DR as observed from 
immunofluorescence measurements.
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2,4,13 Effect o f Milk Proteins on Binding o f Lactoferrin to U937 
Cells
Just like human lactofenin, there was also an appreciable binding of bovine 
lactofenin to U937 cells; binding of bovine lactoferrin being 47 % higher 
than human lactofenin. Binding of labelled bovine lactofenin was reduced 
by the presence of unlabelled bovine lactofenin, especially with excess of 
it which markedly reduced binding to about one third of the total binding
(Fig. 27). Bovine lactoferrin on the other hand did not inhibit binding of
excess
labelled human lactofenin, in the presence of even 20-foldy(of bovine 
lactofenin; if anything binding was slightly increased (Fig. 28). This 
suggests that the recognition mechanisms for human and bovine lactoferrin 
are not identical. Most of the other milk proteins tested had no effect on the 
binding of either human or bovine lactofenin to U937 cells. Human IgA at 
200 jLig/ml was somewhat inhibitory for bovine lactoferrin, but the effect 
was not observed when the IgA concentration was reduced to 10 |Lig/ml, and 
neither concentr ation had any effect on the binding of human lactoferrin. In 
contrast bovine lactoperoxidase, even at 10 pg/ml, inhibited binding of 
human lactoferrin, but had no effect on the binding of bovine lactoferrin. 
Lysozyme, like bovine lactoferTin showed a slight tendency to increase 
binding of human lactofenin, but again there was no effect on the binding 
of bovine lactofenin.
2,4,1,4 Effect o f Heat Treatment on Binding o f Bovine Lactoferrin 
to U937 Cells
Figure 29 shows that binding of labelled bovine Fe-lactoferrin to U937 
cells was inhibited by an excess of native lactofenin both in the apo and 
diferxic forms.
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Fig. 27 : Effect of milk proteins on the binding of bovine lactoferrin 
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Fig. 28 : Effect of milk proteins on the binding of human lactoferrin 
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This result further confirms the earlier finding in section 2.4.1.2. The three 
heat ti’eatments of lactofenin (72 "C for 20 sec, 85 “C for 20 min and 137 "C 
for 8 sec) caused it to become less inhibitory with only 20 % inhibition 
instead of 34 % for the native lactofenin. There was no difference in the 
inhibitory effects of lactoferrin subjected to the different heat treatments, or 
between apo- and Fe-lactofenin.
2.4.2 Iron  U ptake Studies
Iron uptake by U937 cells from ^^Fe-labelled lactofenin or transfenin over 
a 56 h period at 37 “C is shown in Fig. 30. Initially, there seemed to be 
more iron uptake from lactofenin than from tiansferrin, but after this initial 
delay, there was a progressive and linear increase in iron uptake from 
transfenin. With lactofenin, there was no evidence of any sustained iron 
uptake prior to 26 h, and thereafter uptake was much slower than from 
bansfenin, so that by the end of 56 h incubation, there was a 9-fold increase 
for transfenin as compared to only less than double for lactofenin.
However, when a similar expeiiment was performed over a shorter time 
period, using doubly labelled (^^Fe, ^^ I^) proteins, it was evident that much 
of the apparent iion uptake from lactofenin was due to the much greater 
binding of this protein to the cells than to net iron uptake (Fig, 31). Initially 
at 2 h incubation the amount of cell-associated protein and iron in pmol/10^ 
cells for transferrin were 0.61 and 7.74 respectively and for lactoferrin were 
2.95 and 7.06.
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Fig. 30 ; Iron uptake from  transferrin (Tf) and lactoferrin (Lf) by 
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Fig. 31 : M olar ratio of iron : protein bound to U937 cells incubated 
with labelled lactoferrin (Lf) or transferrin (Tf).
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After 18 h the amount of transferrin bound remained fairly constant (0.76 
pmol/10® cells) but the amount of ^^Fe associated with the cells had 
increased 7 x (51.50 pmol/10^ cells), whereas with lactoferrin both protein 
and iron had increased (5.9 and 35.50 pmol/10^ cells). Thus as shown in the 
graph, the molar ratio of cell-associated iron:lactofenin was 2.4 at 2h and 
increased only slightly to 5.9 after 18 h, but for tiansfenin the graph clearly 
illusti'ates that there was a steady accumulation of iron relative to 
transfenin, the ratio of iton to protein being 12.7 at 2 h and increased to 66 
at 18 h.
2.4.3 Effect of Lactoferrin on Uptake of Iron from Other Sources
Since lactofenin itself had little or no ability to donate non to U937 cells, it 
was of interest to determine whether it could affect uptake of iron from 
other sources. Both apolactoferrin and Fe-lactoferrin significantly reduced 
uptake of non-transfenin bound iron in the form of FeNTA, but neither had 
any effect on the uptake of iron from transfenin (Fig. 32 ).
2.4.4 Internalisation of lactoferrin and Transferrin
In order to determine whether bound lactofenin and transfenin were 
internalised, the cells were incubated with doubly labelled proteins for 30 
min at 4 °C or 37 C and the cell-surface bound proteins were then removed 
by rapid acid wash.
Table IV shows that this procedure released 80 % of the cell-associated 
lactofenin regardless of whether incubation was caiiied out at 4 "C or at 37 
°C. In contrast 65 % of bound transferrin was removed from the cell 
surface after incubation at 4 °C but only 41 % after incubation at 37 "C.
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Fig. 32 : Iron uptake by U937 cells from  Fe-transferrin (Fe-Tf) and 
ferric nitrilotriacetate (FeNTA). Values represent means ±  SD (n = 4).
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TABLE IV
Internalisation o f lactoferrin and transferrin by U937 cells
U937 cells were incubated with SOfig/ml of labelled lactofenin or 
tiansferrin for 30 min. Unbound protein was removed and the 
proportion of surface-bound protein determined by acid washing. 
Values represent means ± S.D. of thiee experiments
% of bound protein 
retained after acid washing
Incubation temperature 4°C 37°C
Lactoferrin 16±1 19±1
Transferrin 35+1 56+6
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Thus at 37 °C more than half of bound tiansfenin but < 20 % of lactofenin 
had been internalised.
To determine whether the small proportion of cell-bound lactofenin 
resistant to acid washing had really been endocytosed, the effect of 
primaquine on the interaction of doubly labelled lactofenin with the cells 
was investigated and the results compared with that of transferrin. The 
amount of transfenin internalised doubled in the presence of piimaquine 
(Table V), indicative of slower recycling of internalised transferrin to the 
cell surface. The molar ratio of iron:transferrin retained within the cells 
decreased in the presence of piimaquine, indicating a reduced rate of iron 
deposition, which is consistent with slower cycling of transferrin. In 
contrast, the amount of lactoferrin retained by the cells after acid washing 
was similai' in the presence or absence of primaquine and the molar ratio of 
iron:lactofenin associated with the cells was close to 2 in both cases. This 
confirms that lactoferrin was not being internalised by the cells to any 
measurable extent.
2.4.5 Exchange of Iron Between Lactoferrin and Transferrin During 
Cell Culture
The previous results indicate that U937 cells do not internalise lactofenin 
but despite this, the results shown in Figs. 30 and 31 (see section 2.4.2.1) do 
indicate an apparent slow net accumulation of iron from lactofenin. Since 
iron is taken up much more rapidly from tiansfenin, it seemed possible that 
these apparently contradictory results might be explained by a transfer of 
some ^^Fe from lactofenin to transfenin during culture. To determine 
whether such a transfer occuned, supernatants from 18 h cultures 
containing ^^Fe-lactoferrin and unlabelled transfenin or vice versa were
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TABLE V
Effect o f primaquine on internalisation o f lactoferrin and transferrin
by U937 cells
Cells were labelled with 59pe-iabelled lactoferrin or transferrin 
for 30min at 4°C. Unbound protein was removed and the cells 
incubated with primaquine (3mM) at 37°C for a further 30min prior to 
acid washing. Values represent means + S.D. of three experiments
% of bound protein retained 
after acid-washing
Molar ratio 
Fe-.protein
Primaquine + +
Lactofenin 11+2 13+2 1.8 2.4
Transferrin 83+5 40+4 4.1 7.1
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passed thi'ough anti-transfenin and anti-lactofenin immunosorbents. After 
correction for non-specific binding it was found that 16.6 % of ^^Fe 
originally bound to lactofenin had transfened to transfenin, as against only 
5.9 % of iron transfened from ttansferrin to lactofenin (Table VI). Thus 
the apparent uptake of hon from lactofenin could be due to a prior ti'ansfer 
of some of ^^Fe from lactofenin to transferrin. No transfer of ^^Fe was 
detected in medium prior to incubation with the cell.
2.4.6 Release of Iron, Lactoferrin and Transferrin by U937 Cells
To determine whether transfer of ^^Fe results from cell-associated 
lactoferrin releasing its iron at the cell surface, the relative rates of 
dissociation of non and transferrin/lactofenin from U937 cells was 
investigated. When cells previously incubated with I,^  ^Fe-lactofenin or 
transferrin were washed and reincubated at 4 °C in fresh medium containing 
neither protein, but with 1 mM desfenioxamine (to prevent re-entry of 
released non into the cells), about 80 % of Fe dissociated from the cells 
over a 90 min period (Fig. 33 ) as compared to only about 60 % of the 
lactofenin itself, indicating that some iron was dissociating from the 
membrane-bound lactofeixin. It seems unlikely that desfenioxamine itself 
is responsible for this release as exchange of iron between transferrins and 
desfenioxamine is extremely slow under physiological conditions (Pippard, 
1989). Furthermore similar results were obtained when apotransferrin was 
used instead of desferrioxamine to capture iron released from lactoferrin; 28 
% of iron remaining cell-associated after 90 min, as compared with 20 % in 
the presence of desfenioxamine, while the proportion of lactoferrin 
remaining bound to the cells at this time was 41 % in both cases. The small 
decrease in iron release resulting from substitution of apotransferxin for
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TABLE VI 
Transfer o f iron from  transferrin to lactoferrin
and vice versa during culture o f Ü937 cells
Route Fe - transfer (%)
Transfenin —> lactoferrin 5.9
Lactofenin —> tiansfenin 16.6
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Fig. 33 : D issociation of bound i^^I,^^Fe-labelled lactoferrin from  
U937 cells w ith time. Each point is a m ean from  three separate 
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desferrioxamine may be due a slow return of some of the released iron to 
the cells from transfenin.
In contrast there was no release of iron previously bound to transferrin (Fig. 
34) even though about 35 % of the bound transfenin was released, 
suggesting that most of the iron had aheady been internalised. More than 
92 % of the supernatant activity was TCA precipitable at all time 
intervals for both proteins, suggesting that little protein catabolism occured 
during the incubation.
2.4,7 Studies on Cell Proliferation
2.4.7.1 Effect o f Lactoferrin and Transferrin on the Proliferation o f  
U937 Cells
Cells grown in serum free medium in the presence of eitffifcr lactoferrin oF 
transfenin incorporated more thymidine (p < 0.01) (Fig. 35). The effect 
of Fe-containing lactofenin and transfenin on thymidine uptake was 
similar, with an increase of 61 % and 72 % over the control. Addition of 
apolactoferrin or apotransfeirin also increased thymidine uptake but to a 
lesser extent, the figures being 41 % (apolactoferrin) and 39 % 
(apotransfeirin) greater than the control.
2.4.7.2 Effect o f Heat Treated Lactoferrin and Milk Proteins on the 
Proliferation ofU 937 Cells
Bovine lactofenin also caused a marked increase in ^H-thymidine uptake by 
the cells (Fig. 36). Apolactofenin and Fe-lactoferrin were equally effective. 
Heat treatment of Fe-lactofenin at 72 “C for 20 sec or at 137 °C for 8 sec
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Fig. 34 : Dissociation of bound ^^Fe-transferrin from U937 cells 
with time. Each point is a mean from three separate experiments.
123
<D
CJ
'Oo
70
60 -
CL
o  50
QJ
a .3
(D
.S  30 
"O
S
20H
rcm
o
10 -
0
T
C ontrol Fe-Lf ApoLf Fe-Tf ApoTf
Fig. 35: The effect of lactoferrin and transferrin on the incorporation 
of ^H-thymidine by U937 cells. Columns and vertical bars represent 
means ± SD of five replicate wells from two separate experiments.
f # P <  &0l : p < 0.05 )
124
200
160 -
c0
1o
8  120
CO
>
I<D
(z;
80 -
40 -
0
control fe-iactoferrin apolactoferrin
Fig. 36 : Effect of heat-treated Fe-lactoferrin and apolactoferrin on 
3H-thymidine incorporation by U937 cells. The cells were 
incubated with 50 pg/ml of either untreated lactoferrin ,|1 , or 
lactoferrin heat-treated at 72 ”C for 20 se cO , 85 ”C for 20 min g ,  
or 137 °C for 8 s e c 0 . Results are means ± SD (n = 5).
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did not abolish the stimulatory effect, but when Fe-lactoferrin was subjected 
to the most severe treatment (85 “C for 20 min) it became slightly but 
significantly inhibitory rather than stimulatory. In contiast none of the heat 
treatments altered the stimulatory effect of lactofeiTin.
None of the milk proteins by themselves had any significant effect on 
thymidine incorporation, nor did they modify the stimulatory effect of 
lactoferrin (Fig. 37).
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Fig. 37 : Effect of lactoferrin and milk proteins on the uptake of 
^H-thymidine by U937 cells. The cells were incubated with 50 
pg/ml native lactoferrin plus 50 pg/ml milk proteins, g  or 100 
pg/ml native lactoferrin g  milk protein alone, , Controls 
contained no added lactoferrin. Values are means ± SD (n = 5).
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2.5 DISCUSSION
This chapter has examined the molecular basis of interaction of lactofenin 
with a promonocytic cell line, U937 and its effect on these cells.
2.5.1 Binding of lactoferrin and transferrin
LactofeiTin has been reported to bind to a number of cell types including 
cells of the reticuloendotheliel system, lymphocytes, intestinal binsh border 
membranes, a variety of cultured leukemic cell lines and a human colon 
adenocarcinoma cell line (reviewed by Birgens, 1991). Hepatocytes, 
Kupffer and liver endothelial cells have also been observed to bind 
lactofenin. Binding of lactoferrin to some of these cells was reported to 
occur through specific receptors which have been demonstrated in human 
fetal intestinal brush border membranes (Kawalcami and Lonnerdal, 1990) 
and in phytohaemagglutinin-stimulated peripheral blood lymphocytes 
(Mazurier a/„ 1989).
The binding of lactofenin to the cells of the RES was first reported by Van 
Snick (1974). They found that binding of human milk lactoferrin to mouse 
peritoneal macrophages had occuned through a specific receptor. Since 
then many studies have confinned the binding of lactofenin to monocytes 
and macrophages (Bennet and Davis, 1981; Steinmann et a l,  1982; Bartal 
et a l,  1987; Oria et a l ,  1988). Apart from Van Snick's group others have 
also reported receptor binding of lactofenin to these cells. However, since 
then there has not been any membrane lactofeirrin-binding molecules that 
have been identified. There are also others who have suggested that the 
binding is relatively non-specific (Goavec et a l ,  1985).
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In this study, lactofenin and transfenin have been found to bind to U937
cells; binding was dependent on temperature as was also observed in the
case of lactofenin binding to human adenocarcinoma cells, HT29-D4
at 37 X
(Roiron et a l,  1989). The maximum bindingywas about 4 x as high as ' that) 
at 4 °C (Fig. 18 ). Binding of transferrin at 37 °C was observed to be more 
rapid than that of lactofenin, reaching a plateau in less than 2 h (Fig. 19). 
However at both temperatures, maximal binding of lactoferrin was about 
10-fold greater than that of transferrin. When the binding curves for 
lactofenin and transferrin at both temperatures are extrapolated to 0 h, the 
number of protein molecules bound per cell aie estimated to be about 14.4 x 
10  ^molecules of lactofenin per cell and 1.5 x 10  ^ molecules of transferrin 
per cell.
The binding pattern of lactofenin differs from that of transfenin when the 
incubation was canied out at 37 “C. Transfenin binding showed saturation 
after 2 h incubation. The uptake of transfenin at this temperature is likely 
to represent, initially binding of transfenin to the receptors present on the 
cell surface at the time, and later binding to the receptors which are recycled 
to the surface from the interior during the incubation. The low saturating 
level of transfenin binding at 4 °C can be explained by the fact that 
receptors located inside the cell at this temperature do not recycle to the cell 
surface and therefore cannot rebind more transfenin. Once all the receptors 
have been occupied, no further increase in uptake is possible and a steady 
state is reached between binding, endocytosis and exocytosis of transfeirin. 
In the case of lactoferrin, binding occuned more rapidly within the first 2 h 
of incubation, similar’ to transfenin, but more lactofenin seemed to bind to 
the cells with time. The increase in lactoferrin binding is probably due to 
non-specific binding of lactofenin to the cells as was observed from 
competition experiments.
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The presence of cell membrane receptors for both proteins was suggested 
by the saturation studies performed in the presence of unlabelled proteins 
(Figs. 20 and 21). As predicted binding of labelled transferrin to the cells 
was found to be saturable and was inhibited by the presence of excess/,of 
unlabelled transfenin. Total binding of labelled lactoferrin on the other 
hand increased in an approximately linear' manner within the range of 
concentration used in this study, indicating a non-specific, non saturable 
process, but there was also a specific component to the lactofenin binding 
demonstiated by adding a large excess of non-radioactive lactofenin to the 
incubation medium. Although this represented only a small fraction of the 
total binding, the number of specific sites for lactoferrin (3.0 x 10  ^
sites/cell) was actually slightly greater than for transferTin (1.9 x 10^ 
sites/cell), as demonstrated from Scatchard analyses of the binding data 
(Figs. 22 and 23). The number of specific lactofenin binding sites per cell 
found in this study is similar to that obtained by Roiron et a l  (1989) (N =
4.1 X 10^) and falls between the values obtained by Van Snick et a/.(1976) 
(N = 20 X 10^) using mouse peritoneal macrophages and that of Birgens et 
a/. (1983) (N = 1.6 X 10^) using human blood monocytes.
The affinity of the specific binding of lactofenin to U937 cells (K^ = 83 
nM) is also within the range of values reported for binding to other cells, 
being comparable to that of activated lymphocytes (46 nM) (Rochard et a l , 
1989), lower than that of the high affinity binding sites on hepatocytes (K^ 
20 nM) (McAbee and Esebensen, 1991) and higher than the "high-affinity" 
binding sites on adenocarcinoma cells (K^ _ 408 nM) (Roiron et a l ,  1989). 
When compared to other studies using monocytes or macrophages, the 
binding affinity of lactofenin to U937 was higher than that for 
macrophages (K^ = 600 nM) (Campbell, 1982; Van Snick et a l  1976) but 
lower than binding affinity for human monocytes (K^ = 0.22 nM) (Birgens
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et a l, 1983). Therefore it can be concluded that the quantitative binding 
data (affinity constants and number of binding sites/cell), obtained in this 
study falls between the values obtained by others. The slight differences in 
values could be explained on the basis of different cell types as well as due 
to the neoplastic characteristics or origin of U937 cells. In addition, the 
variation in values obtained could be attributed to the difference in the 
concentration of labelled lactofenin employed in the binding assay. In this 
study the concentration range used was between 1-150 nM, while in other 
studies with higher binding sites, higher concentration range was used, i.e., 
0.2 - 5.0 mM (Van Snick et a l, 1976) and 0.1 - 10 mM (Campbell, 1982). 
According to Bennett and Davis (1981), concentration of lactoferrin >3.1  
ftM may cause cell aggregation which could result in increased binding of 
labelled lactofenin and likely to cause an over estimate of the number of 
binding sites.
The specificity of lactoferrin binding to U937 cells was demonstrated in 
competitive binding studies with vaiious proteins. Cold apolactoferrin was 
able to inhibit the binding of Fe-lactoferrin to the cells, but the inhibition 
was lower than expected. This could be explained by the steric changes that 
lactofenin undergoes when it combines with non. The molecule of Fe- 
lactofemn is more compact and more asymmetric than that of 
apolactofenin. Such observation confirmed what was noted earlier by Van 
Snick et a l ,  (1976).
Although bovine lactofenin could bind to U937 cells, interestingly its 
binding was not inhibited by human lactofenin, indicating that different 
mechanisms of cellular recognition are involved between bovine and human 
lactofenin. Such a difference has also been reported for the interaction of 
lactoferrin with monkey intestinal brush-border membranes which bound
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human but not bovine lactoferrin (Davidson and Lonnerdal, 1988). 
Furthermore the pattern of inhibition of binding by other milk proteins also 
point out to a difference in the nature of the interaction between the milk 
proteins and the two lactoferrins; none of the the proteins with the exception 
of high concentrations of human IgA, inhibited binding of bovine 
lactofenin, whereas binding of human lactoferrin was markedly inhibited 
by bovine lactoperoxidase.
Transfenin, despite its structural homology to lactofenin, did not inhibit the 
binding of lactofenin; a conclusion also reached in studies using other cell 
types (Yamada et a l ,  1987; Bennett and Davis, 1981; Birgens et a l ,  1983). 
Likewise, the binding of transferrin to the cells was not inhibited by either 
apolactofenin or Fe-lactofenin, suggesting that there are different binding 
sites are located for transfenin and lactoferrin on the cell surface.
The nature of the cell surface molecule(s) responsible for binding of 
lactofenin has not been determined. Since lactofenin is a cationic protein, 
it was considered that binding to the negatively charged cell surface might 
be of electrostatic in nature. Inhibition of binding by another cationic 
protein, lactoperoxidase (pl=9.6) seemed to point this way. However, the 
presence of lysozyme, a more basic protein (p l= lL 4) did not result in a 
decrease lactofenin binding to the cells. Similar findings were reported by 
McAbee and Esebensen (1991), who found that lactoperoxidase inhibited 
lactofenin binding to intact hepatocytes, but not lysozyme or cytochrome c 
(pl=10.6). Removal of sialic acid, one of the major sources of negative 
charge on the cell surface, by neuramidase decreased binding of lactoferrin 
(Yamada et a l ,  1987). On the other hand, Moguilevsky et a/.(1985) found 
that sialic acid as well as glycosaminoglycans and phospholipids did not 
contribute to the binding. In contrast removal of sialic acid from lactofenin
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increased its binding affinity to mouse peritoneal macrophages (Van Snick 
and Masson, 1976). Others have reported that lactofenin bound to alveolar 
macrophages in competition with two other cationic neutrophil granule 
glycoproteins, elastase and cathepsin G (Campbell, 1982).
Several mammalian receptors mediate glycoprotein binding through 
recognition of different terminal cai’bohydrate residues. Recognition of 
lactofeiTin could be mediated by fucosyl residues as proposed by Prieels et 
a l,  1978; Goavec et a l,  1985). However in this study fucosyl residues 
were found not to play any significant role in the binding of lactoferrin to 
U937 cells. This conclusion is based on the following findings: firstly, 
competition studies with 30mM fucose did not inhibit binding of lactofeiTin. 
Similar results were obtained with 30 mM glucose. Secondly, treatment of 
the cells with heparinase, which removes acidic sugar residues did not affect 
lactofenin binding and thhdly, the fact that bovine lactofenin which lacks 
fucose residues in the glycan chains could also bind to the cells. These 
results support the findings of Imber and Pizzo (1983) and Moguilevsky 
(1984), who concluded that fucosyl residues were not involved in the 
interaction of lactofenin with peritoneal macrophages and cultured 
hepatocytes because the removal of fucose from the protein molecule did 
not affect its clearance from plasma.
Competition studies with monocyte reactive monoclonal antibodies suggest 
that the binding site does not appear to involve any of the surface reactive 
molecules defined by these monoclonal antibodies.
In conclusion, results from binding studies show that there aie two types 
cell-lactofenin of interaction; a large and non-saturable component which is 
likely to consist of low affinity binding sites that accounts for the non­
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specific binding of lactoferrin and a smaller specific component which is 
made up of high affinity binding sites. The reason for the high level of non­
specific binding of lactofeiTin to U937 and other cells is not cleai'. It is 
possible that lactofeiTin initially binds to a relatively high affinity binding 
molecule, such as that identified on activated lymphocytes (Mazurier et a l ,  
1989), thus giving rise to the specific element of the binding. Further 
lactoferrin may be bound as a result of polymerisation, a known feature of 
lactofenin (Bennett and Davis, 1981; Britigan et a l ,  1991) as mentioned 
eaiiier.
2.5.2 Uptake of iron from lactoferrin and transferrin
Even though the cells bound about 10 times more lactoferrin than 
transferrin, uptake of iron was much more rapid from transferrin than from 
lactoferrin (Fig. 30 ), The amount of iron talcen up at the end of 55 h 
incubation is about 160 pmole/10  ^ cells, which is only three times more 
than the amount taken up from lactoferrin (55 pmole/10^ cells). However, 
when the molar ratio of iron:protein associated with the cells is plotted 
against time (Fig. 31 ), it clearly shows that while the molar ratio of 
ironiprotein for lactoferrin remained almost constant, the molar ratio of 
iron:protein for transfenin increased linearly with time. A closer look at the 
molar ratio of iron: protein after 2 h incubation shows that for lactoferrin it 
was only 2.4 versus 12.7 for tiansferrin, while after 18 h, the figures rose to 
5.9 and 66 respectively. These findings suggest that at 37 °C, there is 
definitely a significant uptake of iron from transferrin with time but only a 
slow uptake of iron from lactoferrin. A previous study by Brock and 
Esparza (1979) also reported that there was no uptake of iron from 
lactoferrin by reticulocytes in contrast to transferrin.
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Since each protein is theoretically capable of delivering 2 iron atoms to the 
cell in each endocytic cycle, this represents only about 3 cycles in 18 h for 
lactofeiTin, as against 33 for transferrin. This marked difference in iron 
uptake was reflected in a difference in the fate of the two proteins follwing 
binding to the cell membrane. Pulse chase studies showed that after binding 
of transfenin to the cells at 4 °C, > 65 % of the bound protein could be 
removed by a 5 sec acid wash with 0.25 M acetic acid/ 0.5 M NaCl, 
whereas only 44 % was releasable after incubation at 37 "C. In contrast the 
amount of lactofenin released after incubation at 4 “C was similar to that at 
37 °C (about 85 %). These findings suggest that while transferrin was 
internalised by the cell, in agreement with the previous work on other cell 
types (lacopetta and Morgan, 1983; Klausner et a l ,  1983), no net 
internalisation of lactofenin could be detected. Transfenin has been known 
to release its iron intiacellularly at acidic pH and then recycles to the plasma 
membrane still bound to its receptor (Dautry-Varsat, 1986). Its recycling 
has been shown to be inhibited by primaquine, a weak base which 
neutralises the acidic compartment thereby blocking the recycling and 
increasing its intracellular pool size (Schwartz et a l ,  1984; Stoorvogel et al, 
1987; Reid and Watts, 1990). Using 3 mM primaquine, it was shown that 
twice the amount of transferrin was retained in the cells in the presence of 
primaquine while there was only a negligible difference in the amount of 
lactofenin retained by the cells in the presence or absence of primaquine. 
The molar ratio of cell-associated iron:transferrin was reduced by about 50 
% in the presence of primaquine, whereas the ratio of cell-associated 
iron:lactofenin remained at about 2 either in the presence or absence of 
primaquine, indicating that primaquine slowed down the process of iron 
uptake from tiansfenin but did not affect any possible iion uptake from 
lactofenin. Roiron-Lagroux and Figarella (1990) also found no evidence 
for the internalisation of lactofenin in adenocarcinoma cells. In conüast, it
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is quite clear that hepatocytes do internalise lactofenin; 80 % of cell- 
associated lactofenin being inti’acellulai' after 60 min at 37 °C (McAbee and 
Esebensen, 1991). In addition it was found that hepatocytes bound and 
internalised lactofenin regaidless of its kon content suggesting that 
lactofenin released into the ciiculation by neutrophils could be cleared from 
the circulation by these cells and hence the need for such a mechanism. 
The observed difference in the fate of lactofenin bound to U937 as 
compai'ed to hepatocytes must be related to its function.
Despite the lack of endocytosis of lactofenin, slow uptake of iron by U937 
cells nevertheless occuned (Fig. 30 ). This slow apparent uptake could 
have been due to the prior transfer of iron from lactofenin bound to the 
cells to transfenin present in the medium which then transfers this iron to 
the cell in the same manner mentioned earlier. Although this might appear 
to be no more than an experimental artifact resulting from "scrambling" of 
ii'on during culture, the fact that more iron was transfened from lactoferrin 
to transfenin than vice versa suggests that this was not the case; lactoferrin 
binds kon with a greater affinity than transferrin (Aisen and Leibman, 
1972), so scrambling in solution ought to result in transfer of kon from 
transfenin to lactofenin. Furthermore results indicate that lactoferrin 
bound to the cells releases some of its kon to the medium, which would 
then be available for binding by either protein. The dissociation studies 
reported here showed that cells preincubated with Fe-lactofenin released 
kon more rapidly than they release lactofenin itself. The molar ratio of 
Fe:lactofenin determined from the graph in fact shows a ratio of < 1, 
indicating that some of the iron has been removed from the protein 
molecule. It also seems unlikely that the radioactivity associated with the 
cells is due to release of kon which had been taken up by the cells as no 
evidence of internalisation of lactofenin was obtained. In contrast there
136
was no release of iron occuned when transfenin rather than lactofenin was 
used, despite the fact that transferrin-bound iron is accumulated by the cells. 
The release of iron from cell-bound lactoferrin implies some destabilisation 
of the lactofenin iron-binding site, a phenomenon known to occur when 
tiansfeiTin binds to the transfenin receptor (Bali and Aisen, 1991: Sipe and 
Murphy, 1991). Alternatively, iron may be removed enzymatically through 
the action of membrane NADH reductase (Sun et a l ,  1991; Thorstensen 
and Romslo, 1988), although this seems less likely given the experiment 
was carried out at 4 °C.
These results appear to contradict earlier reports (Van Snick et a l ,  1977; 
Moguilevsky et a l ,  1987; Birgens et a l,  1988) of kon uptake from 
lactofenin by macrophages and monocytes and its incorporation into 
fenitin. However, the rates of uptake reported in these studies were very 
slow, and comparable to the slow apparent uptake from lactofenin by U937 
cells; Moguilevsky et a l (1987) reported a "cycling time" of about 11 h, in 
comparison to as little as 2-3 min for tmnsfenin recycling in reticulocytes 
(Intragumtomchai et a l ,  1988). Although transfenin was not added to the 
medium in the previous studies, fetal calf serum was present and this 
contains bovine transfenin, which can donate kon to cells in culture (Brock 
and Rankin, 1981). It is therefore possible that kon uptake in those studies 
occuned via the indkect mechanism proposed here. Indeed an earlier study 
by Oria et a l , (1988) carried out in this laboratory clearly indicated that in a 
short term cultures of a murine macrophage cell line, there was no net 
accumulation of kon from transfenin (Oria et a l ,  1988). Bkgens et a l  
(1988) reported that lactofenin was released from monocytes more rapidly 
than kon, in conUast to the present findings, but as thek studies were 
performed at 37 “C in serum-containing medium it seems possible that 
transfenin could have promoted cellular uptake of kon released from
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lactofeiTin during incubation. However, a difference in behaviour between 
the monocytic cell line U937 used here and monocytes/macrophages used 
by others cannot be completely ruled out.
2.5,3 Effect of lactoferrin on uptake of iron from other sources
In addition to iron-transfenin, kon chelates such as FeNTA can also supply 
kon to U937 cells (Fig. 32). When uptake of labelled kon from FeNTA 
and Fe-transferrin were compared directly, it was found that the amount of 
kon taken up from FeNTA was much greater than from transfenin. These 
results aie in accordance with the findings of Brock and Rankin (1981) and 
Djeha and Brock (1992b) that mouse lymphocytes took up kom  more 
rapidly from FeNTA, and kon citrate complexes than from transfenin. 
Similar findings were reported by White and Jacobs (1978) using Chang 
liver cells which took up 30-fold more kon from FeNTA than from 
transfenin and distribute the kon differently in the cell. In contiast Taylor 
et a/. ,(1988) found that kon uptake from FeNTA added dkectly to mitogen- 
stimulated human peripheral blood lymphocytes was quantitatively very 
similar' to that from transfemn. However, thek cultures contained 5 % 
serum, so it is likely that transfemn in the serum mediated the uptake of 
^^Fe (Djeha and Brock, 1992b).
The mechanism by which non-physiological kon chelates enter the cell in 
the absence of physiological kon binding proteins is not clear. One 
mechanism might simply be fluid phase endocytosis. Another mechanism 
is suggested by studies of kon tiansport into hepatocytes indicating that 
non-transfenin bound kon is tiansported into these cells by a membrane 
carrier for kon and this process is driven by the membrane potential 
difference between the interior and exterior of the cell (Wright et a l,  1988).
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One thing that is clear from the binding studies is that lactofenin does not 
donate kon to the cells, instead, when it was added to the cell cultures 
containing ^^Fe-labelled transferrin or FeNTA at kon concentration reported 
to be within the range that characterise kon overload condition (Hershko et 
a l ,  1987), it was found that lactofenin inhibited iron uptake from FeNTA. 
This effect was found with both apolactofenin and Fe-lactofenin, but 
uptake from tiansferrin was not affected which confirms the earlier 
findings. Furthermore the total amount of iron as FeNTA was 6 times 
greater than that requked to saturate all the lactofenin present, so the effect 
was not simply due to sequestration of all the kon in the medium by 
lactoferrin. These observations coupled with the return of kon from 
membrane-bound lactofenin to the medium (Fig. 33), suggest that 
lactofenin may serve to regulate uptake of potentially toxic non-transfenin 
bound kon.
There is now increasing evidence that the non-transfenin bound kon may 
be important in producing conditions of kon loading and cellular damage 
(Wright et a l ,  1986). The non-hansfenin bound iron ckculates in plasma 
and may be complexed to a vaiiety of low moleculai’ weight compounds 
which are effective in the formation of haimful oxygen derivatives 
(Halliwell and Gutteridge, 1986). Superoxide dismutase, catalase and 
glutathione peroxidase, which are useful in limiting such toxicity within 
cells, are virtually absent from the extracellular compartment. Thus the 
major protective mechanism of human plasma in preventing kon from 
participating in the catalysis of hydroxyl radical formation is its binding to 
the proteins or the therapeutic use of effective kon chelator (Hershko, 
1987).
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2.5.4 Effect of lactoferrin on cell proliferation
Iron plays an important role in cell growth and transferrin has been shown 
to promote the cell growth. The ability of tiansferrin to promote cellular’ 
proliferation is closely related to its ability to donate iron to the growing 
cells (Aisen and Listowsky, 1980; Brock et a l ,  1986). More recent studies 
have suggested that lactoferrin may also promote cell growth.
Data obtained from this study by measurement of incorporation of 
radiolabelled precursors i.e. ^H-thymidine into cellular DNA indicate that 
transfeiTin and lactoferrin, both apolactoferrin and Fe-lactofenin have 
stimulatory effect on the growth of U937 cells. Both bovine and human 
lactofemns can enhance the cell proliferation. The stimulatory effect of 
transferrin is due to its iion donating property as iron uptake studies have 
indicated this ability. Earlier work in this laboratory has also shown that 
lactofenin increased the proliferation of a murine macrophage-like cell line, 
P388D1 (Oria et a l ,  1988). Interaction of lactoferrin with lymphoma cell 
lines has also demonstrated some enhancement of the rate of cellular 
proliferation (Hashizume et a l, 1983). Subsequent work by Amouric et a l 
(1984) on adenocarcinoma cell line HT29 also reported stimulatory effect 
of lactofenin in the presence of low concentration of iron. The mechanism 
by which lactoferrin is able to stimulate the cell growth is unclear 
(Hashizume et a l ,  1987; Roiron-Lagroux and Figarella, 1990). Unlike 
transfemn which donates iion to the cell, lactofenin does not seem to 
promote growth in a similai' manner. Little or no iion is taken up from 
lactofeiTin for this puipose. The fact that apolactofenin was as effective as 
Fe-lactofenin proves this point.
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Heat treatment of bovine lactoferrin at 72 “C for 20 sec or at 137 '’C for 8 
sec had little effect on its ability to enhance proliferation, although some 
reduction in its ability to competitively inhibit binding of ^^^l-labelled 
native lactofenin vras observed. These temperatures conespond to those 
used for mild pasteurisation or to spray-drying, respectively, suggesting that 
neither of these tieatments would materially affect the biological activity of 
lactoferrin. However, a more severe heat Ueatment (85 °C for 20 min) 
abolished the proliferation enhancing effect of Fe-lactofenin, but had no 
effect on that of apolactofenin. Moreover the effect on cell binding was 
similar to that of the more mild treatments. These findings suggest that 
lactofenin still in a biologically active form could be supplemented to cow's 
milk based infant formula.
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CHAPTER THREE
ROLE OF LACTOFERRIN IN
IRON ABSORPTION
3.1 INTRODUCTION
Total body iron balance is regulated by non absoiption which occurs in the 
proximal end of the small intestine. The uptake of iron from the diet by the 
intestinal cells is sensitive both to physiological needs as well as to iron 
stores. The mechanisms involved in the processing of iron taken up from 
the diet at the brush border membranes and its release at the basolateral 
membrane as well as its intiacellular storage me not fully understood.
The greater bioavailability of iron and higher concentration of lactoferrin in 
human milk compared to cow's milk have led to the proposal that lactoferrin 
might play a role in iion absorption. This proposal is further supported by 
the finding that lactoferrin receptors have been identified on the brush 
border membranes of some species, including human fetal intestinal 
membrane (Davidson and Lonnerdal, 1988; Hu et a l,  1990). However, 
there is so far no evidence that these receptors actually mediate uptake or 
transport of lactofeiTin bound iron in the mucosal cell. In fact, there have 
been reports suggesting that lactoferrin may inhibit iion absoiption and may 
actually serve as an additional control of iron absorption during neonatal 
period (reviewed by Brock, 1980).
If lactofenin is tiansported across the intestinal cell and enters the 
cii'culation, this ought to result in higher plasma levels of lactoferrin. Since 
cow’s milk contains very little lactofenin, there would be a difference in the 
plasma lactofenin levels of infants fed cow's milk based formulas as 
compared to breast-fed infants. Indeed recent studies in preterm infants 
have demonstiated the presence of lactofenin derived from maternal milk in 
the urine of breast-fed infants, suggesting that lactofemn can be absorbed
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(Hutchens et a l,  1989). In contrast a study by Scott (1989) found no 
difference in plasma lactoferrin levels between these two groups. However 
this study was conducted in full-term infants and it is not known whether 
similar events occur in term infants as their gastiointestinal tracts are more 
developed.
Due to these conti'oversies, a study was undertaken to investigate whether 
lactoferrin plays any role in kon absorption. The objectives of the study 
were:
(i) to investigate the interaction of lactofenin with an in vitro model of the 
human intestinal mucosa, and to study kon and protein (lactoferrin and 
tiansferrin) transport across these cells.
(ii) to determine plasma lactoferrin levels in breast-fed versus formula-fed 
newborn infants.
lion and protein transport studies were canied out using Caco-2 cells, a 
human colon adenocarcinoma cell line, which was first established in 1974 
by Jorgen Fogh (Memorial Sloan-Kettering Cancer Centre, New York) 
(reviewed by Rousset, 1986). The cells have been shown by many workers 
to exhibit enterocyte like differentiation patterns, such as brush border 
micorvilli and associated enzymes and the formation of domes which are 
typical of transporting epithelial monolayers. The Caco-2 cell line has been 
used to examine a variety of intestinal function (Audus et a l,  1990) and is 
useful to study iron transport as the cells can be grown in bicameral 
chambers, and form a highly polarised monolayer which can be used to 
demonstiate vectorial transport (Alvarez-Hernandez, e ta l ,  1991).
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The plasma lactofemn levels were determined using a solid phase enzyme- 
linked immunoabsorbent assay (ELISA). The method is well suited to 
measure low levels of lactofemn and the reagents are stable, sinee alkaline 
phosphatase-conjugated antiserum may be kept for at least 6 months 
without losing activity (Kolsto Otnaess et a l, 1983). Since lactoferrin is 
also present in the secondary granules of neutrophils, extreme care must be 
taken in obtaining plasma to ensure that lactoferrin levels are not artificially 
raised due to neutrophil degranulation.
3.2 MATERIALS
3.2.1 Cell lines
Two cell lines were used in this experiment. The human colon carcinoma 
cell line Caco-2, was kindly provided by Dr. R.l. Freshney, Department of 
Medical Oncology, University of Glasgow. INT 407, a human embryonic 
intestinal epithelial cell line was obtained from Flow laboratories, Irvine, 
Scotland.
3.2.2 Blood Samples
Venous blood was obtained from 15 infants, delivered at the Department of 
Paediatrics, Queen Mother's Hospital, Glasgow. Approval from the Ethical 
Committee of the Hospital and parental consent were granted before taking 
samples. Samples were taken only from healthy infants without any 
jaundice, 48 to 72 hours after delivery. The infants were selected according
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to their method of feeding sinee birth. One group eonsist of infants who 
were exclusively breastfed and the other was a group of formula-fed infants.
3.2.3 M aterials for ELISA
3.2.3.1 Lactoferrin antibody
Rabbit anti-human lactofemn antibody was raised in two rabbits at the 
Depai'tmenfs animal house, Western Infirmary, Glasgow.
3.2.3.2 Lactoferrin antibody-enzyme conjugate
Lactofenin antibody alkaline phosphatase conjugate was prepared from 
antibody (3.2.3.1) and alkaline phosphatase (Serotee Ltd., Kidlington, 
Oxford, U.K.), as described below in section 3.3.6.
3.2.3.3 Myoglobin (1-2 %), Human serum albumin (5 %) and Bovine 
serum albumin (1-2% ) solutions
These solutions were prepared from appropriate amount of myoglobin from 
horse skeletal muscle (Sigma), human serum albumin (Behringwerke) and 
bovine serum albumin (Sigma) dissolved in distilled and dionised water, 
which were then filter sterilised.
3.2.3.4 Polystyrene beads
Polystyrene beads, white etched, 6.4 mm diameter, surface enhanced, were 
purchased from Northumbria Biologicals Ltd., Northumberland, U.K.
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3.23,5  Enzyme substrate
One tablet (5 mg) of p-nitrophenyl phosphate (Sigma) was added to 5 ml of 
diethanolamine buffer (see section 3.2.4.4), The substrate solution was 
prepared fresh for each assay.
3.2.3.6 Standard lactoferrin solution for ELISA
Lactoferrin used for calibration was isolated and purified by the procedure 
described in section 2.3.1. The standard solutions were prepared from a 
stock lactoferrin solution (1 mg/ml) diluted in 5 % human serum albumin to 
give a range of concentrations from 6.12 ng/ml to 300 ng/ml. The diluted 
standards were kept at -20 °C in small aliquots.
3.2.3.7 Other materials
Polystyrene test tubes, 55 x 12 mm, were purchased from Sarstedt Ltd., 
Leicester, U.K. Ninty six well microtitre plates were purchased from 
Millipore, U.K. Plastic microtubes (Scotlab, U.K.) containing 0.6 mg (1.5 
mg/ml) potassium EDTA (BDH) were used for blood collection.
3.2.4 Buffers
All solutions for ELISA were prepared using distilled and deionised water 
which were then filter sterilised.
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3.2.4.1 Phosphate buffers (200 m M , 100 mM, pH  7.2)
27.0 g Na^HPO^ .12 H2 O (BDH) and 4.0 g NaH^ PO4. 2H2 O (BDH) was 
dissolved in 400 ml water and pH was adjusted with 1 M HCl, and the 
solution was then made up to 0.5 litre to make 200 mM solution. This 
buffer was diluted with equal volume of distilled and deionised water to 
make 100 mM buffer.
3.2.4.2 Tris/HCl (0.5 M, pH  8.0)
Tris (60.5 g) was dissolved in 800 ml water and pH was adjusted to 8.0 
using 1 M HCl and the solution was made up to 1 litre.
3.2.4.4 Diethanolamine buffer
97 ml diethanolamine (BDH)
0.2 g NaNg
100 mg MgCl^.bH^O (BDH)
800 ml H^O
pH was adjusted to 9.8 and the solution was made up to 1 litre.
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3.3 METHODS
3.3.1 Cell Cultivation
3 3  J J  Routine culture
Caco-2 cells were cultivated for routine use in Dulbecco's modified Eagles 
medium (DMEM, Gibco, Paisley, U.K.) supplemented with 10 % fetal calf 
serum (Northumbria), 1 % non-essential amino acids (Flow), 1 |Xg/ml 
bovine insulin (Sigma), 100 |ig/ml streptomycin (Flow) and 100 U/ml 
(Flow) in 25 cm^ flasks in a humidified incubator at 37 °C with 5 % CO2 
They were subcultured every 2-3 days using 5 ml FDTA (1 mM, BDH) and 
5 ml trypsin (0.25 %, Sigma).
INT 407 cells were grown in RPMI medium (without HFPFS, Gibco), 
supplemented with 10 % fetal calf serum (Northumbria), 100 |utg/ml 
stieptomycin (Flow), 100 U/ml penicillin (Flow) and 250 ng/ml fungizone 
(Flow). The cells were subcultured every 3 days using FDTA and trypsin 
as above.
33.1,2 Cell Culture in Transwell Bicameral Chambers
For transport experiments, cells were cultured in Transwell inserts (Fig.38) 
until they formed complete monolayers. Each insert has polycarbonate 
membrane and the inside wall has been heated for uniform cell attachment. 
The surface area of the membrane is 0.33 cm^ with 3 [xm pore size. Each 
insert was precoated with a thin layer of collagen by applying evenly 50 [Û
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Fig. 38: A diagram of a bicameral chamber containing a Transwell
insert with polycarbonate membrane on to which Caco-2 cells are 
cultured
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of Type 1 collagen from rat tail (2 mg/ml; Boehringer Mannheim).
Excess collagen was cai'efully removed and the insert was allowed to stand 
inverted to let it dry in a sterile laminar air flow for 30-45 min. Collagen 
mediates cell attachment and enhances the growth as well as differentiation 
of many cell types including epithelial cells. Cells were seeded at a density 
of 10  ^cells/cm^ i.e. 33,000 cells per insert. The culture medium was added: 
200 \xl in the upper and 800 jil in the lower compartments, and changed 
daily. Formation of cell monolayers was monitored every day by 
measuring the transepithelial electiical resistance (TEER) and diffusion of 
phenol red across the monolayers, as described below.
3.3.2 Monolayer Formation and Cell Morphology
33,2.1 Transepithelial Electrical Resistance Measurements (TEER)
Transepithelial electrical resistance measurements of Caco-2 cell 
monolayers were recorded daily before changing the culture medium and 
also before and after performing iron and protein transport studies. The 
device utilised in obtaining TEER values was an Epithelial 
Voltohmeter (EVOM), (World Precision Instruments, U.K.). The device 
consists of a pair of chopstick-like electrodes, 4 mm wide and 1 mm thick. 
The small size of the electr ode sticks facilitates placement of the electrodes 
in the culture wells and one electrode tip, being 2.5 mm longer than the 
other fits into the deeper outer chamber of the well. Each electrode 
contains a silver/silver chloride pellet for voltage changes and a silver 
electrode for passing current. Before taking electrical resistance 
measurements, the electrodes which had been kept in sterile PBS, pH 7.2,
150
were placed in 70 % ethanol for a few minutes and then transferred to a 
culture medium without fetal calf serum and the resistance set at zero. 
Electrical resistance values of the cell monolayers in each Transwell insert 
were measured directly and were then multiplied by the surface area of the 
polycarbonate membrane (0.33 cm^). Electrical resistance values obtained 
in the absence of cells (caused by the electrical system and the collagen 
coated polycarbonate membrane) were considered as background. For each 
experiment, total electrical resistance values were corrected for background 
which ranged from 35 to 50 Q cm^, to obtain the TEER values.
33.2.2 Diffusion of Phenol Red
Another way to assess the confluency of the cell monolayer is to determine 
the degree of diffusion of phenol red across the cell monolayer to the lower 
compartment. The medium in the lower compartment was removed and 
replaced with phenol-red free HBSS (Flow) after carefully washing the 
lower compartment several times with the same medium. The medium in 
the upper compartment was the culture medium which contained phenol 
red. After incubation at 37 °C for 2 h, aliquots of 100 p.1 were removed 
from the upper and lower compartments and A545 readings were taken 
using an ELISA reader.
3.3.2.3 Transmission Electron Microscopy
Caco-2 cells on the polycarbonate membrane were fixed for 24 h at room 
temperature with 2 % glutaryldehyde (Agar Scientific, Stansted, Essex, 
U.K.) in Sorensens phosphate buffer, pH 7.38 and postfixed in 1 % osmium 
tetroxide. After dehydration through a graded series of alcohols, the
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complete membrane from the Transwell insert was cut from the insert walls 
and embedded in Araldite (Agai’ Scientific) which was allowed to 
polymerise overnight at 60 °C. Sections 2 pm thick were cut on a Reichert 
Jung Ultracut E, stained with toluidine blue and examined by light 
microscopy. Ultrathin sections 80-90 nm thick were then cut from suitable 
areas, mounted on 200 mesh copper grids and then stained with uranyl 
acetate and lead citrate. Sections were then examined in a Philips CMIO 
electron microscope.
3.3.3 Iron and Protein Transport Studies
Experiments on iron and protein transport across Caco-2 and INT 407 cell 
monolayers were cariied out only after cultures gave percent diffusion of 
phenol red, < 5 %, and in the case of Caco-2 cells, the values of TEER > 
200 Q cm^, indicating that intact monolayers had been formed. This was 
normally achieved after 15-20 days of seeding the cells in the Transwell 
inserts.
In this experiment, the media in the upper and lower compartments were 
removed and replaced with a similar medium but without fetal calf serum. 
The total volume of medium plus addition in the upper compartment was 
200 pi and in the lower compartment was 600 pi. To the upper 
compai'tment was added ^^Fe-labelled lactoferrin or transferrin (50 pg/ml) 
or a similai' amount of iron as ^^Fe-citrate. Unlabelled apotransferrin (1 
mg/ml) was added to the lower compartment to serve as an non acceptor. 
The cells were incubated at 37 °C with 5 % COj for vaiious time intervals. 
At each interval, the medium from the lower compartment was removed for 
counting and was replaced with an equal amount of fresh medium. For
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protein transport studies, the procedure was similar except that ^^^I-labelled 
lactoferrin and transferrin were used.
At the end of the experiment, the medium in the upper compartment was 
collected and the cells were dissolved in 2 % sodium dodecyl sulphate. The 
medium, cells and the polycarbonate membrane were immediately assayed 
for radioactivity. The integrity of labelled lactoferrin and transferrin in the 
upper and lower compartments was determined by precipitation with 10 % 
(w/v final concentration) trichloroacetic acid and also by using SDS-PAGE 
(see section 2.3.2) and autoradiography which was carried out using a 
Kodak XAR-5 film at -70 °C for 3-7 days.
3.3.4 Preparation of Plasma Samples from Newborn Infants
The presence of lactoferrin in the secondary granules of neutrophils calls for 
specific precautions in the collection and treatment of blood. The 
determination of blood lactoferrin must be performed on plasma and not on 
serum. Venous sampling was considered to be more suitable than capillary 
sampling ( Maacks et a l 1990). Venous blood (0.3-0.5 ml) was collected in 
prelabelled microtubes and shaken to mix with EDTA contained in the 
tubes and immediately placed in ice water. The blood sample was 
centiifuged for 15 sec at 3000 g. The plasma was carefully extracted, 
making sure not to include any cellular particles and transferred to a fresh 
microtube and centrifuged for another 8 min. The upper two-thirds of the 
plasma were collected and placed immediately at -20 °C. For long storage 
the samples were transferred to -70 °C.
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3.3.5 Preparation of Rabbit Anti-Human Lactoferrin IgG solution
The IgG fraction of the anti-semm was used for coating the polystyrene 
beads as well as labelling the enzyme. It was prepared from the anti-serum 
by ammonium sulphate precipitation as described in section 2.3.5.2.
3.3.6 Preparation of Alkaline Phosphatase-Anti Lactoferrin Conjugate
The alkaline phosphatase-IgG conjugate was prepared according to the 
company’s instruction based on one step glutaryldehyde method (Avrameas, 
1969). Alkaline phosphatase was supplied as a precipitate in ammonium 
sulphate. An appropriate volume (0.5 ml) containing 5 mg enzyme (activity 
> 1000 U/mg protein) was centrifuged at 2000 g for 10 min at 4 "C, and the 
supernatant was discarded. A volume, < 1.0 ml containing 2 mg IgG 
solution in PBS (pH 7.2) was added to the enzyme pellet and these were 
dialysed together against PBS overnight at 4 °C with several changes in 
order to remove all the ammonium sulphate present in the enzyme extract. 
The volume of conjugate was made up to 1.25 ml with PBS to which was 
added 10 |Lil glutar yldehyde solution (25 %), and it was allowed to react for 
2 h at room temperature with constant mixing on a rotator. The mixture 
was dialysed against two changes of PBS at 4 overnight and lastly 
against two changes of Tris buffer (pH 8.0). The conjugate was collected 
and diluted to 4 ml with Tris buffer containing 1 % BSA and 0.02 % 
sodium azide. The conjugate was filter sterilised and dispensed into small 
volumes and stored at -20 °C.
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3.3.7 Procedure for ELISA
3.3.7.1 Principle o f  Assay
The method used to determine plasma lactofenin is based on a non­
competitive sandwich antigen assay as reported by Figarella (1986) and 
Scott (1989). The principle of the assay is shown in Fig. 39. Human 
lactoferrin is extracted from the samples by a specific antibody bound to 
polystyrene beads. After washing, solid phase-bound lactoferrin reacts with 
alkaline-phosphatase labelled anti-lactofenin IgG. Excess of non-reacted 
enzyme conjugate is removed by washing and the bound enzymic activity is 
revealed with subsequent addition of substrate, p-nitrophenyl phosphate (p- 
NPP), which develops a yellowish colouration that can be measured at X4Q5 
nm. The concentration of lactoferrin in the sample is thus directly 
proportional to the enzymic activity present on the solid phase.
3.3.7.2 Coating o f  the solid phase
In initial attempts to set up the ELISA assay, different types of polystyrene 
microtitre plates kindly provided as trial samples by Dynatech., Sussex, 
U.K. were used as a solid phase. This was not susseccful due to high 
background readings. Polystyrene beads were therefore used as the solid 
phase (Figaiella, 1986 and Scott, 1989).
Fifty polystyrene beads were placed in a clean glass universal which had 
been rinsed several times with sterile water and dried by alcohol to remove 
any tiaces of detergent. The beads were washed with absolute ethanol and 
rinsed three times with filtered, distilled and deionised water and lastly with
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Procedure for ELISA
Ab © iLAbl Ab 1
Solid phase-bound rabbit 
anti-hLf antibody (IgG)
5^ig/ml 37“C for Ih and 4"C 
overnight Blocker : 2% myoglobin
in 5% HSA Solid phasebound Ab-Ag complex AP - rabbit anti-human Lf antiboc
(IgG) conjugate 1: 4(X)
A b
AP
AP - labelled sandwich complex
p- nitrophenyl-phosphate p- nlirophenylate
Fig. 39: Principle of ELISA according to the design of sandwich antigen 
assay for the determination of plasma lactofeiTin
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phosphate buffer (200 mM). About 7.5 ml (150 fil per bead) of anti- 
lactoferrin IgG (5 fxg/ml) was steadily poured to cover the beads and mixed 
gently on a roller for an hour at 37 then at 4 °C overnight without further 
mixing. The beads were washed four times with phosphate buffer (100 
mM) and were either used immediately or stored at 4 °C in the same buffer.
3.3,73 Assay procedure
Into the required number of polystyrene test tubes was pipetted 200 p,l of 
HSA solution (5 %) and 20 fxl standards, controls and samples that diluted 
with HSA (5 %). To each tube was added one coated bead and these were 
incubated at 37 for 2 h. Each bead was washed thiee times with 4 ml 
filtered, distilled and deionised water. Three hundred microlitie of diluted 
enzyme conjugate (1:400) was added to each bead and incubated at 37 "C 
for 1.5 h. Excess enzyme conjugate was removed and the bead was washed 
as before and transfened to a fresh polystyrene test tube. To each tube was 
added 200 |Lil /7-nitrophenyl phosphate solution followed by incubation in 
the dai’k at room temperature for 30 min, at the end of which the reaction 
was quenched by adding 50 p,l sodium hydroxide (3 M). A volume of 200 
pi of the coloured product was pipetted out from each tube and placed in a 
96-well microtitre plate to be read at 405 nm, using an ELISA reader.
3.3.8 Assay Optimisation
3.3.8.1 Optimal antibody coating concentration 
As the capacity of polystyrene beads to bind the antibody is limited,
157
it was necessary to determine an optimal concentiation that would coat the 
bead fully, but at the same time not be present in too much excess. 
Therefore, various concentrations of anti-human lactoferrin IgG (1, 5, 10 
and 30 pg/ml) were used to coat the polystyrene beads, and the 
conesponding beads were tested for their ability to bind lactoferrin 
following the procedure described in 3.3.7.3.
3.3.8.2 Choice o f blockers
A blocker is used to fill any vacant sites on the bead in order to reduce non­
specific binding of lactoferrin. Blockers that were tested included 1 % and 
2 % BSA, 1 % and 2 % myoglobin and incubation buffer (200 mM 
phosphate buffer containing 10 % rabbit serum; Figaiella, 1986). These 
blockers were added to the coated beads and the assay was continued as 
described in 3.3.7.3.
33.8.3 Optimal dilution fo r  alkaline phosphatase-anti lactoferrin 
conjugate
Several dilutions of enzyme conjugate were tested in the assay to obtain a 
range of optical densities giving a maximum A405 value of 1.5 for the 
highest standard solution. The stock enzyme conjugate was diluted in 
appropriate volumes of PBS for the following dilutions; 1:200,1:400, 1:600 
and 1:1000.
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33.8 .4  Selection o f assay conditions
For the first incubation period, two procedures were tested. These involved 
incubation for either 2 h at 45 °C (Figarella, 1986), or at 37 “C for 1 h 
followed by overnight incubation at 4 ‘’C ( Scott, 1989). The incubation 
period with the enzyme conjugate was at 37 "C for either 1,1.5 or 2 h. The 
enzyme subtrate reaction was allowed to continue for 30, 45 and 60 min.
3.3.8.5 Accuracy o f the assay
The accuracy of lactofenin detection was checked by adding known 
quantities of lactofenin (50-200 ng/ml) to rabbit plasma and comparing the 
measured values to the expected ones.
3.3.8.6 Specificity o f the assay
Cross reactivity of the lactofenin antibody was checked against bovine 
lactofenin and human transfenin by measuring difenent amounts (50-200 
ng/ml) of human lactofenin in rabbit plasma to which had been added equal 
amount of bovine lactofenin and human transfenin respectively.
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3.4 RESULTS
3.4,1 Iron and Protein Transport Studies
3.4,1.1 Transepithelial electrical resistance measurements (TEER)
Caco-2 cells grown on polycarbonate membranes of the Trans well inserts 
demonstrated a gradual increase in TEER values (Fig.40). Electrical 
resistance across the collagen-coated, polycarbonate membranes without 
cells ranged from 35-49 Q.cm^. Tests on uncoated membranes indicated 
that the electrical resistance due to the collagen layer was only 6-8 Q.cm^. 
For the first four days after seeding the cells to the polycarbonate 
membranes, the TEER values of the cell monolayers were only slightly 
higher than the background, about 80 O.cm^. The values staited to increase 
on the fifth day with a gradual increase and reaching maximum at day 16 
(251.2 n.cm^) and remained almost constant until day 20 .
With INT 407 cells, observations under the light microscope showed a good 
monolayer was formed by day 7. However, the TEER values did not show 
any increase and in fact, they were only slightly higher than the background 
values (78.1 Q.cm^) (Fig. 40).
The TEER values of the monolayers were also measured before and after 
every tiansport experiment. These values were found to be unchanged after 
the expeiiment, suggesting that the monolayers remained intact during and 
after the experiment.
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Fig. 40 : T ransepithelial electrical resistance values o f cell
m onolayers cultured in  Trans well bicam eral chambers. Each point 
represents a m ean o f at least 4 inserts.
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3,4,1,2 Diffusion o f  phenol red across the cell monolayers
Passage of phenol red already present in the culture medium from the upper 
compartment to the lower one, filled during the assay with phenol red-free 
medium was used as another simple and non destructive test to determine 
the confluency of the cell monolayers. Diffusion of phenol red through 
Caco-2 cells is shown in Fig. 41. After two days of culturing in the 
Transwell inserts, transport of phenol red was about 15.4 %. This value 
was close to that of background i.e. in the absence of cells (17.1 ±1 %; 
n=5). The diffusion of the phenol red gradually decreased, reaching a 
minimum from day 15 onwards.
Percent diffusion of phenol red across INT 407 cell monolayer (Fig. 41) 
showed a rapid decrease from the initial 14.8 ± 0.5 % at day 2 to 6.9 ± 0.2% 
at day 7.The decrease in percent diffusion was faster for INT 407 than for 
Caco-2 cells, indicating that INT 407 monolayers were formed earlier. 
From day 7, the amount of phenol red excluded changed only slightly and 
remained low until day 17 and onwaids.
3.4,13 Electron microscopy o f Caco-2 cells
The degree of moiphologic differentiation of Caco-2 cells with the 
expression of microvilli and tight junctions and the ability of the cells to 
form complete monolayers on collagen coated, polycarbonate membrane 
were assessed by examining the cell morphology after day 17. Figures 42 
and 43 show representative pictures of Caco-2 cells after 17 days of 
culture in the Transwell inserts and on the same day the transport studies 
were carried out. The cells demonstrated highly polarised structure with
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Fig. 41 : Passage of phenol red across the cell monolayers cultured in 
the Transwell bicameral chambers. Each point represents a mean of at 
least three determinations.
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Fig. 42: A transmission electron micograph of Caco-2 cells which had been 
cultured in a Transwell insert for 17 days: magnification x 89000. (M, 
microvilli; JC, junctional complex; N, nucleus).
164
Fig. 43: A higher magnification of the same cell showing clearly
enterocytic-like differentiation features which include microvilli (M), 
terminal web (T), junctional complex (JC) and interdigitation (I), x and 
RER refer to mitochondria and rough endoplasmic reticulum.
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abundant microvilli in the apical surface, well developed tight junctions and 
the presence of desmosomes.
3,4J ,4  Transport o f Iron Across Caco~2 Monolayers
Figure 44 demonstiated that the transport of ferric ii'on across Caco-2 
monolayers to the lower compartment increased with time. There was a 
large increment in the amount of iron transported from lactoferrin and 
citrate but an insignificant increase from transfenin from 1 h to 23 h of 
incubation. The amount of iron transported was highest from lactoferrin 
whereas transport of transfenin-bound iron was almost undetectable. In 
contrast to these results, there tended to be greater amount of iron retained 
by the cells when the metal was initially bound to transfenin rather than to 
lactoferrin, although the greatest retention occuned with ferric citrate 
(Table VII).
3,4,1,5 Transport o f Lactoferrin and Transferrin Across Caco-2 
monolayers
The passage of lactofenin and transfenin across Caco-2 monolayers to the 
lower compartment demonstrated that the transport of both proteins, like 
fenic iron, increased with time, but the amount of transfenin transported 
was slightly more than lactoferrin at the end of 23 h incubation (Table 
VIII). However, about 80 % of the proteins that had been transported to the 
lower compartment was in a low molecular weight form, suggesting that 
there was very little transport of intact lactofenin or transferrin across the 
monolayer as determined by trichloroacetic acid precipitation and SDS- 
PAGE (Fig.45).
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Fig. 44 : T ransport o f iron across the Caco-2 cell m onolayers grown 
in  the Trans well bicam eral cham bers (n = 2).
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TABLE VII
Iron uptake by Caco-2 and INT 407 cell 
cultured in bicameral chambers
Iron uptake from 50pg/ml of 80% satuiated Fe-transferrin, Fe- 
lactofenin, or an equivalent amount of Fe-citrate determined after 
23h culture in bicameral chambers
% of added Fe incorporated by
S OUI ce of iron: Caco-2 INT 407
Fe-citiate 8.7+1.4 9.8+1.5
Fe-lactoferrin 2 .6+ 1.0 1 .4+0.8
Fe-transferrin 3.6+0.8 2.9+1.0
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TABLE VIII
Transport o f lactoferrin and transferrin across Caco-2 and INT  
407 cellmonolayers cultured in bicameral chambers
% of radioactivity detected in the lower chamber
Incubation
time(h)
125I-Lf 125I-Tf
Caco-2 INT 407 Caco-2 INT 407
1 . 0.3+0.03 6.3+0.12 0.4+0.03 4.8+0.12
5 1.1+0.08 12.2+0.83 1.4+0.09 10.3+0.98
23 3.5+0.10 42.1+0.5 4.5+0.11 35.4+3.4
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8 9 10
Fig. 45: A utoradiograph of culture supernatant of Caco-2 cells from both 
the upper and lower chambers containing ^^^I-labelled proteins. Lanes are 
referred to as follows: (1) Lf in the upper chamber after 23 h incubation 
(2) Lf in the lower chamber at 3 h (3) Lf in the lower chamber at 5 h (4) 
Lf in the lower chamber after 23 h (5) Lf solution used in the study. Lanes 
6-10 refer to labelled transferrin corresponding to lactoferrin in lanes 1-5 
respectively.
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The amount of lactofenin and transfenin found in the upper compartment 
was similar, about 95 % of the total proteins initially added. In contrast to 
the proteins found in the lower compartment, more than 97 % of these 
proteins were still intact (Fig.45).
More lactoferrin (1.7 %) remained bound to the cells at the end of 
incubation as compared to tr ansferrin (0.4%).
3.4.1.6 Transport o f  Lactoferrin and Transferrin Across INT 407 Cell 
Monolayers
The TEER values of INT 407 cells grown in the Transwell inserts had been 
found to be low and did not increase like Caco-2 cells, even though the 
percentage of phenol red diffusion to the lower compai'tment was < 5 %, 
suggesting confluency. Thus a parallel study was conducted to see the 
pattern of transport of lactoferrin and transfenin across these cells. As 
shown in Table VIII, the transport of both proteins increased with time 
and by 23 h, about 42 % and 35 % of lactofenin and transferrin were found 
in the lower compartment. In contrast to Caco-2, these proteins were found 
mainly intact (62.6 % and 76.3 %, respectively).
3.4.1.7 Transport o f Iron Across INT 407 Cell Monolayers
Just as more protein was tr ansported across INT 407 cells than Caco-2 cell 
monolayers, a higher percentage of iron was also found to be transported to 
the lower compartment. More iron was transported as Fe-citrate and Fe- 
lactofenin than as Fe-transfenin (Fig.46). As in the case of Caco-2 cells, 
the amount of non retained by INT 407 cells was higher when iron was
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Fig. 46 : T ransport of iron across IN T 407 cell m onolayers cultured in 
Transw ell bicam eral cham bers (n = 2).
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initially bound to transferrin as compared to lactofeiiin, the difference was 
double (Table VII)
3.4,2 Plasma Lactoferrin Levels in the Newborn
3.4.2 J  Detection Range
The assay used was found to be lineai up to 200 ng/ml lactofemn. Above 
this concentration, the graph started to form a plateau. The lower detection 
limit i.e. the lowest cencentration of lactoferrin used in the calibration assay 
was 6.1 ng/ml, which was found to be 1.5 x the value of the background. 
The standard curve for lactofemn in this assay is shown in Fig,47.
3.4.2.2 Accuracy o f the Assay
The percentage recovery of added lactoferrin to rabbit plasma was found to 
be more than 94 % at lactofemn concentiations between 50-200 ng/ml.
3.4.2.3 Specificity o f  the Assay
Cross reactivity of the rabbit-anti human lactofemn antibody against bovine 
lactofemn and human laetofenin was found to be less than 8 % and 7 % 
respectively. ^
3.4.2.4 Concentration ofAnti~lactoferrin Antibody
The concentiation of anti-lactoferrin antibody which gave the steepest 
dilution curve (Fig. 48) was chosen to coat the polystyrene beads.
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Fig. 47 : A standard curve for lactoferrin using ELISA
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Fig. 48 : Determination of optimal concentration of anti-human
lactoferrin antibody for coating the polystyrene beads (n = 3).
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The concentration of the antibody was 5 \ig/ra[ which showed linearity up 
to 200 ng/ml lactofemn. Lower concentrations were not sufficient to coat 
the polystyrene beads whereas at higher concentrations of antibody, the 
graph reached a plateau at the same lactoferrin concentration (5 pg/ml).
3.4.2.S Choice o f Blocking Agent
Two percent myoglobin was chosen as a blocking agent as this resulted in a 
considerable reduction of blank values compared to the other blockers 
(Fig.49).
3.4.2.6 Concentration o f Enzyme Conjugate
The dilution of enzyme conjugate chosen for the assay was 1:400. Further 
dilution had resulted in insufficient of /?-nitrophenylate being produced, 
whereas a lower dilution was not found to increase sensitivity but to raise 
the value of blank absorbance (Fig.50).
3.4.2.7 Assay conditions
Coating the polystyrene beads with the antibody at 37 C for 1 h and then 
overnight at 4 “C was found to be satisfactory and the results obtained were 
identical to those with beads coated at 45 “C for 2 h. Incubation with anti- 
lactofenin enzyme conjugate for 1.5 h at 37 ^C was found to be optimal. 
The enzymic reaction to produce a coloured product giving a maximum 
absorbance of 1.5 took about 30 min. Longer reaction resulted in maximum 
absorbance approching 2.0 and less sensitivity to variation in lactoferrin 
concentration.
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Fig, 49 : Determination of different types and concentration of
blocking agents used for ELISA (n = 3).
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Fig. 50 : Titration of anti-human lactoferrin antibody alkaline
phosphatase conjugate used for ELISA (n = 3)
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3A.2,8 Background information on the infants
For the study of plasma lactofemn in the newborn, 15 venous blood 
specimens were obtained from Caucasian babies born at 37 weeks 
gestation or over with normal delivery. Their birthweights were greater 
than 2.2 kg. The babies were healthy with no clinical signs of infection. 
The blood specimens were taken between 48-72 h after delivery. The 
infants were divided into two groups, the first group (n=7) consisting of 
babies who were exclusively breast-fed, and the second group (n=8) was 
made up of babies who received standard stage 1 infant formulas: SMA 
Gold Cap (Wyeth Ltd., U.K.), Cowgate Milk (Cow Milk Ltd., U.K.), and 
Oster Milk (Farleys Ltd., U.K.) which were provided by the Hospital.
3.4,2,8 Plasma lactoferrin levels in full-term breast-fed versus 
formula-fed infants
The range of plasma lactoferrin levels measured in the combined group of 
full-term infants was found to between 100 and 336 ng/ml with a mean 
value of 178 ± 46.6 ng/ml, corresponding to 2.1 nM.
The effect of feeding regime on the plasma lactoferrin levels of these infants 
is shown in Fig. 51. Plasma lactoferrin levels of breast fed infants were 
found to be between 136-336 ng/ml, with a mean of 191.9 ± 46.4 ng/ml. 
Infants fed with commercial formulas had plasma lactoferrin level in the 
range of 100-216 ng/ml, and a mean of 155.4 ±30.0 ng/ml. Even though the 
mean plasma lactoferrin level of breast fed infants was higher than that of 
formula fed infants, a t-test showed no significant difference between the 
means of the two groups (p < 0.05)
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Fig. 51 : Plasm a concentration o f fifteen full term  newly born
infants, exclusively breast-fed or formula-fed. Each point is a 
mean of duplicate determ inations.
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3.5 DISCUSSION
3,5.1 Iron and Protein Transport studies
The human colon caicinoma cell line, Caco-2 grown on collagen coated 
polycarbonate membranes mounted in Transwell bicameral chambers was 
found to exhibit structural and functional differentiation features normally 
associated with the characteristics of mature enterocytes as have been 
reported by earlier workers (Pinto et a l,  1983, Grasset et a l ,  1984, Hidalgo 
et a l ,  1989; Alvarez-Hemandez et a l, 1991). The Caco-2 cell monolayers 
were seen from transmission electron micrograph to be covered by brush 
border microvilli. The stiuctural and functional differentiation of the brush 
border microvilli is associated with polarisation of the epithelial 
monolayers as displayed by the presence of tight junctions and the 
appearance of desmosomes which are known to be specific features of 
polarised epithelia (Cereijido, 1978).
The electron micrographs of these cells were taken on day 17 after seeding 
on to the polycarbonate membranes, when they have already become 
columnar in shape. Therefore changes in cell dimensions and formation of 
these features during the earlier stages of culture were not examined. 
However, Hidalgo et a l (1989) had reported that the height of the cell had 
increased as much as 489 % from day 3 to day 16. The microvilli started to 
appear on day 3 but were poorly organised.
The development of polarity of the Caco-2 monolayers was determined 
from measurements of TEER across the monolayers. The TEER values of
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day 1 to post confluence obtained in this study were similar' to those 
observed by Alvai'ez-Hernandez (1991) but slightly higher than the values 
obtained by Hidalgo (1989) at day 8 which then remained almost constant 
up to day 18. The TEER values increased above 250 on day 16
suggesting that Caco-2 monolayers had then formed a tight bai'rier. The 
tightness of the bai'rier was further confirmed by the impermeability of the 
cells to phenol red. The minimum percentage of phenol red diffusion 
obtained was 5.8 ± 0.4 % from day 14. Halleux and Schneider (1991) 
obtained the minimum percentage of phenol red diffusion as 6 % after day 7 
of cultivation, suggesting that confluency was reached a few days earlier. 
The use of different passages of cells plus a different type of membrane 
could contribute to the slight difference.
Unlike Caco-2 cells, INT 407 cells did not differentiate in culture after 
cultivation of more than 20 days. Results from phenol red exclusion 
indicate that these cells formed a complete monolayer, in fact the minimum 
percentage of phenol red diffusion (6.9 ± 0.2 %) was reached after only 7 
days in culture. However TEER values across these cells did not increase 
and never reached more than 90.5 ± 0.3 O.cm^. Therefore, although on the 
one hand INT 407 cells could be cultured on the polycarbonate membrane 
and could form a monolayer, the cells did not differentiate as Caco-2. The 
finding is not totally unexpected because attempts to either culture 
intestinal epithelial cells or establish cell lines derived from enterocytes 
have not been successful (Qudroni et a l  1979; Raul et a l ,  1978). Similar' 
results were obtained by Chantret et a/.(1988) when using various colon 
carcinoma cell lines and most of these cells do not develop enterocytic 
differentiation in culture, with the exception of a few cell lines, including 
Caco-2 cells.
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Having established that Caco-2 cultured in the Trans well inserts had 
undergone enterocytic differentiation, they were then used as a model of 
enterocytes to study the transport of iron and proteins (lactoferrin and 
tiansfeiTin) across the brush border into the cell as well as across the cell. 
Undifferentiated INT 407 cells were used as a control. Since INT 407 cells 
also formed good monolayers, the difference in the pattern of transport 
could be attributed to special features of differentiated Caco-2 cells.
Transport of lactofemn and transfenin across Caco-2 monolayers is similar, 
with only 4 % of the proteins being tr ansported within 24 h. The rermning 
proteins were found in the upper compartment with only a small percentage 
of transfenin (0.5 %) and lactofenin (1.7 %) being retained by the cells and 
the membrane. Even though only one-third of transferrin was bound by the 
cells as compared to lactoferrin, more non was incorporated into the cells 
when it was initially bound to transfenin.
Most of the ^^ I^ activity that have been detected in the lower compartment 
was TCA soluble, indicating that these proteins had been degraded and 
only < 20 % of the protein was still intact. With the present set up, it is not 
known exactly where protein degradation has taken place, either in the 
cytosol or as the proteins cross over the basal membrane. In contrast almost 
half of the proteins were found to have been tiansported 
across INT 407 cells. At the end of 23 h, about 42 % of lactoferrin and 49 
% of transferrin was detected in the lower compartments and unlike the 
eariier finding with Caco-2 cells, only 43 % and 37 % of these proteins 
were degraded. These findings suggest that neither lactoferrin nor 
transfenin was transported across Caco-2 cell monolayers and the passage
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of these proteins across INT 407 cells could occur through intercellular 
spaces rather than tianscellulaiiy.
Transport of lactofemn bound iron by Caco-2 cells was comparable to 
transport of iron presented as fem e citrate, and greater than that of iron 
transported from transferrin. If iron transport across the cells, rather than 
release from lactofeiTin is the rate-limiting step, th#i Fe-lactofenin and 
ferric citrate would be expected to behave similarly. In contrast, since 
Caco-2 cells express transferrin receptors (Schreider and Halleux, 1991), 
iron bound to transferrin may be taken up by endocytosis of the transferrin- 
iron complex and used for cell metabolism. The fact that rather more iron 
from transferrin than from lactoferrin was found within the cells, despite the 
minimal transport of transferrin-ii*on across the monolayer, tends to support 
this hypothesis, though proof would require examination of the intracellular 
distribution of iron. As there was little evidence that either lactofenin or 
transfenin themselves are transported across the cell monolayers, this 
suggests that iron from lactoferrin detected across the monolayer was due to 
the release of this iron from membrane bound lactofenin and not due to it 
being transported by the protein itself. If this is tme, then iron from 
lactofenin or citiate would be expected to behave similarly and being taken 
up by the cell following the same route.
These findings are in line with the in vivo study of iron absorption from 
^^Fe-labelled bovine lactofemn in newly born infants which did not 
demonstrate any difference from the absorption of ferrous chloride 
(Fairweather-Tait et a l ,  1987). These workers concluded that lactofeiTin- 
bound iron was handled by the body in exactly the same way as other non- 
haem dietary iron. In addition other in vivo studies show that lactofemn
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neither inhibits nor enhances absorption of inorganic iron (Fransson et a l , 
1983; Davidson et a l , 1990).
3.5.2 Plasma Lactoferrin levels in newborn infants
Further work to see the relevance of lactofemn in non absorption was to 
determine its presence in the plasma of newborn infants. In general it is 
thought that lactofenin is not absorbed, but recent studies in preterm infants 
have demonstrated the presence of lactofenin derived from maternal milk in 
the urine, suggesting in this case that lactofenin can be absorbed. It is not 
known whether similar events occur in term infants, but it has been shown 
that premature infants absorb large amounts of intact macromolecules from 
milk into their plasma (Jakobsson et a l ,  1986).
For this purpose, the non-competitive sandwich ELISA was used to 
determine the plasma lactofenin levels in newborn infants, based on the 
combination of the methods devised by Figarella (1986) and later modified 
by Scott (1989). Polystyrene beads were used as the solid phase instead of 
the microtitre plates in order to reduce the high background readings due to 
non-specific binding of lactoferrin to the sides of the plates. Other steps 
were also taken to counter this problem such as tiansfening the polystyrene 
beads to fresh polystyrene test tubes before the enzymic reaction. Use of 2 
% myoglobin as a blocking agent further reduced the blank values when 
compared to rabbit serum (10 %), which was used in Figarella's method.
The concentration of plasma lactofemn detected by ELISA in this study 
ranged from 6.1 to 200 ng/ml. Considering the small amount of blood 
sample that can be obtained from the infants, this range of concentration is
185
suitable for the detection of plasma lactofenin with some dilution of the 
plasma. Within this range of concentration, the percentage recovery of 
lactofemn from the plasma is > 94 %
Plasma lactofemn levels of all the full term infants tested in this study were 
between 100-336 ng/ml with a mean value of 170.8 ± 46.6 ng/ml, 
corresponding to 2.1 nM. The range of plasma lactoferrin level found in 
this study was comparable to that found by Kolsto Otnaess et a l  (1983) 
who reported that lactofeiTin levels in cord plasma ranged between 20-300 
ng/ml. They also found that the values in cord plasma were identical to 
those in the plasma taken from day 5 post paitum. Scott (1989) on the other 
hand reported higher mean value of plasma lactofenin in term infants up to 
the age of 21 days (385 + 113 ng/ml). However in this case, capillary blood 
was taken instead of venous sampling which had been shown to give higher 
lactofemn concentiation (Maacks et a l ,  1990) as the capillary sampling 
technique could have resulted in neutrophil activation and release of 
lactofemn. In this study extieme care had been taken to ensure that 
degranulation of neutrophils had been kept to a minimum.
Plasma lactofenin levels of infants found in this study were higher than the 
levels in adults which had been reported by many workers. Figarella 
(1986), reported mean adult value of 113 ± 20 ng/ml, with a range of 30- 
240 ng/ml. Scott (1989) using similar* procedure as Figarella, but using 
venous sampling instead of capillary sampling as in the infants reported a 
similar mean adult value of 122 ± 40 ng/ml, with a range of 42-202 ng/ml. 
Kolsto Otnaess et a l  (1983) also reported a slightly higher values in infants 
plasma but they were not significantly different from the adult values (20- 
200 ng/ml).
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As the breast-fed infants consume much higher levels of lactofemn than 
formula-fed infants, a comparison was made between plasma lactofenin 
levels of these two groups. The plasma lactofenin levels of exclusively 
breast-fed infants were found to be higher (191 ± 46.8 ng/ml) than the 
formula fed infants (155 ± 30 0 ng/ml). However t-test showed no 
significant difference between the mean values of the two groups. Despite 
the higher concentration of lactoferrin in human milk than in cow's milk and 
therefore cow's milk based feeding formulas, this study and that of Scott
(1989) were unable to demonstrate that this difference has any effect on 
plasma lactofemn levels in the newborn. This suggests that in term 
newborn infants, lactofenin despite its high concentration in breast milk and 
its resistance to proteolytic degradation is not absorbed by the intestinal 
cells. On the other hand, studies in preterm infants have shown that 
molecular* forms of lactofenin have been detected in the stool and urine of 
those infants who were breast-fed (Goldman et a l, 1990; Hutchens et a l, 
1991). However the development of gastrointestinal tract and renal 
tubular function in preterm infants is not well characterised, and therefore it 
is not known whether there is an increased permeability of lactoferrin in this 
case.
In conclusion the present work seems to indicate that lactoferrin does not 
enhance the absorption of iron nor it itself being absorbed by the intestinal 
cells of healthy newly born term infants. This observation could be 
explained on the present understanding that in the early period of infancy, at 
least up to 6 months, they have sufficient endogenous iron to meet their 
requirements (Aggett et a l ,  1989). This is reflected in the low incidence of 
anaemia among healthy full term infants irrespective of whether they are 
breast-fed or fed with iron supplemented or unsupplemented formulas
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(Wharton, 1989). Iron absorption is known to be lower in the early 
postnatal period than at any later time in childhood, and the amount and 
bioavailability of dietary iron aie therefore less important before 4 months 
of age (Cook and Both well, 1984). The findings of Kolsto Otnaess et a l
(1983) that lactofemn levels in the cord plasma of healthy full term infants 
were the same as the levels after 5 days post paitum supports this view.
In contiast preterm infants have less total body iion than term infants since 
premature birth intenupts iron acquisition from the mother during the 
period of maximal iron absorption by the fetus. Despite the lower total 
body iron pool, transfenin saturation of 100 % often occur due to low level 
of transferrin (Sullivan, 1992). This puts the premature infants at risk of 
oxygen radical injury and the absorption of lactofemn from maternal milk 
(Hutchens et a l ,  1991) may be a strategy for combating this problem. Thus 
absorbed apolactofenin may be a partial explanation for the reported lower 
incidence of retinopathy of prematurity in prematurity in breast-fed infants 
(Cunningham, 1987).
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CHAPTER FOUR
GENERAL DISCUSSION AND 
FUTURE PERSPECTIVES
The work reported in this thesis has attempted to examine the possible roles 
of lactofemn in cellular ii'on uptake and non absorption. For this purpose, 
the molecular basis of the interaction of lactofenin with a monocytic and an 
enterocyte-like differentiated colon carcinoma cell line has been studied.
Cellular* uptake of ir on may occur by various routes but the most studied 
and best characterised mechanism is that of uptake from transfenin which 
occurs via receptor mediated endocytosis (Dautry-Varsat, 1986; Crichton 
and Charloteaux-Wauters, 1987; Theil and Aisen, 1987). The present work 
has shown that transfenin can indeed deliver its iron, most probably via a 
similar pathway to U937 cells. Lactofenin on the other hand does not seem 
to donate its iron despite its ability to bind to these cells. This finding 
appears to contradict that of Van Snick et a l  (1974; 1976) who reported 
some uptake of iron from lactofenin by peritoneal macrophages. The group 
used this observation as a basis for explaining the hypoferraemia associated 
with inflammation. They proposed that the rapid drop of serum iron 
accompanying acute inflammation results from the release of unsaturated 
lactofenin from stimulated neutrophils into the extracellular environment. 
Lactoferrin that is released removes ir on from transferrin or it competes 
with transfenin for the iron released by the macrophages. It then returns 
this iron to the macrophages of the reticuloendothelial system, where it 
becomes incorporated into iron stores. Although a transfer of iron from 
transfenin to lactofemn is favoured thermodynamically the kinetics of iron 
exchange from transferrin at physiological pH are very slow (Morgan, 
1977) and this coupled with the rapid elimination of lactofei*rin by the liver 
(Moguilevsky et a l ,  1987); McAbee and Esebensen, 1991) suggests that 
little iron transfer actually occurs before lactofenin is cleared from the 
circulation.
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A closer look at the rates of iron uptake reported in in those studies revealed 
that they are indeed extremely slow compared to transfenin and in fact the 
iron uptake measured was actually due to the lactofenin being ingested by 
the cells (Oria et a l  1988, Ismail and Brock, 1993). Therefore it seems 
unlikely that the mechanism proposed by Van Snick et a l (1974, 1976) 
would operate at the systemic level as at this physiological pH the affinity 
for iron by transferrin is high, resulting in no movement of iron to 
lactofenin in plasma (Fletcher, 1989). Furthermore the amount of 
lactofenin-iron taken up by the reticuloendothelial system from the general 
circulation is probably too small to account for the fall in serum iron 
circulation (Kluger and Bullen, 1987). However there is a possibility that 
lactofemn might be involved in the hypofenaemia at the local inflammatory 
lesions, where the acidic condition favours the binding of "free" iron to 
lactofemn instead of transferrin, as lactofemn has a higher affinity for iron 
at this pH, but the question of slow rate of iron uptake from lactofemn still 
remains.
A more likely conclusion from the present work, and that of others seems to 
indicate that lactofemn released from neutrophils may have the following 
alternative functions and/or fate. Firstly, lactofemn may bind to monocytes 
and macrophages and in so doing may offer a protective mechanism against 
uptake of "free" iron released from tiansferrin or from the phagocytosed 
microorganisms. This protective mechanism offers a mean of reducing the 
possible involvement of "free" ii’on in the generation of potentially harmful 
hydi’oxyl radical which may cause tissue damage. This work has shown 
that lactofemn inhibited the uptake of excess non-tiansfenin bound iion in 
the form of FeNTA. The fact that this effect was found with both 
apolactofenin and Fe-lactofenin suggests that the inhibitory effect was not 
simply due to binding of all the iion by lactofemn in the medium. Rather it
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appeal's that lactofenin in some way regulates uptake of this potentially 
toxic non-transfenin bound iron at the cell membrane. Further evidence for 
such a role is provided by the ability of lactofemn to abolish the inhibitory 
effect of FeNTA on lymphocyte proliferation (Djeha and Brock, 1992b), 
and prevent membrane damage to monocytes (Britigan et a i,  1991). 
Substantial binding of lactoferrin by a relatively non-specific mechanism, as 
found in this study would allow lactofemn to perform this function not only 
with monocytes and macrophages but with a wider range of cell types.
The likely fate of the released lactoferrin is that it may be cleared rapidly 
from the ciiculation by the liver (Imber and Pizzo, 1983) with hepatocytes 
accumulating > 90% (McAbee and Esebensen, 1991; Ziere et a l  1992) and 
the remaining lactofemn being cleared by Kupffer and liver endothelial 
cells. Studies by McAbee and Esebensen (1991) have shown that hepatic 
cleai'ance of plasma lactoferrin may occur by a high-capacity, clathrin 
dependent endocytic pathway whose biochemical features resemble in every 
way a receptor-mediated process, in contiast to the present finding and that 
of Birgens et a l  (1988) which indicate that lactofemn binding to monocytes 
was not followed by endocytosis of the protein. The presence of such an 
efficient pathway in hepatocytes thus provides a continuous clearance of 
plasma lactoferrin and its iron from the circulation especially from the 
inflammatory sites where the concentrations of both lactoferrin and iron 
have increased many folds.
Others have evidence that hypofenaemia is due not to an accelerated 
removal of iron from the serum tiansfeirin pool but rather to an altered 
processing of iron within the reticuloendothelial system which limits the 
supply of ii’on to the extracellular iron pool (Letendre and Holbein, 1983). 
Konijin and Hershko (1977) put forth the idea that hypoferraemia results
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from surplus apofenitin synthesis which binds a lai’ger-than-normal 
proportion of iron entering the cell. Enhanced fenitin synthesis in response 
to inflammation precedes the block of iron release and is not simply the 
result of increased tissue iron concentiations (Cartwright and Lee, 1971).
There are many aspects of this work that still need to be examined and 
expanded. This study has shown that human lactofenin binds to two 
populationsof sites on U937 cells: a relatively small number of high affinity 
receptor binding sites and a large number of low affinity binding sites 
which constitute the non-specific binding. Although the binding seems 
complex, investigating the nature of the specific binding is crucial in 
understanding its involvement in regulating cell functions. For this 
purpose, the specific receptor has to be identified, isolated and 
characterised. Receptor isolation might provide the basis for generation of 
monoclonal anti-receptor antibodies, which would be an extremely valuable 
tool for these functional studies. The role of lactofenin in hypofenaemia is 
still unsettled especially at the systemic level for the reasons mentioned 
earlier and also because the lactofemn hypothesis does not provide a good 
explanation for the defective iron metabolism in intestinal cells and 
hepatocytes. It is not known how neutrophilic lactofemn is involved in the 
reduction of iion absorption and iron réutilisation from hepatocytes, both of 
which are associated with hypofenaemia. In vivo study involving animals 
lacking in specific granules in their neutrophils may help enlighten the 
problem. If lactofemn is an essential element in hypofenaemia, such 
animals should not develop the usual disturbances in iron metabolism.
The present work has also attempted to determine the possible involvement 
of lactofemn in iron absorption. Although lactoferrin receptors have been 
identified in the mucosal membranes (Davidson and Lonnerdal, 1988; Hu et
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a l, 1990) there is still no dii'ect evidence that these membrane proteins
05
actually mediate uptake or transport^the lactofenin-bound iron across the 
mucosa. This work using Caco-2 cells which can undergo enterocyte-like 
differentiation in culture has shown that lactofemn does not enhance the 
absorption of iron nor it itself being transported tianscellulaiiy. In fact the 
small amount of iron taken up might follow the same route as other non- 
haem iron such as ferric citrate. This observation is further supported by an 
in vivo study which shows that plasma lactoferrin levels of breast-fed 
infants are not significantly different from those who were foimula fed, 
despite the higher amount of lactofemn in breast milk. These findings are 
consistent with the idea that lactoferrin may serve as a regulator rather 
than as an enhancer of iron absorption as proposed by Brock (1980). This 
may be true especially during the early period of infancy when there is an 
adequate level of iron stores. Later in infancy, when the iron stores have 
been depleted and the proteolytic activity of the infant’s gut is increased, 
lactofenin can be degraded and the bound iion can be released and hence be 
absorbed. The presence of lactofemn binding molecules in the brush 
border membrane might aid in this regulating activity. The advantage of 
such a mechanism might be a protection against the toxic effects of excess 
iron as in the case of monocytes mentioned eailier.
If lactofemn does aid in regulating the uptalce of iion by the enterocyte, 
more work is needed to understand the regulatory mechanism and factors 
that ate involved in either promoting or inhibiting the uptake of the 
lactofenin-bound hon. Since studies have repeatedly shown that iron 
absorption is inversely proportional to the body's iron stores (reviewed by 
Coniad, 1987), information regarding the state of hon repletion of the body 
must be communicated to the enterocyte which must then be able to process 
dietary iron absorption. The precise means by which these two aspects of
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intestinal non metabolism are intenelated aie also not known. The present 
work could be expanded to study some of these uncertainties. Caco-2 cells 
which have been considered by many workers as a good in vitro model for 
the iron transport system can be employed to follow the uptake of 
lactofenin-bound iron at various levels of iion stores of the cells. The in 
vivo study on plasma lactofemn between breast-fed and formula-fed infants 
could be extended to cover a larger sample in order to obtain a more 
confident statistical analysis. A longitudinal study to measure both plasma 
lactofemn and iion status of these infants would be desirable. In addition 
the effect of lactofenin-supplemented formulae on these aspects could also 
be studied.
Lactofenin in milk plays a role in stimulating tissue growth and 
development, but the growth promoting effect of lactofenin has been found 
to be somewhat different from the iron donating effect of transfenin. The 
mechanism of this growth enhancement is not known and more research 
along this line is needed.
Last but not least, in view of the functional properties of lactofenin, 
especially its protective effects, it would be beneficial to supplement cow's 
milk based infant formula with lactofenin. To do this more feasibility 
studies of adding lactofenin in a biologically active form are needed.
In conclusion this work has shown that lactoferrin-cell interactions either 
with monocytic or enterocyte-like cell lines, may serve to regulate rather 
than facilitate iron uptake by these cells. Two properties of lactofenin, 
namely its ability to bind iron extremely tightly even at low pH, and its 
readiness to bind to a vaiiety of cells and other molecules, in most cases in a 
relatively non-specific manner may be critical to its functions. The first
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property would allow lactofemn to sequester any "free" iron in situations or 
locations where low pH predominates and cause ti’ansfeiiin to lose its iron 
such as the upper gastrointestinal tract or in the inflammatory lesions. The 
ability of lactofenin to bind to a wide range of cells and tissues could focus 
this protective effecty on to cell surfaces, and hence protect them against 
membrane lipid peroxidation and excessive uptake of non-transfenin bound 
iron which can be taken up very rapidly and could be cytotoxic.
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